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Abstract 
Neurodegenerative diseases have become an increasing problem in our aging 
society. Many studies have addressed these complex diseases in the recent years. 
Scientists have learned a lot about specific proteins, their regulation and roles in 
diseases, yet there are still many unanswered questions in this area. As the 
knowledge increases, it has become apparent that these diseases affect more than 
one protein and that entire processes are dysregulated or dysfunctional, leading to 
similar but often non-identical symptoms in patients of different neurodegenerative 
diseases. Emerging evidence is accumulating that while the proteins involved in these 
diseases are diverse, many of them ultimately disrupt basic cellular processes in 
neurons. It is therefore not surprising that recent reports have shown that impairments 
of endocytosis or autophagy, two processes involved in maintaining proteostasis in 
synapses, can lead to neurodegeneration. 
This thesis was designed to shed light on questions of if and how the family of 
endophilin-As, key proteins in synaptic endocytosis, is involved in neurodegeneration. 
Taking advantage of the complex endophilin mouse model, this thesis shows that 
endophilin mutants have progressive motor impairments depending on the number of 
deleted endophilin alleles and the animal age. The motor deficits are prominently 
detected in the Rotarod test which requires motor coordination and in the overall 
running ability on a motorized treadmill and subtly found in gait analysis or general 
muscle strength. 
Furthermore, data presented here also reveal signs of neurodegeneration in mouse 
models for endophilin deficiency. The evidence points to a mild form of 
neurodegeneration that is found in the hippocampus, cortex and cerebellum. These 
findings include an increase in apoptotic and necrotic cells in brain sections from 
different endophilin mutants and a strong gliosis in endophilin 1,2-DKO mice.  
Unexpectedly, data reported in this thesis, complemented by additional data 
produced in the laboratory, indicate that endophilin has a previously unknown role in 
autophagy in addition to its well-described role in endocytosis. Most prominently, an 
E3 ubiquitin ligase, Fbxo32, is robustly up-regulated in various endophilin mutants. 
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Fbxo32 has previously been suggested to act as a mediator between the ubiquitin-
proteasome system and autophagy. Congruously, endophilin mutants are overloaded 
with poly-ubiquitinated proteins that are marked for degradation through the UPS and 
have decreased levels of Atg5, a protein involved in the formation of the 
autophagophore. However, because of this double role of endophilin, it is challenging 
to discriminate between the impact of endocytosis and autophagy impairments on the 
systemic level. 
In order to answer this question, two additional mouse models for defective 
endocytosis, synaptojanin-1 and dynamin 1,3 deficient mice, were also tested for 
motor impairments and the regulation of autophagy markers. In this study, no motor 
impairments were discovered in aged synaptojanin-1 deficient mice and only mild 
motor deficits in dynamin mutants. In addition, the amount of poly-ubiquitinated 
proteins and Atg5 were unchanged in synaptojanin and dynamin deficient mice. 
To elucidate how defective autophagy and endocytosis impact motor behavior in the 
endophilin mouse model, this thesis attempted to normalize altered proteostasis in 
the endophilin mutants by genetically reducing the levels of Fbxo32. In fact, motor 
deficits were ameliorated in endophilin mutants who are also heterozygous for 
Fbxo32. Taken together, this work sheds light on endophilin’s role in endocytosis and 
autophagy and the increasing importance of protein homeostasis on neuronal 
survival. 
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1. Introduction 
1.1. The central nervous system and neurodegenerative diseases 
 
The central nervous system (CNS) consists of the brain and the spinal cord and acts 
as the control unit of the body. It is characterized by a complex interplay between 
different types of cells that orchestrate the flow of information in our brains and 
enables us to interact with our environment. The CNS integrates information from the 
body and its surroundings, processes them and triggers an appropriate response. 
Thus, it regulates basic body functions such as body temperature and breathing but 
it also makes it possible for us to have abstract thoughts, to understand the world 
around us and to learn from previous experience. Evolutionary speaking, the 
continuous development of the CNS in mammals, especially primates, has enabled 
us to orient ourselves in the world, have complex social interactions with each other 
and even engage in studies of nature, physics or medicine. 
The processing of information needed for such complicated actions is achieved 
through a combination of chemical and electrical signaling in the CNS with the help 
of cells that were optimized for this task, neurons. They consist of a cell soma and an 
axon (Figure 1). Sensory neurons react to outside stimuli, for example tactile stimuli 
in hair cells or chemical stimuli in the olfactory bulb. These stimuli induce an electrical 
impulse, an action potential, which starts at the soma and is transferred along the 
axon until it reaches specialized compartments, the synapses. A synapse is the 
connection point between two neurons or between a neuron and a sensory or motor 
cell. Synapses consist of a pre-synaptic side, a cleft and a post-synaptic side. On the 
pre-synaptic side, the electrical signal triggers voltage-gated channels to open which 
causes a calcium influx in the synapse and thereby the release of chemical 
components, the neurotransmitters. These transmitters pass the synaptic cleft and 
bind to receptors on the post-synaptic side where they stimulate the post-synaptic 
neuron to repeat the same process or execute a specific task. Through a multiplex  




Figure 1 - Schematic representation of neuronal signal transduction. A 
stimulated neuron carries an electric signal along the insulated axon to the pre-
synaptic terminal. At the synapse (magnified in insert) neurotransmitters are released 
into the synaptic cleft and detected by receptors on the post-synaptic membrane. 
Original illustration by C. M. Rostosky. 
 
chaining of neurons, the original stimulus is transported and amplified through the 
nervous system until it triggers a response, for example a muscle contraction. 
The second major type of cells in the CNS are glia cells. While glia cells do not 
transmit nervous signals, they perform essential tasks by supporting neurons and 
acting as immune cells inside the brain. For example, astrocytes provide the neurons 
with nutrients and oxygen and they clear excess neurotransmitters form the synaptic 
cleft while microglia remove dead neurons from the CNS (reviewed in Khakh & 
Sofroniew, 2015; Nayak, Roth, & McGavern, 2014). In addition, oligodendrocytes 
provide the electrical insulation of the axons that is crucial to carrying the electrical 
signal from the soma to the synapse. Interestingly, recent studies point to an even 
more substantial role of glia cells in the development of the CNS and the regulation 
of neuronal survival (reviewed in Zuchero & Barres, 2015). 
  Introduction 
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Neurons differ in shape and the use of different neurotransmitters and receptors, 
which has a great influence on the functional output. For example, the released 
neurotransmitters can excite or inhibit the post-synaptic neuron and thereby increase 
or decrease the probability that the post-synaptic neuron will produce an action 
potential. This happens through the use of excitatory neurotransmitters (e.g. 
glutamate) or inhibitory neurotransmitters (e.g. gamma-aminobutyric acid (GABA), 
glycine). However, many neurotransmitters can be inhibitory or excitatory depending 
on the context and especially on the receptors present on the post-synaptic side (e.g. 
acetylcholine, dopamine). 
A neuron usually gets input from several surrounding neurons, both inhibitory and 
excitatory. In the soma, all inputs are integrated; only when the excitatory signal 
reaches a specific threshold, does the neuron fire an electrical signal. In mammals, 
the CNS has developed to form brain regions that function specifically to perform 
given tasks. For example, the cerebellum is the key region to control motor 
coordination, neurons in the hippocampus perform learning tasks and the cortex is 
needed for abstract thinking. The regions are constituted of different types of neurons 
and glia cells that are organized in a structure supportive to the function. The 
communication between single neurons in every region as well as between the 
regions has to be well orchestrated in order to facilitate complex brain function. 
If there are problems with this orchestration, it often causes a neurodegenerative 
disease. These diseases are defined by cell death in the CNS, primarily of neurons 
with tremendous consequences for the affected patient. The causes for 
neurodegenerative diseases are often genetic mutations, but also drug abuse or 
exposure to environmental toxins. Even though the cause, affected brain regions and 
symptoms are various among several described conditions, one common 
denominator is that the diseases develop and progress with aging. This becomes 
especially obvious in the occurrence of dementia, a characteristic of many 
neurodegenerative diseases. According to the annual health report from the German 
government 1,640 people of the age of 55-65 years were diagnosed with dementia in 
German hospitals in 2016 while at the same time 19,874 of the age 75-85 were 
diagnosed with the same condition (German health report, 
  Introduction 
6 
 
“Gesundheitsberichterstattung des Bundes”; http://www.gbe-bund.de). The life 
expectancy increases every year and with that the percentage of older citizens in our 
society, so we may expect the prevalence of dementia to rise even further in the next 
years. 
As a result, the number of studies about neurodegeneration published each year has 
doubled from 2007 (2,195 Pubmed entries) to 2017 (4,445 Pubmed entries) and much 
progress has been made in understanding the specific features of neurodegenerative 
diseases. One interesting emerging hypothesis from these studies is that problems in 
homeostasis and protein turnover could be a common cause, or at least act as a 
contributing factor, for several neurodegenerative diseases (Douglas & Dillin, 2010; 
Nixon, 2013; Liang & Sigrist, 2018). In order to maintain functional proteins, that are 
necessary to fulfill cellular tasks like synaptic transmission, proteins constantly are 
degraded and newly transcribed, translated, assembled and transported to necessary 
location. This process is called proteostasis and is difficult to maintain in synaptic 
structures because they are often located very far away from the cell soma and the 
nucleus, where messenger ribonucleic acid (mRNA) is transcribed that contains the 
information for the protein translation and assembly. According to the hypothesis, the 
long distance to the cell soma makes synapses the most vulnerable structures in the 
neuron that will therefore be the first place where defective proteostasis causes 
negative effects. Since the whole proteostasis machinery becomes less effective with 
aging (reviewed in Cuervo, et al., 2005; Martinez-Vicente, Sovak, & Cuervo, 2005), 
the occurrence of misfolded proteins will cause more and more problems as the 
system ages. When non-functional proteins accumulate in the synapses, they 
interfere with the effectiveness of the synaptic signal transduction. Once synapses 
become non-functional, they are degenerated causing the axons to retract and 
ultimately neurons to die (Burke & O'Malley, 2013). 
 
1.1.1 Synaptic morphology  
Signal transduction at the synapse occurs in specialized compartments on both sides 
of the synaptic cleft, the pre- and post-synapse. These structures ensure that the 
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signal is processed in a precise and fast manner and ultimately causes an appropriate 
response to the input information from the environment. 
The pre-synapse is a small sub-compartment that buds from the neuronal axon. It is 
filled with small membranous structures, the synaptic vesicles (SVs) which hold the 
neurotransmitters (Figure 2). When an action potential reaches the pre-synapse, 
some SVs fuse with the plasma membrane and release the neurotransmitters into the 
synaptic cleft. As a result, they chemically transmit the signal to the post-synapse, 
where they are recognized by specific receptors. For the release of the 
 
Figure 2 - Structure of a synapse. The pre-synaptic side is characterized by the 
synaptic vesicles and the electron dense active zone, the post-synaptic side 
comprises a post-synaptic density which is also electron dense. (A) Schematic 
representation of a synapse. (B) Electron microscopy image of stained synapse from 
a hippocampal neuronal culture. Scale bar 200 nm. Modified from (Südhof, 2012) and 
(Kaeser, et al., 2011). 
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neurotransmitters, SVs have to fuse with the plasma membrane in a process called 
exocytosis. This process consists of three main steps: docking, priming and fusion of 
the SVs to the plasma membrane. A number of proteins are involved in these steps. 
They are enriched in the active zone at the plasma membrane. Exocytosis occurs 
primarily at these active zones (reviewed in Südhof, 2012). The complementary 
process to exocytosis, which retrieves the excess membrane from the plasma 
membrane and forms new SVs, is called endocytosis. This process is explained in 
detail in chapter 1.2. 
The post-synaptic side is located in dendritic spines of a connected neuron. The 
spines host the post-synaptic density (PSD), the counterpart to the active zone in the 
pre-synapse. Its defining components are receptors for the neurotransmitters. Upon 
binding of the neurotransmitter to the receptors, the dendritic spine depolarizes and 
calcium enters the spine. If enough spines are depolarized in the post-synaptic neuron 
to exceed the depolarization threshold, the neuron fires an action potential (reviewed 
in Voglis & Tavernarakis, 2006). 
 
Figure 3 - 3D reconstruction of dendritic spines. (A) Dendrite from a GFP-
expressing hippocampal CA1 cell shows several dendritic spines that differ in size 
and morphology. (B) Example of a stubby spine, defined by a broad and short neck. 
(C) Example of a mushroom spine, defined by the thin neck and the big, mushroom-
shaped head. (D) Example of a thin spine, defined by an elongated neck and a thin 
head. Scale 1 µm, illustration from (McKinney, 2010). 
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A dendritic spine consists of a neck and a head (Hotulainen & Hoogenraad, 2010). 
They are morphologically classified into three types of spines: mushroom, stubby and 
thin (McKinney, 2010; see Figure 3). Importantly, the morphology of dendritic spines 
is tightly linked to the synaptic strength and is thus an important aspect for signal 
transduction. The development of high-resolution live-imaging techniques has made 
it possible to monitor the morphology of synaptic spines during long-term potentiation 
(LTP) and long-term depression (LTD). The continuous stimulation of spines by LTP 
leads to an increase in dendritic spine head size while LTD has opposite effects 
(Matsuzaki, Honkura, Ellis-Davies, & Kasai, 2004). LTP also causes the generation 
of new dendritic spines (Engert & Bonhoeffer, 1999; Fukazawa, et al., 2003; Alger & 
Teyler, 1976; Fortin, et al., 2010). Together, these studies show that spine density 
and morphology are highly plastic and seem to have functional relevance for the 
synapse (reviewed in Rochefort & Konnerth, 2012). 
The length and head size of the spines are regulated by actin filaments and actin 
regulators. Head enlargement upon LTP stimulation is mediated by the Arp2/3 
complex that causes actin branching (Hotulainen, et al., 2009). The increased size is 
important to create space for more receptors which then stabilize and strengthen the 
synapse. Head size also correlates with the number of SVs in the pre-synapse (Harris 
& Stevens, 1988; Harris & Stevens, 1989; Schikorski & Stevens, 1997). Because of 
that, mushroom spines, which have a large head, are regarded as mature spines 
while thin and stubby spines are classifies as young or dormant spines (Matsuzaki, et 
al., 2001; reviewed in Woolfrey & Srivastava, 2016). 
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1.2. Endocytosis – an essential process for maintaining synaptic 
activity 
 
In order to ensure continuous firing of neurons, the pre-synaptic compartment always 
needs to have enough SVs to release when an action potential reaches the synapse. 
The complementary process that is responsible for the replenishment of the SV pool 
is called endocytosis. It recycles the excess membrane of the fused SV from the 
plasma membrane to form new SVs that will subsequently be used for a new round 
of exocytosis. Several mechanisms how endocytosis could work have been 
hypothesized and observed in studies. These modes of endocytosis include clathrin-
mediated endocytosis (CME), ultrafast endocytosis, bulk endocytosis and kiss-and-
run and are explained in the following sections. 
 
1.2.1 Clathrin-mediated endocytosis 
The most studied and generally accepted mechanism of endocytosis in the CNS 
synapse is the clathrin-mediated endocytosis (reviewed in McPherson, Ritter, & 
Wendland, 2000-2013). The key factor for this process is the clathrin triskelion that is 
composed of three clathrin-heavy-chains and 3 clathrin-light-chains. The assembly of 
several clathrin triskelia creates a football-like structure that encapsulates membrane 
structures to form SVs (compare Figure 4 and Figure 5A). Clathrin binds to adapter 
proteins, most prominently to adaptor protein 2 (AP2) that is recruited to the plasma 
membrane by a specific phospholipid, phosphatidylinositol(4,5)bisphosphate 
(PI(4,5)P2). AP2 is also responsible to recruit transmembrane proteins (cargo) to the 
SVs: it binds to PI(4,5)P2, cargo and one arm of a clathrin triskelion, thereby initiating 
the formation of the clathrin coat. 
Upon assembly of several clathrin triskelia, the membrane starts to form clathrin-
coated pits (CCPs). The curvature of the neck of the CCP, that connects it to the 
plasma membrane, is recognized by the BIN1/amphiphysin/Rvs167p (BAR) domain 
of endophilin-A. Endophilin-A binds to the neck of the CCP and further enhances the 
membrane curvature. Endophilin-A also has a SRC Homology 3 (SH3) domain that 
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recruits other factors to the clathrin-coated structures that are involved in endocytosis 
(Cestra, et al., 1999; Verstreken, et al., 2003; Sundborger & Hinshaw, 2014). 
One such protein is the dynamin GTPase that is responsible for the fission of the SV 
from the membrane (Sundborger & Hinshaw, 2014). However, dynamin also localizes 
to CCPs in the absence of endophilin, showing that the recruitment can be 
compensated by other proteins (Milosevic, et al., 2011). It binds to the PI(4,5)P2 on 
the neck of the CCPs through its pleckstrin homology (PH) domain and uses the 
energy set free by GTP hydrolysis to provide a twisting force that cuts the neck.  
Another protein that is recruited by endophilin-A is synaptojanin-1 (Verstreken, et al., 
2003). Synaptojanin-1 is a polyphosphoinositide phosphatase (McPherson, et al., 
1996) that dephosphorylates PI(4,5)P2 and thus reduces the binding affinity of the 
adaptor proteins. The change of the lipid composition of the clathrin-coated vesicle 
(CCV) recruits the uncoating factor heat shock cognate 70 (Hsc70). This ATPase 
together with another cofactor, auxilin, releases the clathrin coat using the energy 
from ATP hydrolysis. 
In the final step of the cycle, the SVs need to mature to be functional for a new cycle 
of exocytosis. The SVs are re-filled with neurotransmitters via the cargo in the 
membrane and acidified by the vATPase (Rizzoli, 2014). 
 
Figure 4 - Clathrin mediated endocytosis. Clathrin is recruited to the plasma 
membrane and helps to form SVs. The neck of the vesicles is covered with endophilin 
molecules that tighten the neck for the fission through dynamin 1. The newly formed 
SV sheds the clathrin coat and matures to become a functional SV for a new round 
of exocytosis. Original illustration by C. M. Rostosky. 
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1.2.2 Ultrafast endocytosis 
The time estimates for CME are several seconds to 1 min and it can be argued that 
this time frame would not be sufficient to control responses to stressful situations like 
a flight-or-fight decision. Therefore, Watanabe et al. proposed a mechanism for 
endocytosis that requires 50-100 ms (Watanabe, et al., 2013). In their study, they 
stimulate hippocampal neurons with a single optogenetic stimulus, freeze the neurons 
rapidly with high pressure and study synaptic terminals by electron microscopy. They 
observed large membrane structures lateral to the fusion site that are not SVs and 
have no clathrin coat, pointing to a clathrin independent mode of endocytosis 
(compare Figure 5D). 
In a follow-up study, Watanabe et al. report evidence that the large membrane 
structure fuses with an endosome, forming a synaptic endosome that is subsequently 
resolved into clathrin-coated vesicles (Watanabe, et al., 2014; reviewed in Watanabe 
& Boucrot, 2017). Interestingly, the authors later found that endophilin and 
synaptojanin-1 play a role in this process (Watanabe, et al., 2018). The authors 
support data that the sorting of the synaptic endosome into SVs happens with the 
same mechanism as CME and within a time frame of 5-6 s. This finding would point 
to a primary role of clathrin in sorting membrane into several SVs independent on 
where the membrane originates (i.e. plasma membrane of synaptic endosome). The 
goal of clathrin-dependent vesicle formation could be to produce SVs that have the 
same characteristics (size, cargo) enabling the same output for every action potential 
that reaches the synapse. However, it remains an open question if ultrafast 
endocytosis is a general mechanism, a mechanism occurring only in a specific cell 
type or if its occurrence depends on the synaptic activity, e.g. happens only in 
synapses with a high turnover. 
 
1.2.3 Activity-dependent bulk endocytosis 
Activity-dependent bulk endocytosis (ADBE) was first described in 1984 as large 
plasma membrane invaginations following a strong stimulation (Miller & Heuser, 
1984). Since then, this mode of endocytosis has been studied further, showing that 
indeed ADBE occurs only after strong stimulation, most likely in cases where CME is 
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not able to retrieve SVs from the plasma membrane before the next round of 
exocytosis (reviewed in Clayton & Cousin, 2009). Given its activity-dependence, Wu 
et al., could successfully show that its occurrence is controlled by the calcium sensor 
calmodulin (Wu, et al., 2009). 
In ADBE, the excess membrane from the fusion of many SVs is quickly retrieved in a 
very large, endosome-like structure (bulk endosome) from which smaller SVs are later 
sorted (compare Figure 5C). The invagination of the plasma membrane is likely actin-
driven and its fission from the plasma membrane is dependent on dynamin. Similar 
to ultrafast endocytosis, the final formation of the SVs is also dependent on clathrin 
(Takei, Mundigl, Daniell, & De Camilli, 1996; Gad, Löw, Zotova, Brodin, & Shupliakov, 
1998; Andersson, Jakobsson, Löw, Shupliakov, & Brodin, 2008). 
While the ADBE has a mechanism similar to ultrafast endocytosis, there are some 
important differences: ultrafast endocytosis happens much faster than ADBE and the 
amount of internalized membrane is usually larger in ADBE. Moreover, while the 
endocytosed membrane in ultrafast endocytosis fuses with an endosome for sorting, 
the bulk endosome directly serves as the sorting station in ADBE (Watanabe & 
Boucrot, 2017). 
 
1.2.4 Kiss-and-run endocytosis 
Kiss-and-run endocytosis was hypothesized as a fast and efficient coupling of exo- 
and endocytosis. In this model, the SV does not fully fuse with the plasma membrane 
during exocytosis, but forms only a pore to the synaptic cleft. Through this pore, the 
neurotransmitters leave the SV which subsequently is pinched off again from the 
plasma membrane as an already complete SV that only needs to re-acidify and be 
filled with new neurotransmitters (compare Figure 5B).  
The existence of this process is however subject of much debate. Because of the fast 
time frame and the fact that the process is hard to distinguish from the early steps of 
fusion during exocytosis, it is difficult to prove or disprove kiss-and-run endocytosis 
(Rizzoli & Jahn, 2007). One of the strongest points in favor of the kiss-and-run 
hypothesis is the observation that endocytosis can occur faster than the time frame 
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of CME allows. However this could also be achieved through ultrafast or bulk 
endocytosis (see chapters 1.2.2 and 1.2.3) or through the existence of a “readily-
retrievable pool”, an assembly of mature SVs that can quickly be exocytosed after 
stimulation. Evidence for such a pool was presented by two groups in 2006 
(Farnández-Alfonso, Kwan, & Ryan, 2006; Wienisch & Klingauf, 2006). 
Other studies have used various forms of labeled SVs and analyzed uptake, release 
or quenching of these labels over time. One prominent study used hydrophobic (FM 
1-84 and FM 1-43) and hydrophilic styryl dyes (FM 2-10) to label SVs. The study 
reports that upon fusion with the plasma membrane, the hydrophilic dye was released 
faster from the SVs than the hydrophobic dyes. The author argued that the release 
 
 
Figure 5 - Modes of endocytosis. Graphic representation of (A) clathrin-mediated 
endocytosis, (B) kiss-and-run, (C) bulk endocytosis and (D) ultrafast endocytosis. 
Illustration from (Watanabe & Boucrot, 2017). 
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speed would be the same for both dyes if the SV would completely collapse into the 
plasma membrane (Klingauf, Kavalali, & Tsien, 1998). This observation was later 
challenged by two studies that used similar approaches but could not reproduce the 
finding (Richards, Guatimosim, & Betz, 2000; Fernández-Alfonso & Ryan, 2004; 
reviewed in Rizzoli & Jahn, 2007). 
Whether or not kiss-and-run endocytosis exists will remain controversial and can 
probably only be decided by the development of new tools that allow an even better 
spatial and temporal resolution. 
 
  
  Introduction 
16 
 
1.3. Key proteins in endocytosis 
1.3.1 Endophilin-A 
In vertebrates, the family of endophilin proteins consists of three members of the 
endophilin-A sub-family (A1, A2 and A3) and two members of the endophilin-B sub-
family (B1 and B2). Endophilin-A was discovered in 1997, endophilin-B in 2000 
(Ringstad, Nemoto, & De Camilli, 1997; Micheva, Kay, & McPherson, 1997; Huttner 
& Schmidt, 2000; Farsad, et al., 2001; Pierrat, et al., 2001). All family members 
possess an N-terminal BAR domain and a C-terminal SH3 domain and form crescent-
shaped homodimers (Modregger, Schmidt, Ritter, Huttner, & Plomann, 2003; Gallop, 
et al., 2006; Masuda, et al., 2006; Weissenhorn, 2005; s. Figure 6). Endophilin-A1 is 
brain specific, while A2 is ubiquitously expressed and A3 is enriched in brain and 
testis (Giachino, et al., 1997; Ringstad, Nemoto, & De Camilli, 1997; So, et al., 2000). 
Endophilin-B1 and B2 were detected in several tissues including brain, but are not 
ubiquitously expressed (Farsad, et al., 2001; Modregger, Schmidt, Ritter, Huttner, & 
Plomann, 2003). 
Endophilin-As are best studied for their role in CME (s. chapter 1.2.1) but have 
recently also been implied to play a role in clathrin-independent endocytosis, more 
specifically in ultrafast endocytosis (Boucrot, et al., 2015; Watanabe, et al., 2018). 
Because of endophilin-As role in endocytosis, it is not surprising that it is concentrated 
at pre-synaptic terminals (Bai, Hu, Dittman, Pym, & Kaplan, 2010). Endophilins-B on 
the other hand are rarely observed on synaptic structures but are rather cytosolic in 
 
Figure 6 - Crystal structure of an endophilin-A1 dimer. Subunits are colored in 
blue or yellow. Illustration from (Ambroso, Hegde, & Langen, 2014). 
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the perinuclear region or bound to other intracellular membrane structures (e.g. 
mitochondria; Farsad, et al., 2001; Modregger, Schmidt, Ritter, Huttner, & Plomann, 
2003). They are hypothesized to play a role in autophagy and apoptosis (reviewed in 
Kjaerulff, Brodin, & Jung, 2011). 
Endophilin-A has been shown to perform two important tasks during endocytosis: it 
recruits essential players to the forming CCP, namely dynamin and synaptojanin, 
through the SH3 domain (Meinecke, et al., 2013; Ringstad, et al., 1999; Verstreken, 
et al., 2003; Milosevic, et al., 2011). It also induces membrane curvature at the neck 
of CCPs through the BAR domain (Bai, Hu, Dittman, Pym, & Kaplan, 2010; Farsad, 
et al., 2001; Gallop, et al., 2006; Masuda, et al., 2006).  
The induction of membrane curvature was originally proposed to be achieved through 
a scaffolding mechanism in which the crescent shape of endophilin-A dimers causes 
the membrane to bend in the same way (Blood & Voth, 2006; Blood, Swenson, & 
Voth, 2008; Arkhipov, Yin, & Schulten, 2009). More recent studies have since shown, 
that the BAR domain of endophilin on SVs actually resides at a significant distance 
from the membrane, making it unlikely that endophilin acts only through a scaffolding 
mechanism (Jao, et al., 2010). The authors instead observed amphipathic α-helices 
that embed into the plasma membrane upon binding and employ membrane curvature 
induction through a wedging mechanism (compare Figure 6). However, in a follow-up 
study they report that tubulation depends on the scaffolding mechanism (Ambroso, 
Hegde, & Langen, 2014) pointing to different curvature inducing mechanisms on the 
neck and surface of CCPs. They further propose that phosphorylation of the insertion 
site by Leucine-rich-repeat kinase 2 (LRRK2), a kinase strongly associated with PD, 
acts as a regulation mechanism to switch between scaffolding and wedging curvature 
induction. Further evidence for such a mechanism was recently reported in a 
drosophila model (Soukup, et al., 2016). 
 
1.3.2 Synaptojanin-1 
Synaptojanins are members of the inositol-5-phosphatase family which is defined by 
its property to dephosphorylate phosphoinositide lipids in membranes. They thereby 
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contribute to the regulation of membrane phosphorylation status and various 
processes that rely on different membrane compositions, as for example endocytosis 
(Pirruccello & De Camilli, 2013).  
There are two synaptojanins, synaptojanin-1 and -2. Both of them contain an N-
terminal Sac1 domain, a central 5-phosphatase domain and a C-terminal proline-rich 
domain (PRD). The Sac1 domain dephosphorylates the phosphoinositides PI4P, 
PI3P and PI(3,5)P2 and the 5-phosphatase domain dephosphorylates PI(4,5)P2 and 
PI(3,4,5)P3 (Guo, Stolz, Lemrow, & York, 1999). While the Sac1 and 5-phosphatase 
domain are similar, the PRD is very different between the two isoforms (Nemoto, 
Arribas, Haffner, & De Camilli, 1997). Both synaptojanins are highly expressed in the 
brain, but synaptojanin-2 is additionally expressed in muscle tissue and the testis 
(Nemoto, Arribas, Haffner, & De Camilli, 1997). They also differ in their subcellular 
localization: while synaptojanin-1 was found to be enriched in synaptic terminals 
(McPherson, Takei, Schmid, & De Camilli, 1994), synaptojanin-2 reportedly localizes 
to the cytoplasm, mitochondria and the plasma membrane (Nemoto & De Camilli, 
1999; Malecz, et al., 2000). 
Because of its brain specificity and its localization to synaptic structures, 
synaptojanin-1 was proposed to act in endocytosis. In fact, synaptojanin-1 is recruited 
to SVs by its PRD through the endophilin SH3 domain (Cestra, et al., 1999; 
Verstreken, et al., 2003). At the SVs, it dephosphorylates PI(4,5)P2 through its 5-
phosphatase domain  (McPherson, et al., 1996; Cremona, et al., 1999; Mani, et al., 
2007; Chang-Ileto, et al., 2012). This change of the lipid composition reduces the 
binding affinity of the adapter proteins and enables the recruitment of the uncoating 
factor heat shock cognate 70 (Hsc70). 
Interestingly, synaptojanin-1 was recently found to also have a role in other forms of 
endocytosis. Like endophilin, it was shown to act in ultrafast endocytosis by facilitating 
the formation of the neck after membrane invagination by its 5-phosphatase activity 
(Watanabe, et al., 2018). 
 




The scission of the SV neck that pinches off the SV from the plasma membrane is 
achieved by the GTPase dynamin (Sundborger & Hinshaw, 2014). Dynamin is 
encoded by three dynamin genes, dynamin 1, 2 and 3. Dynamin 1 is brain-specific 
while dynamin 2 is expressed ubiquitously and dynamin 3 is expressed in several 
tissues including the brain but is not ubiquitously expressed (Cao, Garcia, & McNiven, 
1998). In the brain, dynamin 1 is the most enriched of the three proteins and locates 
to synaptic terminals (McPherson, Takei, Schmid, & De Camilli, 1994; Cao, Garcia, & 
McNiven, 1998; Ferguson, et al., 2007). 
Dynamins have four functional domains: an N-terminal GTPase domain, a pleckstrin 
homology domain, a GTPase effector domain and a C-terminal PRD (reviewed in 
Hinshaw, 2000). The PRD contains several SH3 binding sites that are for example 
recognized by endophilin or amphiphysin and has therefore been proposed to be 
recruited through this domain (Grabs, et al., 1997; Ringstad, Nemoto, & De Camilli, 
1997). However, dynamin is recruited to endocytic pits even in the absence of 
endophilin (Milosevic, et al., 2011). 
Dynamins form cytosolic tetramers that then oligomerize on the necks of the SVs. The 
binding to the neck is facilitated through the pleckstrin homology domain that binds 
the PI(4,5)P2 on the SV neck. The function of dynamin is further enhanced by the 
GTPase effector domain that activates the GTPase domain. After the oligomerization, 
this GTPase domain hydrolyses GTP. The energy set free by this reaction is used to 
create a twisting force that further tabulates the membrane and ultimately cuts it 
(reviewed in Hinshaw, 2000). 
Even though dynamin has been extensively studied for its role in CME, studies show 
that it also participates in clathrin independent modes of endocytosis (reviewed in 
Mayor, Parton, & Donaldson, 2014). 
 
 




Auxilin is an important cofactor for Hsc70 and both of them are necessary for effective 
uncoating of CCVs (s. chapter 1.2.1). It is neuron specific and enriched in synaptic 
terminals (Ahle & Ungewickell, 1990). Auxilin contains three domains: the N-terminal 
PTEN-like domain facilitates the binding to PI(4,5)P2 (Lee, Wu, Eisenberg, & Greene, 
2006; Massol, Boll, Griffin, & Kirchhausen, 2006), the central region contains binding 
motifs for AP-2, clathrin and dynamin (Scheele, Kalthoff, & Ungewickell, 2001; 
Newmyer, Christensen, & Sever, 2003) and the C-terminal J domain carries a 
histidine-proline-asparatic acid motif through which auxilin binds to Hsc70 (Eisenberg 
& Greene, 2007). 
The cyclin-G-dependent kinase is a homologous protein to auxilin. It is ubiquitously 
expressed and up-regulated in the brain in the absence of auxilin (Yim, et al., 2010). 
Therefore, the loss of auxilin can be partly – but not completely – compensated by 
cyclin-G-dependent kinase. 
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1.4. Mouse models of defective endocytosis 
 
Mouse models for the most important players in endocytosis have been available for 
several years. They are an important tool for studying the in vivo relevance of the 
specific protein. They further allow studying consequences of the deletion on an 
organismic scale. Given that the process of endocytosis is disrupted in all of these 
animals, they all share similar phenotypes. In this section, the key aspects of the 
available mouse lines are summarized: 
 
1.4.1 Endophilin-A mouse models 
Mouse mutants carrying a triple knock-out (TKO) of all three endophilins-A show that 
endophilin-A is essential for the survival of the mouse, as complete knock-out (KO) 
results in death of the animals just a few hours after birth (Milosevic, et al., 2011).  
 
Figure 7 - Accumulation in CCVs in endophilin deficient neurons. (A) 
Quantification of clathrin coated structures shows that relative number of CCVs is 
increased in endophilin DKO and TKO neurons.  (B-D) Tomographic reconstruction 
of a series of ultrathin sections from control (B), endophilin DKO (C) and TKO neurons 
(D). From (Milosevic, et al., 2011). 
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However, deletion of endophilin A1 and A2 (DKO) causes a reduction of live span to 
14-21 days and ataxia whereas mice that have a KO of endophilin 1 and 3 and are 
heterozygous (HT) for endophilin 2 (endophilin-1KO-2HT-3KO mice) live up to 18 
months and develop epileptic seizures as they age showing that deletion of specific 
endophilin-As can be at least partially compensated by other endophilins (Milosevic, 
et al., 2011). 
Electron microscopy analysis of synapses from TKO brains revealed an accumulation 
of CCPs and CCVs, showing that the process of endocytosis is disrupted in these 
brains at the level of both fission and uncoating of SVs (Figure 7; Milosevic, et al., 
2011). Excitation of TKO neurons with sustained stimuli results in increased 
depression time and the recovery is significantly delayed in these cells (Milosevic, et 
al., 2011).  This indicates that defects in endocytosis have functional consequences 
for exocytosis and synaptic transmission. 
Endophilin TKO and DKO hippocampi were analyzed by next-generation-sequencing 
(NGS). NGS is a state-of-the-art technique to quantify levels of mRNA in a reliable, 
fast and cost-efficient manner. The read-out is a list of differentially expressed genes  
 
Figure 8 – Pathway analysis and upregulation of Fbxo32 in endophilin TKO 
brains. (A) Ingenuity pathway analysis of next-generation sequencing (NGS) results 
of endophilin TKO hippocampi reveals the ten most changed pathways. (B) 
Correlation of NGS and qPCR levels of up-regulated proteins in endophilin TKO 
hippocampi. Note that Fbxo32 is highly up-regulated both by NGS and qPCR. From 
(Murdoch, et al., 2016). 
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(verses control, DEGs). Ingenuity pathway analysis revealed that synaptic 
transmission as well as autophagy and degradation pathways are affected in 
endophilin TKO animals (Figure 8 and Murdoch, et al., 2016). 
Interestingly, when looking at single proteins, the expression that was up-regulated 
most strikingly, was the E3-ubiquitine ligase F-Box protein 32 (Fbxo32 or atrogin-1, 
see chapter 1.6). Overexpression was further verified by quantitative Polymerase- 
Chain-Reaction (qPCR, Figure 8 and Murdoch, et al., 2016). This up-regulation and 
the changed stress response, apoptosis and protein degradation pathways point to a 
misregulation of protein homeostasis in endophilin mutants which could have possible 
effects on cell survival as will be further discussed in this thesis. 
 
1.4.2 Synaptojanin-1 mouse models 
Synaptojanin-1 KO mice were first presented by (Cremona, et al., 1999). These mice 
carry a disruption in the poly-phosphoinositide phosphatase, synaptojanin-1, a key 
factor for the uncoating of SVs during CME (s. chapter 1.3.1). KO of synaptojanin-1 
causes the animals to die within a few hours after birth. The synaptic terminals in 
these animals show a high abundance of CCVs, and at the same time a reduction of 
 
 
Figure 9 - Accumulation of CCVs in synaptojanin-1 KO synaptic terminals. 
Electron microscopy images of a KO (A) and WT (B) synaptic terminal in cortical 
neurons. Scale bar 160 nm. Bar graphs shows percentage of CCVs as mean value ± 
SD. Modified from (Cremona, et al., 1999). 
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uncoated SVs (Figure 9, and Cremona, et al., 1999). This phenotype results in 
increased synaptic depression after prolonged stimulation, likely because the fusion 
pool of SVs is not replenished quickly enough (Cremona, et al., 1999). 
Synaptojanin-1 HT mice have a normal life span and do not display any obvious 
phenotype. 
Recently, another synaptojanin-1 mouse model was published that carries a R258Q 
mutation in the Sac domain (Cao, et al., 2017). This mutation was found in patients 
with Early-Onset Parkinsonism (Krebs, et al., 2013; Quadri, et al., 2013; Olgiati, et al., 
2014). Similar to synaptojanin KO, neurons from these SJ1RQ-knock-in (KI) mice 
showed an accumulation of CCVs. In addition, the mutation caused structural 
changes in dopaminergic nerve terminals of the dorsal striatum (Cao, et al., 2017).  
These mice display motor deficits, seizures and developmental problems. Only 60% 
of them survive until adulthood. However, HT SJ1RQ-KI mice have a normal life span 
and no phenotype (Cao, et al., 2017). 
 
1.4.3 The dynamin-1,3 mouse model 
Two dynamin mouse models have been generated: dynamin 1 KO mice (Ferguson, 
et al., 2007) and dynamin 1,3 DKO mice (Raimondi, et al., 2011). The dynamin single  
 
Figure 10 – Accumulation of CCPs in the dynamin 1,3 DKO synapse. (A) electron 
microscopy image of pre-synaptic terminals shows an accumulation of clathrin coated 
structures. (B) Tomographic reconstruction of a series of ultrathin sections reveals 
that the clathrin coated structures are connected to the membrane and are thus 
CCPs. Scale bar: 250 nm, insets: 50 nm. From (Raimondi, et al., 2011). 
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KO animals die within 2 weeks and accumulate CCPs in synaptic terminals. Basic 
synaptic transmission is still functional in dynamin 1 KO neurons but the recovery is 
significantly slowed down which causes defects in synaptic transmission upon 
sustained stimulation. 
Mice missing dynamin 1 and 3 in general have a stronger phenotype than the dynamin 
1 KO mice. New-born pups die within only a few hours after birth and the accumulation 
of CCPs is even more prominent (Figure 10 and Raimondi, et al., 2011). Synaptic 
transmission is also less efficient in the DKO neurons, however it is not completely 
abolished (Raimondi, et al., 2011). 
 
1.4.4 The auxilin mouse model 
The KO of auxilin in mice causes early mortality in the first three weeks, but mice 
surviving that long then continue to have a normal life span (Yim, et al., 2010). In 
 
Figure 11 - Accumulation of CCVs in auxilin KO neurons. Electron microscopy 
images from auxilin WT (A) and KO (C-D) neurons. CCVs and empty clathrin coats 
accumulate in synaptic terminals as quantified in (B). Scale bars: 200 nm. Illustration 
from (Yim, et al., 2010). 
  Introduction 
26 
 
auxilin KO mice, the authors report a strong up-regulation of the cyclin-G-dependent 
kinase (GAK) which is a homologous protein to auxilin that is ubiquitously expressed. 
Interestingly, the more GAK is up-regulated, the longer auxilin KO mice survive (Yim, 
et al., 2010), showing that GAK can partially compensate for auxilin loss. 
Endocytosis is strongly impaired in neurons from auxilin KO mice, resulting in an 
accumulation of CCVs (Figure 11 and Yim, et al., 2010). Moreover, the neurons also 
display a high abundance of empty clathrin coats. This finding is likely explained by a 
chaperone function of auxilin for clathrin prevent the formation of such structures in 
the cytosol. 
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1.5. Protein degradation as an important part of proteostasis  
 
The process of proteostasis, or protein homeostasis, is an essential process that 
ensures the constant availability of functional proteins for the diverse cellular tasks. 
As all processes that occur within the cell require proteins, problems in proteostasis 
impact virtually every cellular function. 
The life time of proteins depends on protein synthesis and folding, trafficking and 
protein degradation (reviewed in Klaips, Jayaraj, & Hartl, 2017). Together these 
processes regulate that proteins are synthesized in appropriate amounts, locate to 
the respective compartments and are degraded when they are dysfunctional or 
present at too high levels. Endophilin mutants have recently been reported to display 
problems in protein degradation (Murdoch, et al., 2016). Degradation is maintained 
by two distinct processes, autophagy and the ubiquitin-proteasome-system (UPS) 
that are summarized in this chapter. 
 
1.5.1 Autophagy 
Autophagy is a well-studied process through which cells degrade cellular structures, 
including whole organelles, and make the components available again for the 
generation of new proteins and membranes (Takeshige, Baba, Tsuboi, Noda, & 
Ohsumi, 1992; Baba, Takeshige, Baba, & Ohsumi, 1994). Thereby it ensures the turn-
over of misfolded, dysfunctional or “aged” proteins and organelles and is critical for 
the continued abundance of functional proteins. Because of the relevance of 
autophagy for every cell, the research by Yoshinori Ohsumi that elucidated the 
molecular mechanism of autophagy was awarded with the Nobel Prize in 2016. 
Three distinct mechanisms of autophagy exist: macroautophagy, microautophagy 
and chaperone mediated autophagy. All of them deliver proteins and organelles to 
lysosomes where they are degraded by proteases. However, how the structures, that 
need to be degraded, are recruited is different in the three distinct mechanisms of 
autophagy. 




The best studied mechanism of autophagy is macroautophagy, it is therefore often 
simply referred to as autophagy. Several autophagy-related genes (Atgs) are involved 
in orchestrating the three steps of macroautophagy. In short, a phagophore is formed 
and elongated, that proceeds to engulf organelles and cytosolic cargo and finally 
fuses with a lysosome, where the cargo is degraded. Autophagy is triggered by 
different signaling mechanisms. Starvation or cellular stresses activate the AMPK 
pathway that then activates autophagy through an so called ULK complex. 
Alternatively, the ULK complex can also be activated through growth signals that are 
mediated by the PI3K-AKT pathway. 
Macroautophagy is initiated by the formation of a phagophore, a crescent-shaped 
membrane structure. The origin of this membrane is subject of on-going debate. The 
endoplasmic reticulum (ER), the Golgi complex and the plasma membrane have been 
suggested as a source, while others have suggested a de novo formation from 
localized synthesis of lipids (reviewed in Reggiori, 2006; and Simonsen & Tooze, 
2009). Some evidence for an ER origin of the membrane was provided by studies that 
used different imaging techniques to observe phagophore formation (Axe, et al., 2008; 
Hayashi-Nishino, et al., 2009; Ylä-Anttila, Vihinen, Jokitalo, & Eskelinen, 2009). 
The nucleation of the phagophore is well studied in yeast where the group around 
Yoshinori Ohsumi discovered a pre-autosomal structure (PAS) consisting of at least 
5 Atgs (Atg1, Atg2, Atg5, Atg8 and Atg16; Suzuki, et al., 2001; reviewed in Suzuki & 
Ohsumi, 2010). The further formation depends on Atg1 in a complex with Atg13 and 
Atg17 (see Figure 12). The nucleation of the phagophore in mammalian cells seems 
to occur without a PAS (reviewed in Klionsky, 2007) and is likely initiated from the ER 
membrane (Axe, et al., 2008; Hayashi-Nishino, et al., 2009; Ylä-Anttila, Vihinen, 
Jokitalo, & Eskelinen, 2009). Still, the mammalian homologue of Atg1, ULK1, is 
required for the initiation of the process (Kundu & Thompson, 2008) and works 
together in a complex with Atg13 and FIP200, the mammalian homologue of Atg17 
(Chang & Neufeld, 2009; Hara & Mizushima, 2009; Hosokawa, et al., 2009; Jung, et 
al., 2009). 




Figure 12- Mechanism of macroautophagy. Autophagy is induced by signaling 
pathways like the AMPK stress pathway and the PI3K-AKT growth pathway. A large 
number of Autophagy related proteins (Atgs) is involved in the nucleation and 
elongation of the phagophore, the maturation of the autophagosome and the 
subsequent fusion with the lysosome. Illustration from (Cicchini, Karantza, & Xia, 
2015). 
 
Other important factors in the formation process are the vesicular protein sorting 34 
(Vps34) and its binding partner beclin-1 (reviewed in Backer, 2008). Vps34 is a PI3 
kinase that phosphorylates PIs in the phagophore thereby contributing to its 
elongation and the recruitment of other Atgs (Jaber & Zong, 2013; Xie & Klionsky, 
2007). The activity of Vps34 is enhanced through the binding to beclin-1. 
After initiation of the phagophore, several Atgs play a role in promoting or inhibiting 
phagophore maturation. These include ultraviolet irradiation resistant-associated 
gene (UVRAG), endophilin B1, Atg14L and Bcl-2 (Liang, et al., 2006; Takahashi, et 
al., 2007; Matsunaga, et al., 2009; Pattingre, et al., 2005). 
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The further elongation of the phagophore is mediated by a complex of Atg5, Atg12 
and Atg16L in concert with light chain 3 (LC3B). Atg5 and Atg12 are conjugated 
through the activity of the E1 ubiquitin activating enzyme Atg7 which activates Atg12 
using ATP. Atg12 then binds to Atg10, an E2-like ubiquitin carrier that in the next step 
facilitates the binding to Atg5. The Atg5-Atg12 conjugate then forms a complex with 
Atg16L (reviewed in Glick, Barth, & Macleod, 2010). Due to the action of Atg5, which 
is restricted to the early phase of autophagy, it is often used as a marker for this 
process. LC3B, on the other hand, is used as a marker for both early and mature 
phagosomes and autophagosomes. 
Atg7, together with Atg3, is also involved in the lipidation of LC3B, in which LC3B is 
conjugated to phosphatidylethanolamine (PE), a major phospholipid. The lipidated 
LC3B is recruited to the phagophore by the Atg5-Atg12-Atg16L complex (Fujita, et 
al., 2008). LC3B is located both on the outer and inner surface of the phagophore and 
plays a role in selecting cargo. The cargo can be protein aggregates, cytoplasmic 
components or whole organelles such as mitochondria, ER or Golgi. Most likely, LC3B 
acts as a receptor that binds to adapter molecules on the cargo (Glick, Barth, & 
Macleod, 2010). 
Once the cargo is completely engulfed, the phagophore closes due to the action of 
LC3B. At this point, the structure is called an autophagosome. After closure, LC3B is 
released from the autophagosome (reviewed in Simonsen & Tooze, 2009). In the final 
step, the autophagosome fuses with lysosomes. The fusion is not well studied but 
relies on the small G protein Rab7 and on Presenilin, a protein highly implicated with 
Alzheimer ’s disease (Eskelinen, 2005). 
Due to the low pH in the lysosomes and the proteases inside, the autophagosome 
cargo is degraded. These proteases include cathepsin B and D (Koike, et al., 2005).In 
addition, the lysosomal protein LAMP1 and LAMP2 are important for the degradation, 
possibly by maintaining the pH in the autolysosome (Tanaka, et al., 2000). 
Nutrients and metabolites that are the product of the degradation are finally released 
to the cytoplasm where they are available for protein synthesis and other cellular 
processes. 




Microautophagy refers to the degradation of cytoplasmic components and organelles 
without the formation of an autophagosome. It was originally described in yeast as 
the direct invagination of lysosomal membrane to capture the cytoplasm and its 
contents (Kunz, Schwarz, & Mayer, 2004; Uttenweiler, Schwarz, Neumann, & Mayer, 
2007; reviewed in Tekirdag & Cuervo, 2017). In mammalian cells, microautophagy 
does not happen immediately at the lysosome, but rather at late endosomes (LE) 
and/or multi-vesicular bodies (MVB) and has thus been termed endosomal-
microautophagy (eMI; Sahu, et al., 2011). LEs are large endosomal structures that 
mature into lysosomes (Piper & Luzio, 2001). 
The internalization of cargo for degradation is mediated through the ESCRT 
machinery which is present on LE. Several components of this machinery have been 
shown to be necessary for eMI (Sahu, et al., 2011; Mukherjee, Patel, Koga, Cuervo, 
& Jenny, 2016). Microautophagy degrades proteins either unspecifically “in bulk” or 
selectively if the proteins contain a Lys-Phe-Glu-Arg-Gln (KFERQ) motif (Dice, 1995). 
However, this motif is not sufficient to target proteins for microautophagy (Koga, 
Kaushik, & Cuervo, 2011). 
The degradation can occur either directly in the LE or after fusion of the LE with a 
lysosome (Sahu, et al., 2011; Mukherjee, Patel, Koga, Cuervo, & Jenny, 2016). The 
degradation and final products are similar to the process of macroautophagy. 
 
1.5.4 Chaperone mediated autophagy 
The third process of autophagy is called chaperone-mediated autophagy as it relies 
on cargo selection by a chaperone. Unlike macroautophagy, the cargo is directly 
recruited to the lysosomes where it is subsequently degraded (Tekirdag & Cuervo, 
2017). 
The selection of cargo is mediated by the chaperone Hsc70, which also plays a role 
in the uncoating of clathrin-coated vesicles (s. chapter 1.2.1). It binds to proteins 
carrying a KFERQ motif (Dice, 1995). This motif is sufficient to target proteins for 
chaperone-mediated autophagy (Sahu, et al., 2011; Koga, Kaushik, & Cuervo, 2011). 
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Hsc70 then binds to the cytosolic tail of LAMP2A on the lysosomal membrane and 
thereby transports the cargo to the site of degradation. After binding, the protein is 
unfolded by Hsc70. Unfolding is necessary for successful degradation of the protein 
(Salvador, Aguado, Horst, & Knecht, 2000). After unfolding, the target protein is 
transported into the lysosome where it is then degraded. 
 
Figure 13 - Modes of Autophagy. Graphic summary of macroautophagy, 
microautophagy and chaperone-mediated autophagy from (Tekirdag & Cuervo, 
2017).  
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1.5.5 The Ubiquitin-Proteasome-System 
An alternative, or rather, complementary way to regulate proteostasis is the Ubiquitin-
Proteasome-System (UPS). While autophagy is thought to target long-living proteins 
to adept to extracellular influences like starvation, the UPS targets short-living 
proteins and is believed to be more important for intracellular processes (Rock, et al., 
1994; Lee & Goldberg, 1996; Fuertes, Martín De Llano, Villarroya, & Knecht, 2003). 
The system works through the proteasome, a complex of over 40 subunits which is 
located in the nucleus and in the cytoplasm. The proteasome consists of two main 
components: the 20S core particle and the 19S regulatory particle (Figure 14; Coux, 
Tanaka, & Goldberg, 1996). The core particle is made up of two inner α-rings and two 
outer β-rings that together form a barrel-like structure and consist of proteases (Groll, 
et al., 1997; Chowdhury & Enenkel, 2015). The regulatory particle is composed of a 
base and a lid that together select the substrates for the proteasome (Rosenzweig, 
Osmulski, Gaczynska, & Glickman, 2008; Chowdhury & Enenkel, 2015). 
The selection of substrates for the UPS occurs through a number of enzymes classed 
as E1, E2 and E3 that selectively add poly-ubiquitin chains to proteins to mark them 
 
 
Figure 14 - Structure of the 26S proteasome. The proteasome consists of a 20S 
core particle and a 19S regulatory particle. CP: core particle, RP: regulatory particle, 
Rpn: RP non-ATPase, Rpt: RP triple-ATPase, α1-7: members of the inner α-ring, β1-
7: members of the outer β -ring. Adapted from (Tanaka, 2009). 
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for proteasomal degradation. These enzymes are responsible for ubiquitin activation, 
ubiquitin conjugation and ubiquitin ligation respectively (Hershko & Ciechanover, 
1998). Briefly, ubiquitin is activated in an ATP-dependent manner by the E1 activating 
protein and then transferred to the cysteine residue of an E2 conjugating enzyme. In 
the last step, the ubiquitin is transferred via the E3 ligase to a lysine residue of a target 
protein.  
In order for a protein to be marked for degradation, it is loaded with several ubiquitin 
proteins. Ubiquitin itself carries seven lysines (K6, K11, K27, K29, K33, K48 and K63; 
Ben-Saadon, Zaaroor, Ziv, & Ciechanover, 2006). However, poly-ubiquitination of the 
different lysine residues causes different effects. Poly-ubiquitination on lysine residue 
K48 of the first and subsequent ubiquitin proteins marks a protein for degradation, 
while ubiquitination of K63 has effects on trafficking and other cellular processes 
(Sadowski, Suryadinata, Tan, Roesley, & Sarcevic, 2012; Pickart & Fushman, 2004; 
Ben-Saadon, Zaaroor, Ziv, & Ciechanover, 2006; Silva, Finley, & Vogel, 2015). 
Importantly, a large number of E3 ubiquitin ligases ensures the specificity of the 
process: While there are only a few known E1 enzymes (Liu, Goldberg, & Qiu, 2007), 
there are at least 40 E2 enzymes in humans (Valimberti, Tiberti, Lambrughi, Sarcevic, 
& Papaleo, 2015; Wenzel, Hunsaker, Greco, Willemsen, & Berman, 2010; Burroughs, 
Jaffee, Iyer, & Aravind, 2008) and several hundred E3 ubiquitin ligases (Zheng & 
Shabek, 2017; Sluimer & Distel, 2018). 
Of note, there are E3 ubiquitin ligases that can function alone, as the family of 
homologous to the E6AP carboxyl terminus (HECT) domain proteins or of the really 
interesting new gene (RING) family (Metzger, Pruneda, Klevit, & Weissman, 2014), 
while others function in a complex (Hershko & Ciechanover, 1998). The best studied 
example for such a complex is the Skp1, Cullin1, F-box protein complex (SCF; 
Skowyra, Craig, Tyers, Elledge, & Harper, 1997). The principle of substrate poly-
ubiquitination of the SCF complex and a RING protein is illustrated in Figure 15. 
K48 poly-ubiquitinated proteins are subsequently recognized by the regulatory 
particle of the proteasome. It consists of 19 subunits that can be classified into 
“regulatory particle triple-ATPase” (Rpt) and “regulatory particle non-ATPase” (Rpn) 
subunits (Tanaka, 2009). Rpn10 and Rpn13 are located on the base of the regulatory  




Figure 15 - Substrate poly-ubiquitination through a RING protein or the SCF 
complex. In both pathways, ubiquitin is activated by an E1 ubiquitin-activating protein 
and subsequently bound by an E2 conjugating protein. In the RING protein pathway, 
the substrate and the E2 protein are both bound to the RING protein and the ubiquitin 
is then transferred to the target protein (left). In case of the SCF complex, the target 
protein is bound by the F-box protein, which is conjugated to Skp1, Cullin1 (Cul1) and 
the RING E3 ubiquitin ligase RBX. The E2 ubiquitin conjugating protein is bound by 
RBX and Cul1 which then ligase ubiquitin to the target protein (right). The 
ubiquitinated protein is either mono-ubiquitinated, multi-mono-ubiquitinated (at 
different lysine residues) or poly-ubiquitinated. Proteasomal degradation only occurs 
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particle and function as receptors for ubiquitin, thereby directing poly-ubiquitinated 
proteins to the proteasome (Husnjak, et al., 2008; Schreiner, et al., 2008). The poly-
ubiquitin chain is then removed from the target protein by the deubiquitinating enzyme 
Rpn11 (Ventii & Wilkinson, 2008). The target protein is ultimately degraded through 
catalytic enzymes in the core particle of the proteasome into oligopeptides of 3-15 
amino acids that are further degraded by oiligopeptidases (Tanaka, 2009; Groll, et al., 
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1.6. Fbxo32, an E3 Ubiquitin-Ligase involved in autophagy 
 
One example for an E3 ubiquitin-ligase is the F-box only protein 32 (Fbxo32, also 
called MAFbx or atrogin-1, UniProtKB: Q969P5). It was first discovered by two 
independent studies in 2001 as a regulator of muscle atrophy (Bodine, et al., 2001; 
Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001). In these studies, Fbxo32 was 
reported to be expressed in muscles and severely up-regulated upon several 
conditions, including fasting, denervation, immobilization and diabetes. Fbxo32 was 
recently also found to be upregulated in endophilin mutants (see Figure 8 and 
Murdoch, et al., 2016). 
 
1.6.1 Structure of Fbxo32 
Fbxo32 is a 355 amino acid protein that is well conserved between human and mouse 
and contains several functional domains (Gomes, Lecker, Jagoe, Navon, & Goldberg, 
2001; Csibi, Tintignac, Leibovitch, & Leibovitch, 2008; Julie, Sabrina, Marie-Pierre, & 
Leibovitch, 2012). It is located in the cytoplasm and is also present in the nucleus due 
to two nuclear localization sequences (NLS) and a nuclear export sequence (NES) 
contained in a leucine charged domain (LCD; Figure 16; Julie, Sabrina, Marie-Pierre, 
& Leibovitch, 2012). 
Fbxo32 was found to be part of an E3 ubiquitin ligase complex together with Skp1, 
Cullin1 and RBX forming a SCF complex (Gomes, Lecker, Jagoe, Navon, & Goldberg, 
2001; Skowyra, Craig, Tyers, Elledge, & Harper, 1997). It can bind both Skp1 and 
Cullin1 through an F-box domain in the central part of the protein, which also is 
responsible for the specific substrate binding for the E3 ubiquitin ligase function (Bai, 
et al., 1996; Bodine, et al., 2001; Skowyra, Craig, Tyers, Elledge, & Harper, 1997; 
Bodine & Baehr, 2014). However, Fbxo32 has no WD40 repeats or leucine-rich 
regions which are often found in other F-box proteins (Figure 16; Winston, et al., 1999; 
Cenciarelli, et al., 1999). 
Besides the name giving F-box domain, Fbxo32 also possesses a leucine zipper 
domain (LZ), a cytochrome c heme binding site (cytC) and a PDZ binding domain at 
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the C terminus (Figure 16; Bodine, et al., 2001; Gomes, Lecker, Jagoe, Navon, & 
Goldberg, 2001; Csibi, Tintignac, Leibovitch, & Leibovitch, 2008; Julie, Sabrina, 
Marie-Pierre, & Leibovitch, 2012). As Fbxo32 has no WD40 or leucine rich domain, 
the PDZ binding domain likely functions to bind specific complementary sequences 
on target proteins for poly-ubiquitination (Doyle, Lee, Lewis, Kim, & MacKinnon, 
1996).  
 
Figure 16 - Sequence and domain structure of Fbxo32. Amino acid sequence (top) 
and domain representation (bottom) of human Fbxo32. Fbxo32 contains two nuclear 
localization sequences (aa62-67 and aa280-295; green), a leucine zipper motif (aa99-
135; pink), a leucine charged domain containing a nuclear export sequence (aa140-
190; yellow), an F-box domain (aa228-267; turquoise), a cytochrome-c site (aa317-
322; red) and a PDZ binding domain (aa346-355; dark green). Adapted from (Julie, 
Sabrina, Marie-Pierre, & Leibovitch, 2012). 
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1.6.2 Role and targets of Fbxo32 in proteasomal degradation 
Fbxo32 functions as an E3 ubiquitin-ligase and thus selects targets for poly-
ubiquitination and subsequent degradation by the UPS (s. chapter 1.5.5). As Fbxo32 
has been reported as a mediator of muscle atrophy, many studies on this protein were 
originally conducted in the context of muscle development and disease. 
As such, many interaction partners and E3 ubiquitin ligase targets were identified in 
this area including the myoblast determination protein (MyoD; Tintignac, et al., 2005) 
and myogenin (Jogo, Shiraishi, & Tamura, 2009; Foletta, White, Larsen, Léger, & 
Russell, 2011), two transcription factors that are involved in muscle differentiation 
(Davis, Weintraub, & Lassar, 1987; Sassoon, et al., 1989; Edmondson & Olson, 
1993), the eukaryotic translation initiation factor 3 subunit f (eIF3-f; Lagirand-
Cantaloube, et al., 2008), that plays a role in mTOR dependent muscle differentiation 
(Csibi, et al., 2010), two sacromeric proteins, vimentin and desmin (Lokireddy, et al., 
2012; Bodine & Baehr, 2014), the dual specificity protein phosphatase 1 (DUSP1; Xie, 
et al., 2009) a regulator of the skeletal muscle development kinase, mitogen-activated 
protein kinase 1 (MAPK1; Keren, Tamir, & Bengal, 2006) and calcineurin which 
promotes cardiac hypertrophy in response to pathologic stimuli in cardiomyocytes (Li, 
et al., 2004; Willis & Patterson, 2006). 
However, targets of Fbxo32 mediated ubiquitination were also found in the context of 
other cellular processes. These include c-Myc, a transcription factors that works as 
an oncogene (Mei, et al., 2015), krueppel-like factor 4 (KLF4), a transcription factor 
active during embryonic development (Zhou, et al., 2017), the charged multivesicular 
body protein 2B (CHMP2B) which plays a role in autophagy (Zaglia, et al., 2014) and 
CtBP1 which is involved in epithelial to mesenchymal transition (EMT) and dynamin-
independent endocytosis (Sahu SK1, et al., 2017; Amstutz, et al., 2008; Bonazzi, et 
al., 2005). 
Lastly, Fbxo32 seems to have a role in the regulation of apoptosis and cell survival. 
It was shown to play a direct role in the NF-κB signaling pathway by targeting the 
inhibitor of the transcription factor RelA, IκBα, to proteasomal degradation (Meshram, 
et al., 2017). The NF-κB pathway is ubiquitously expressed and regulates 
inflammation, apoptosis, oncogenesis and proliferation (Mincheva-Tasheva & Soler, 
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2013). The inhibitor IκBα, which is the most common inhibitor of NF-κB in the nervous 
system, retains the transcription factor in the cytoplasm and its degradation through 
the 26S proteasome is part of the mechanism of the signal transduction (Chen, 2005; 
Mincheva-Tasheva & Soler, 2013). By targeting IκBα for proteasomal degradation, 
Fbxo32 functions directly in the regulation of the NF-κB signaling pathway.  
Interestingly, two of the above mentioned Fbxo32 targets, DUSP1 and KLF4, were 
also implicated in the regulation of cell survival. DUSP1 de-phosphorylates the stress-
activated protein kinase JNK (Zhou, et al., 2017; Xie, et al., 2009), which regulates 
apoptosis and autophagy by phosphorylation of specific transcription factors (Sui, et 
al., 2014; Xie, et al., 2009). KLF4 was also shown to induce apoptosis upon oxidative 
stress in chronic myeloid leukemia cells (Li, et al., 2010) 
 
Figure 17 - Expression of Fbxo32 in different tissues upon starvation. RNA 
hybridization for Fbxo32 in muscle, heart, liver, kidney and brain samples of fed and 
starved mice. Brackets show amount of loaded RNA in micrograms. While Fbxo32 is 
most strongly expressed in muscle tissue, it is also found in a lower quantity in the 
brain samples (arrows). Modified from (Gomes, Lecker, Jagoe, Navon, & Goldberg, 
2001). 
  Introduction 
41 
 
Taken together, these targets of Fbxo32 dependent poly-ubiquitination and 
subsequent proteasomal degradation point to a role of Fbxo32 in muscle 
differentiation and atrophy as well as general cell survival. While Fbxo32 is strongly 
expressed in skeletal muscles, it was also found to be expressed in the central 
nervous system (Figure 17; Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001). Given 
the above mentioned functions of Fbxo32 in muscles, this thesis hypothesizes that 
Fbxo32 might play a similar role in regulating cell survival in the brain. 
 
1.6.3 Fbxo32 as a mediator between autophagy and the UPS 
After its discovery as a muscle-enriched E3 ubiquitin ligase, Fbxo32 was further 
studied in mouse and zebrafish animal models (Bodine, et al., 2001; Zaglia, et al., 
2014; Bühler, et al., 2016). In the acute model of muscle denervation, Fbxo32 KO had 
a positive effect in preventing muscle degeneration in mice (Bodine, et al., 2001). 
Further studies showed that Fbxo32 was up-regulated in models of acute muscle 
atrophy and that its down-regulation had a positive effect on muscle survival (Sakai, 
et al., 2017; Lee, Kim, Kim, Choi, & Nam, 2017). 
However, genetic ablation also resulted in an age-dependent increase on 
cardiomyopathy in mice (Zaglia, et al., 2014) and progressive heart failure and 
myopathy in zebrafish (Bühler, et al., 2016).  
Furthermore, the Fbxo32 KO models imply that Fbxo32 plays a role in autophagy in 
addition to its described role in the UPS (see chapter 1.6.2). Zaglia and colleagues 
report that a member of the endosomal sorting complex (ESCRT), charged 
multivesicular body protein 2b (CHMP2B), is a target of Fbxo32 mediated poly-
ubiquitination (Zaglia, et al., 2014). The ESCRT complex is involved in the formation 
of multi-vesicular bodies (MVB, see also chapter 1.5.3) which can fuse with 
autophagosomes before the final fusion with the lysosome, thereby contributing in 
targeting the proteins engulfed in the MVBs for degradation (Fader & Colombo, 2009). 
Using the Fbxo32 KO mouse model, they show that CHMP2B accumulates in the 
heart due to inefficient degradation. They hypothesize that this accumulation leads to 
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autophagy impairment which in turn causes the observed phenotype of 
cardiomyopathy.  
Supporting this hypothesis, a mouse model lacking Atg5, a key factor for autophagy 
(see chapter 1.5.2), displayed a similar phenotype of age-dependent cardiomyopathy 
(Taneike, et al., 2010). In addition, Bühler and colleagues showed that in their 
zebrafish KO model the autophagy marker LC3B is strongly up-regulated and that 
autophagy inhibition had no additional effect in fish missing Fbxo32 (Bühler, et al., 
2016). 
In summary, Fbxo32 is strongly up-regulated in models of starvation, denervation, 
immobilization or diabetes and seems to play a role in the induction of muscle atrophy 
likely through targeting key muscle regulators for degradation. On the other hand, 
genetic ablation of Fbxo32 in mouse or zebrafish animal models also results in 
myopathy, showing that both overexpression and deletion of Fbxo32 can potentially 
have negative effects for the organism. Because of that, and the implication of Fbxo32 
to autophagy, Fbxo32 has been proposed to act as a mediator between UPS 
dependent protein degradation and autophagy (Zaglia, et al., 2014). 
This thesis will further explore the importance of Fbxo32 levels and its role in 
autophagy. 
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1.7. Neurodegenerative diseases  
 
Neurodegenerative diseases are a cluster of human pathological conditions that 
primarily affect neurons. These diseases are not only a problem because of their 
increasing prevalence and expected health costs, but also because they reduce the 
live quality of affected patients dramatically. In the final stages of the disease, many 
patients require intense nursing for even the most basic daily tasks and the memory 
loss is a burden for both the patient and his or her family. While the symptoms of the 
disease can be treated in many cases, dead neurons cannot be regenerated, so brain 
functions that have been lost can generally not be restored. 
A variety of human conditions, including Alzheimer’s Disease (AD), Parkinson’s 
Disease (PD) and Huntington’s Disease (HD), are classified as such diseases. While 
all neurodegenerative diseases are characterized by neuronal death, the location and 
magnitude of the cell death differs and is responsible for the different symptoms that 
define the specific disease. For example, in the case of PD the most affected cell type 
is dopaminergic neurons. These neurons are enriched in the substatia nigra pars 
compacta. This is a small brain region in the midbrain important for motor planning 
and eye movement. Because of this, the most obvious phenotype in PD patients, 
which can be easily observed even with an untrained eye, is motor deficits, particularly 
tremor in the hands and gait anomalies. 
As many studies have investigated neurodegenerative diseases, several hypotheses 
have been formulated about the causes for such diseases. Many proteins have been 
identified, that – when mutated or dysregulated – contribute to neurodegeneration. 
These proteins include amyloid-β and tau for AD, α-synuclein and LRRK for PD as 
well as huntingtin, ataxin-2, superoxide dismutase 1 and prion proteins for several 
other diseases. Interestingly, many of these proteins accumulate in context of the 
specific diseases and form cytotoxic aggregates (Bayer, 2015). In light of this, an 
emerging hypothesis is that problems in proteostasis could contribute to 
neurodegeneration or even be a common denominator of several neurodegenerative 
conditions (Douglas & Dillin, 2010; Nixon, 2013; Liang & Sigrist, 2018). As 
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proteostasis is an essential function for all cellular processes (see chapter 1.5), it is 
not surprising that impairments in proteostasis may also impact neuronal survival. 
According to this hypothesis, the reason why neurons are especially vulnerable to 
problems with proteostasis is their specific architecture. Due to the elongated shape 
of neurons with long axons, synapses are often a significant distance away from the 
nucleus and the protein synthesis machinery that can at least partially compensate 
for impairments in protein degradation. This deteriorates even further with aging, as 
the proteostasis system loses effectiveness with age (reviewed in Cuervo, et al., 
2005; Martinez-Vicente, Sovak, & Cuervo, 2005). Protein aggregates in the synapse 
would then cause the degeneration of synapses which consequently causes axonal 
retraction and finally neuronal death (Burke & O'Malley, 2013). 
 
1.7.1 Defective endocytosis and neurodegeneration 
In the past years, several studies have been published that link defects in endocytosis 
to neurodegeneration. These studies encompass a variety of approaches and 
originate from groups working on diverse aspects of neurodegeneration. In their 
totality it is intriguing how strongly they connect defective endocytosis to 
neurodegenerative diseases. 
For example, protein interaction studies have shown that endophilin interacts with 
several proteins that are strongly associated with neurodegenerative disorders 
(Ralser, et al., 2005). The authors showed that endophilin 1 and 3 interact with ataxin-
2. Mutations in the gene encoding ataxin-2, SCA2, have been identified as the cause 
of spinocerebellar ataxia type 2 (Sanpei, et al., 1996).  
Endophilin has also been shown to interact with LRRK2 (Matta, et al., 2012), 
mutations of which are the most common cause for familiar and sporadic PD (Nichols, 
et al., 2005; Di Fonzo, et al., 2006; Gilks, et al., 2005; reviewed in Kumari & Tan, 
2009). Interestingly, recent studies report that LRRK2 might play a role in the 
regulation of endophilin in CME through the phosphorylation of the insertion site of 
endophilin’s amphipathic α-helices (Ambroso, Hegde, & Langen, 2014; Soukup, et 
al., 2016). This is further supported by another study of LRRK2 KO mice which reports 
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defects in neurotransmission and endocytosis in neurons from these mice (Arranz, et 
al., 2015). 
The link to PD is solidified by a study that shows a direct binding between parkin, 
another key protein in PD (reviewed in Dawson & Dawson, 2010), and all three 
endophilins (Trempe, et al., 2009). Moreover, PD disease progression was shown to 
correlate with an accompanying increase of endophilin 1 in the cortex of PD patients 
(Shi, et al., 2009). In addition to this, a number of patients with juvenile or early-onset 
PD have been reported to carry mutations of genes important to endocytosis, more 
precisely the uncoating process: synaptojanin-1 (Quadri, et al., 2013; Krebs, et al., 
2013; Olgiati, et al., 2014) and auxilin (Edvardson, et al., 2012; Köroğlu, Baysal, 
Cetinkaya, Karasoy, & Tolun, 2013; Olgiati, et al., 2016). On the other hand, 
endophilin was also reported to be up-regulated in the brains of AD patients, possibly 
pointing to a more basic role of endophilin in several neurodegenerative diseases 
(Ren, et al., 2008). 
The creation of animal models for defective endocytosis has made it possible to 
further elucidate the connection to neurodegenerative disorders. Endophilin DKOs 
were reported to display symptoms of cerebellar ataxia which is likely caused by the 
retraction of climbing fibers from the inferior olivary nucleus to the cerebellum 
(Milosevic, et al., 2011). In the same model, it was later reported that parkin is up-
regulated in both endophilin TKO and p18 DKO mice (Cao, Milosevic, Giovedi, & De 
Camilli, 2014). 
In addition, a fly model lacking endophilin in the eye was shown to display 
photoreceptor cell degeneration. In the same study, the authors report that the 
balancing of phosphorylation of endophilin through LRRK2 is important to maintain 
neuronal survival in dopaminergic neurons (Soukup, et al., 2016). 
Recently, a mouse model was published that carries a mutation of synaptojanin-1 that 
was identified in patients of early-onset Parkinsonism (Cao, et al., 2017; Quadri, et 
al., 2013; Krebs, et al., 2013; Olgiati, et al., 2014). These mice display changes in the 
structure of dopaminergic synapses in the dorsal striatum (Cao, et al., 2017). A 
second study in a fly model of the same mutation reported dopaminergic neuron 
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degeneration, emphasizing the connection of the synaptojanin-1 mutation to PD 
(Vanhauwaert, et al., 2017). 
The cause for the neurodegeneration in endocytic mutants is not clear yet. One theory 
is that defects in endocytosis will ultimately lead to defects in exocytosis, as 
exocytosis requires the continuous availability of SVs. This process is likely age 
dependent, as basic synaptic transmission is still possible in all presented models of 
defective endocytosis and only becomes impaired upon strong stimulation (Milosevic, 
et al., 2011; Cremona, et al., 1999; Cao, et al., 2017; Raimondi, et al., 2011; Yim, et 
al., 2010). Once exocytosis is impaired, the synaptic strength, both pre- and post-
synaptically, is weakened, causing synapses to disappear. As a result, axons will 
retract, which is an early hallmark of neurodegeneration (Burke & O'Malley, 2013; 
Schirinzi, et al., 2016). 
However, some recent studies in this area report that loss or mutations of endocytic 
proteins causes defects in autophagy and hypothesize this as a possible cause for 
the observed neurodegeneration (Soukup, et al., 2016; Vanhauwaert, et al., 2017). In 
this scenario, the defect in autophagy would impair proteostasis in synapses which 
are de facto isolated from the nucleus and the protein synthesis machinery due to the 
long distance between them. The imbalance in proteostasis would then result in a 
disruption of synaptic processes with the same consequences as detailed above. 
 
1.7.2 Autophagy impairments and neurodegeneration 
Defects in protein homeostasis and protein aggregation are common hallmarks of 
both aging and neurodegeneration (Martin, Austad, & Johnson, 1996; Kumar, et al., 
2016). It is therefore not surprising that defects in autophagy are often observed in 
the context of neurodegenerative diseases (Kumar, et al., 2016). This is prominently 
observed in tauopathies, including AD and other neuropathies such as PD, HD and 
Creutzfeldt–Jakob/prion diseases (Lee & Leugers, 2012; Giráldez-Pérez, Antolín-
Vallespín, Muñoz, & Sánchez-Capelo, 2014; Davies, et al., 1997; Cescatti, et al., 
2016). The formed protein aggregates, which are not degraded by autophagy, have  




Figure 18 - Consequences of defective autophagy. Up-regulation of autophagy is 
a cellular mechanism for adaptation to stress and cytotoxicity and has protective 
consequences (left). Defective fusion of autophagosomes with lysosomes leads to 
neurodegeneration and premature aging (middle). Impaired autophagosome 
formation causes tissue degeneration (right). Illustration from (Levine & Kroemer, 
2008). 
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cytotoxic effects that disturb normal cellular functions (Bucciantini, et al., 2002). 
Similarly, models of autophagy deficiency often cause neurodegeneration or 
neurodegenerative phenotypes and an increase of autophagic capacity has 
potentially protective effects (reviewed in Rubinsztein, Mariño, & Kroemer, 2011; 
Levine & Kroemer, 2008). The effects of different disruptions of autophagy are 
summarized in Figure 18. 
Autophagy plays an especially important role in neurons as these cells are long-living 
and have specialized structures, the synapses, which are often located a long 
distance from the nucleus where protein synthesis begins (Wang & Hiesinger, 2012; 
see chapters 1.1). It has previously been suggested that defective proteostasis is a 
first indicator and possible common denominator of several neurodegenerative 
diseases (Douglas & Dillin, 2010; Nixon, 2013; Liang & Sigrist, 2018). 
This theory builds on the fact that proteostasis is a key factor for cell survival. In 
addition to the cytotoxic effects of protein aggregates, cellular processes require 
functional proteins and organelles and can be perturbed depending on the severity of 
the imbalanced proteostasis (Douglas & Dillin, 2010). Autophagy is the process which 
ensures the constant availability of functional organelles and proteins. Dysfunctional 
organelles, for example mitochondria with increased reactive oxygen species (ROS) 
production, and protein aggregates can be disposed of by the autophagic machinery 
(Okamoto & Kondo-Okamoto, 2012; Menzies, Fleming, & Rubinsztein, 2015). 
Autophagy, however, becomes less effective with aging and is therefore thought to 
be a key factor for normal mammalian aging (Cuervo, et al., 2005; Martinez-Vicente, 
Sovak, & Cuervo, 2005). In case of neurodegenerative diseases, the age-related 
decline of autophagic capacity is further aggravated by mutations that either cause 
an increase in misfolded proteins and consequently aggregation, dysfunctional or 
missing proteins that perturb organelle function like ATP production by mitochondria, 
thereby increasing the autophagic load, or by the disruption of autophagic proteins 
directly (Novack, 2017; Levine & Kroemer, 2008).  
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Taken together, the emerging role of autophagy in aging and neurodegeneration 
presents an interesting field of study with possible new therapeutic strategies for the 
treatment of neurodegenerative diseases. 
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1.8. Aims of the study 
 
Neurodegenerative diseases are a burden for the patients, their families and society 
in general. While our knowledge has greatly increased with the advancement of 
science, many questions remain unanswered. This thesis aims to look into the role of 
defective endocytosis as a possible cause for neurodegenerative diseases. 
Specifically, it will profit from the use of different mouse models for defective 
endocytosis, with a focus on endophilin deficient mice. These mice were 
characterized over the course of 18 months for motor deficits and biochemical as well 
as structural changes in the brain. 
NGS analysis of endophilin mice has shown that the E3 ubiquitin ligase Fbxo32 is 
strongly up-regulated in the brains of these mice. As this protein has been proposed 
to be a mediator between UPS mediated protein degradation and autophagy, the 
scope of this study is also to explore the autophagic system in the endophilin mouse 
model. Perturbations were investigated using imaging and biochemical analysis. 
In addition to this, a rescue experiment to revert the high levels of Fbxo32 was 
performed by crossing the endophilin mouse model with Fbxo32 deficient mice. The 
resulting offspring were then also characterized for motor behavior. 
In short, the aims of the thesis were to: 
 Characterize onset and progression of motor deficits in the endophilin mouse 
model and synaptojanin-1 and dynamin mutants 
 Describe neurodegenerative changes in the brains of the endophilin mutants 
and correlate them with the observed phenotype  
 Investigate the autophagic machinery in endophilin mutants as well as other 
endocytic mutants 
 Genetically reduce Fbxo32 levels in endophilin mutants and describe these 
mice by motor behavior tests 
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2. Materials and Methods 
2.1. Materials 
2.1.1 Reagents and consumables 
All chemicals used for this study are listed in Table 1. They were stored at room 
temperature (RT) or at 4° C following supplier’s specifications. The consumables and 
kits used for this study are listed in Table 2. Consumables and Equipment used for 
cell culture experiments are listed in Table 3. 
Table 1 - List of chemicals and their providers 
 
Chemical Supplier catalog number 
2-Mercaptoethanol  Carl Roth 4227.3 
Acetic acid (CH3COOH) Carl Roth X895.2 
Agarose Biozym 840004 
Ammonium chloride NH4Cl VWR APLIA3260.0500 
Ammonium Persulfate (APS) AMRESCO 0486 
Bovine serum albumin (BSA)  Carl Roth CP84.2 
Bromphenolblue Carl Roth A512.1 
Calcium chloride (CaCl2) Carl Roth CN93.1 




Cold fish gelatin Sigma Aldrich G7765 
DAPI Carl Roth 6335.1 
Dithiothreitol (DTT) Carl Roth 6908.1 
DNAse I Type II Bovine Sigma Aldrich d4527 
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Chemical Supplier catalog number 
EDTA  Carl Roth 8043.2 
Ethanol absolute VWR 20816,298 
Ethidium bromide  VWR E406 
Finger paint (red) Staedtler 8801 
Glycerol  Carl Roth 7530.1 
Glycin Carl Roth 3908.3 
Goat Serum  Life Technologies 10000C 
HCl  Sigma Aldrich H1758 
Heparin  Sigma Aldrich H3393 
HEPES  Carl Roth HN77.2 
Isoflurane Sigma Aldrich 792632 
Isopentane Sigma Aldrich M32631 
LuminataTM Classico Western HRP 
Substrate 
Millipore WBLUC0500 
LuminataTM Forte Western HRP Substrate Millipore WBLUF0500 
Magnesium chloride (MgCl2) VWR 8.14733.0100 
Magnesium sulfate (MgSO4*7H2O) Sigma Aldrich 63138 
Methanol  VWR 20903.368 
Mowiol 4-88  AppliChem A9011 




Paraformaldehyde (PFA)  AppliChem A3813 
Entellan Neu mounting medium Millipore 107961 
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Chemical Supplier catalog number 
PhosStop tablets Sigma Aldrich 04906837001 
Potassium chloride (KCl) Volu-Sol 83608.26 
Potassium dihydrogen phosphate 
(KH2PO4) 
Carl Roth 3904.1 
Potassium phosphate dibasic (K2HPO4) Carl Roth P749.2 
cOmplete ULTRA Tablets, EDTA-free, 
Protease Inhibitor Cocktail 
Sigma Aldrich 05892953001 
Protease and Phosphatase Inhibitor 
Cocktail (100X) 
Thermo Fisher 78440 
ProteinaseK Roche 3115879001 
Rotiphorese Gel 30 Carl Roth 3029.2 
SDS  Sigma Aldrich L4509-500G 
Skim Milk Powder  Fluka 70166 
Sodium bicarbonate (NaHCO3) Carl Roth P029.3 
Sodium chloride (NaCl) AppliChem A1430,0010 
Sodium hydroxide pelltets (NaOH) Carl Roth 6771.1 
Sodium phosphate monobasic 
(NaH2PO4*H2O) 
Carl Roth K300.1 
Sucrose Carl Roth 9097.1 
TEMED  Sigma Aldrich T7024 
Tris-Base Sigma Aldrich T1503 
Tris-HCl Carl Roth 9090.2 
Triton X-100 AMRESCO 0694 
Tween-20 AMRESCO 0777-1L 
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Table 2 - Kits and consumable products 
Product Supplier Catalog number 
Amersham Hybond PO45 PVDF  GE Healthcare 10600023 
Coverslips 18x18 mm VWR 631-1331 
Cuvettes polystyrol/polystyrene Sarstedt 67-742 
Embedding mold 22x22x20 Thermo Scitific 2219 
Eppendorf tubes (1.5 mL) StarLab E1415-1500 
Eppendorf tubes (2 mL) StarLab S1620-2700 
Filter Ø150 mm Machery-Nagel 531 015 
GoTaq Flexi DNA polymerase kit  Promega M8291 
High-Performance 
chemiluminescence film 
GE Healthcare 28906837 
Hydrophobic marker Kisker Biotech  MKP-1 
Medical X-Ray Film Foma ------- 
Microscope slides Carl Roth 2111 
Needles 27G B.Braun 465 7705 
Nitrocellulose membrane BIO-Rad 1620115 
PageRuler Plus Prestained Protein 
Ladder  
Thermo Scientific 26619 
Pasteur pipet plastic Carl Roth EA63.1 
24G perfusion needle B.Braun 465 7675 
Petri dish 2 cm Sarstedt 82.1135.500 
Petri dish 10 cm Sarstedt 82.1473.001 
Pierce BCA Protein Assay kit Thermo Scientific 23225 
Plastic pipets 10 mL Sarstedt 86.1254.025 
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Product Supplier Catalog number 
Rapid GolgiStain Kit  FD Neuroscience PK401A 
Super frost slides Th. Geyer 769 5019 
Syringe 1 mL VWR 613-2040 
Tips 10 μL TipOne   StarLab S111-3210 
Tips 20 μL TipOne StarLab S120-1810 
Tips 200 μL TipOne StarLab S1120-8800 
Tips 1000 μL TipOne StarLab S1111-6001 
Tubes 15 mL Sarstedt 62.554.502 
Tubes 50 mL Corning 430829 
TUNEL kit Sigma-Aldrich 11684795910 
Whatman Western Blot Paper  TH-Geyer 4-01-60-0041 
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Table 3 - Cell Culture consumables and equipment 
Product Supplier Catalog number 
Centrifuge Eppendorf 5810R 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 41639-100ML 
DMEM, high glucose, pyruvate ThermoFisher Scientific 11995073 
Fetal Bovine Serum, qualified, 
heat inactivated 
ThermoFisher Scientific 10500064 
Incubator HERAcell 240 ThermoFisher Scientific 51026331 
Neubauer counting chamber VWR 631-0696 
Nucleofactor X Core Unit Lonza AAT-1002B/X 
P4 Primary Cell 4D-Nucleofector® 
X Kit S (32 RCT) 
Lonza V4XP-4032 
PBS tablets VWR 97062-732 
Penicillin-Streptomycin (10,000 
U/mL) 
ThermoFisher Scientific 15140122 
Petri dish 10 cm Sarstedt 83.3902.300 
T-25 flask  CytoOne CC7682-4825 
T-75 flask Paper  Sarstedt 83.3911.002 
Trypsin-EDTA (0.05%), phenol 
red 
gibco 11580626 
Waterbath Memmert WNB 14 
 
  




All solutions and buffers used for this study are listed in Table 4 together with 
instructions how to prepare them. 
Table 4 - List of solutions and buffers 
Solution Recipe 
ammonium chloride 50 mM NH4Cl in PBS 
blocking solution for 
immunocytochemistry 
3% (w/v) BSA, 0.2% (w/v) cold fish gelatin, 0.1% 
(v/v) Triton-X100 in PBS 
blocking solution for 
immunohistochemistry 
3% (w/v) BSA, 0.1% (w/v) cold fish gelatin, 0.1% 
(v/v) Triton-X100, 0.05% (v/v) Tween-20, 1% goat 
serum in PBS 
Cell lysis buffer 1% (w/v) SDS, 25 mM Tris Base, 150 mM NaCl, 1 
mM EDTA, 1% (v/v) protease inhibitor cocktail in 
dH2O 
Chloral Hydrate 4.125 mM chloral hydrate in PBS 
Chromalaun-gelatin 0.3% (w/v) gelatin, 1 mM CrK(SO4)2*12H2O in dH2O; 
heat dH2O to 58° C and dissolve gelatin on the 
stirrer, add the CrK(SO4)2*12H2O only after the 
solution has cooled down to RT, filter 
HBSS buffer 5.36 mM KCl, 141.7 mM NaCl, 10 mM HEPES, 3.4 
mM L-Giutamine, in dH2O 
heparin solution 100 U/mL in PBS 
Homogenization buffer 2 M NaCl, 0.5 M EDTA, 1 M HEPES in dH2O pH 7.4 
add 1 phospho-stop tablet/10 mL, 1 protease 
inhibitor tablet/50 mL and 1 mM DTT for activation 
imaging buffer for live cell 
imaging 
136 mM NaCl, 2,5 mM KCL, 2 mM CaCl2, 1 mM 
MgCl2, 10 mM HEPES, in dH2O, p.H. 7.4 
  




6x Laemmli buffer 62.5 mM Tris, pH 6.8, 50% (v/v) Glycerol, 12% (w/v) 
SDS, 0.06% (w/v) Bromophenol blue. Add 5% 2-
Mercaptoetanol freshly prior to use 
5% milk 5% (w/v) skim milk powder in TBS-T 
Mowiol 4-88 3.6 M glycerol, 3 M Mowiol 4-88, 133 mM Tris-Base 
in dH2O. Stir at 45°C, centrifuge at 5000 g for 15 min, 
collect supernatant, store at -20°C 
4% paraformaldehyde 
(PFA) 
4% (w/v) PFA in PBS, pH 7.4; heat PBS to 58° C, 
add sodium hydroxide dropwise until PFA dissolves 
phosphate buffered saline 
(PBS) 
137 nM NaCl, 2,7 mM KCL, 10 mM Na2HPO4x2H2O, 
2 mM KH2PO4 in dH2O, p.H. 7.4, autoclave 
Poly-L-Lysine 1 mg/mL Poly-L-Lysine in dH2O 
primary antibody solution for 
immunocytochemistry 
3% (w/v) BSA, 0.2% (w/v) cold fish gelatin in PBS 
Running Buffer   125 mM Tris Base, 0.96 M Glycine, 0.5% (w/v)SDS 
secondary antibody solution 
for immunocytochemistry 
3% (w/v) BSA, 0.2% (w/v) cold fish gelatin, 1% (v/v) 
goat serum in PBS 
SNET buffer 20 mM Tris (pH 8.0), 5 mM EDTA (pH 8.0), 400 mM 
NaCl, 0.5 % (w/v) SDS in dH2O 
TAE buffer 40 mM Tris, 19 mM CH3COOH, 1 mM EDTA, in 
dH2O, pH 8.0 
TBS-T 1% (v/v) Tween-20 in TBS 
TE buffer 10 mM Tris-HCl, 0.2 mM EDTA in dH2O, pH 7.5 
Transfer Buffer 25 mM Tris-Base, 0.2 M Glycine, 20% (v/v) Methanol 
in dH2O 
Tris buffered saline (TBS) 20 mM Tris-Base, 150 mM NaCl in dH2O, pH 7.6 




All antibodies used for immunohistochemistry and western blot analysis are listed in 
Table 5 - Table 8. 
Table 5 - Primary antibodies used for immunohistochemistry 
Target protein Manufacturer species concentration 
a-synuclein Cell Signaling 2628 rabbit 1:100 
bassoon Enzo SAP7F407 mouse 1:400 
p-Foxo3A Cell Signaling 13129 rabbit 1:200 
Cleaved caspase 3 Cell Signaling 9664 rabbit 1:600 




Table 6 - Secondary antibodies used for immunohistochemistry 
Target species Fluorophore Manufacturer species concentration 
Mouse  Alexa488 Life Technologies Goat 1:200 
Mouse  Alexa568 Life Technologies Goat 1:200 
Mouse  Alexa594 Life Technologies Goat 1:200 
Mouse  Alexa647 Life Technologies Goat 1:200 
Rabbit Alexa488 Life Technologies Goat 1:200 
Rabbit  Alexa568 Life Technologies Goat 1:200 
Rabbit  Alexa594 Life Technologies Goat 1:200 
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Table 7 - Primary antibodies used for western blot analysis 
Target protein Manufacturer species concentration 
Actin Millipore C4 mouse 1:7500 
ATG5 Cell Signaling 2630 rabbit 1:1000 
ATG9A Abcam 108338 rabbit 1:1000 
ATG16L Abcam 188642 rabbit 1:1000 
Dynamin 1, 2 & 3 SySy 115002 rabbit 1:1000 
Endophilin A1 SySy 159 002 rabbit 1:2000 
Endophilin A2 SantaCruz A-11 mouse 1:200 
Endophilin A3 SantaCruz S-15 goat 1:200 
Endophilin B1 Novus Bio 24733 mouse 1:200 
Fbxo32 ECM AX2045 rabbit 1:4000 
GAPDH Sigma G9545 rabbit 1:10000 
HPRT Abcam 10479 rabbit 1:4000 
K48 linkage poly-
ubiquitin 
Cell Signaling rabbit 1:1000 
K63 linkage poly-
ubiquitin 
Cell Signaling Rabbit 1:1000 
LC3 Cell Signaling d11 rabbit 1:1000 
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Table 8 - Secondary antibodies used for western blot analysis 
Target species Tag Manufacturer Species concentration 
Rabbit HRP Cell Signaling Goat 1:4000 
Rabbit IR 680 Li-Cor Goat 1:7500 
Rabbit  IR 800 Li-Cor Goat 1:7500 
Mouse  IR 680 Li-Cor Goat 1:7500 
Mouse  IR 800 Li-Cor Goat 1:7500 








The plasmids listed in Table 9 were used to transfect cells for live cell imaging. 
Table 9 - Plasmid used in the study 
Plasmid name vector Protein Fluorescence 
marker 
Endo2-GFP pCMV_EGFP-N1 endophilin A2 EGFP 
CLC-EGFP pCAG_EGFP clathrin light chain EGFP 








All equipment used for this thesis is listed in Table 10. 
Table 10 - List of equipment 
Equipment Manufacturer 
Accurpette VWR 
Bio Photometer Eppendorf 
Cryostat CM1850UV Leica 
Curix 60 developer AGFA 
DigiGait Mouse specifics 
DMI 6000 b microscope  Leica 
EV231 power supply (genotyping) Consort 
EW2200-2NM balance Kern&Sohn 
Examiner Z1 LSM710 microscope Zeiss 
Fine balance ALJ 120-4 Kern&Sohn 
Grip strength meter TSE systems 
Heating plate Mr3001 Heidolph 
37°C Incubator memmert 
LKB perfusion pump Phermacia 
LSM800 microscope Zeiss 
Mastercycler epgradient eppendorf 
MM400 Bead mill Retsch 
NanoDrop Spectrophotometer Peqlab 
Odyssey Infrared Imager Li-Cor 
Perfection V850 Pro Scanner Epson  
  




Pipets (2.5 µL, 10 µL, 20 µL, 100 µL, 200 
µL, 1000 µL) 
eppendorf 
Power supply (SDS-PAGE) Bio-Rad 
Rotarod TSE systems 
SevenEasy pH Meter Mettler Toledo 
Shaker Unimax 1010 Heidolph 
Steam autoclave type DSL Holzner 
Table centrifuge (5424) eppendorf 
Thermomixer comfort eppendorf 
Ultra View Spinning Disk Nikon/Perkin Elmer 
UV imaging system Intas 









The software used for acquisition and analysis of data for this study is listed in Table 
11. 
Table 11 - List of software programs 





San Jose, CA USA 
DigiGait Analyzer Mouse Specifics Framingham, MA USA 
DigGait Imager Mouse Specifics Framingham, MA USA 
Fiji NIH Bethesda, MD USA 
Imaris 8.0.2 Bitplane Zurich Switzerland 







Microsoft Office  Microsoft 
Corporation 
Redmond, WA USA 
Prism 6 GraphPad La Jolla, CA USA 
Volocity PerkinElmer Rodgau Germany 
ZEN black Carl Zeiss AG Oberkochen Germany 
ZEN blue Carl Zeiss AG Oberkochen Germany 
 
  





2.2.1 Experimental mice 
All animal procedures in this thesis were performed according to the European 
Guidelines for animal welfare (2010/63/EU) and with explicit permission from the 
Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit 
(LAVES), registration number 14/1701. Animals were bred and housed in the Zentrale 
Tierexperimentelle Einrichtung (ZTE) Göttingen with ad libitum access to water and 
food. Animals were kept in groups of 1-5 animals on a 12h/12h light/dark cycle. 
Experiments were conducted in the light phase. Individually ventilated or open cages 
were used. Endophilin mutant mice were originally described in (Milosevic, et al., 
2011), synaptojanin-1 KO mice were described in (Cremona, et al., 1999), dynamin 
1,3 DKO mice were described in (Raimondi, et al., 2011). Fbxo32 KO mice were kindly 
provided by Prof. Marco Sandri (University of Padova, Padova, Italy). All mouse lines 
were bred in the ZTE Göttingen. C57BL/6J WT animals were obtained from Janvier 
and used as an additional control throughout the thesis.  
 
2.2.2 DNA extraction and genotyping 
Mouse tail or ear punch samples were used for genotypic characterization of animals. 
All samples were digested in SNET buffer containing 167 µg/mL ProteinaseK, shaking 
for at least 1 hour at 55°C. DNA was precipitated with 100% Ethanol and centrifuged 
at 20.000 g for 30 min. The pellet washed with 70% Ethanol and centrifuged at 20.000 
g for 20 min. The final product was resuspended in TE buffer and DNA concentration 
was measured on a Nanodrop. Samples were stored at -20°C. 
The GoTaq Flexi DNA polymerase kit from Promega was used to perform 
Polymerase-Chain-Reaction (PCR) to amplify WT and transgenic alleles for Fbxo32, 
endophilin -1, -2, -3, dynamin-1 or synaptojanin-1, yielding specific band sizes. The 
products were run on a 0.8 % or 1.2 % agarose gel. 
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PCR protocol Fbxo32 




5x reaction buffer  5 µl 
MgCl2 (25mM) 2 µl 
dNTP (10mM) 0.5 µl 
Primer MA61KO-F1 (10μM) 0.5 µl 
Primer MA61KO-R1 (10μM) 0.5 µl 
Primer MA61KO-LACZ (10μM) 0.5 µl 
DMSO 1.5 µl 
Taq Polymerase (5U/μl) 0.25 µl 
DNA (~600 ng) 3 µl 




95°C 5 min  
 
x37 
95°C 30 sec 
59,5°C 45 sec 
72°C 1,5 min 
72°C 7 min 
10°C ∞ 
 
WT band ~422bps, KO band ~553bps 
  
  Materials and Methods 
68 
 
PCR protocol Endophilin-A1 




5x reaction buffer  5 µl 
MgCl2 (25mM) 2 µl 
dNTP (10mM) 0.5 µl 
Primer Endo1-for (10μM) 0.5 µl 
Primer Endo1-RV1-WT (10μM) 0.5 µl 
Primer Endo1-RV3-Neo (10µM) 0.5 µl 
Betaine (5M) 2 µl 
Taq Polymerase (5U/μl) 0.2 µl 
DNA (~800 ng) 3 µl 




94°C 5 min  
 
x35 
94°C 30 sec 
60°C 30 sec 
72°C 1.5 min 
72°C 5 min 
10°C ∞ 
 
WT band ~384bps, KO band ~950bps 
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PCR protocol Endophilin-A2 





5x reaction buffer  5µl 
MgCl2 (25mM) 4 µl 
dNTP (10mM) 0.5 µl 
Primer for (10μM) WT / KO 0.5 µl 
Primer rev (10μM) WT / KO 0.5 µl 
Betaine (5M) 2 µl 
Taq Polymerase (5U/μl) 0.25 µl 
DNA (~800 ng) 3 µl 




95°C 5 min  
 
x37 
95°C 30 sec 
59.5°C 45 sec 
72°C 1.5 min 
72°C 7 min 
10°C ∞ 
 
WT band ~1280bps, KO band ~1000bps 
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PCR protocol Endophilin-A3 




5x reaction buffer  5 µl 
MgCl2 (25mM) 2 µl 
dNTP (10mM) 0.5 µl 
Primer mEndo3_SDL-F (10μM) 0.5 µl 
Primer mEndo3_LOX-R (10μM) 0.5 µl 
Primer mEndo3_KO-R (10μM) 0.5 µl 
DMSO 1.5 µl 
Taq Polymerase (5U/μl) 0.2 µl 
DNA (~600 ng) 3 µl 





95°C 5 min  
 
x35 
95°C 30 sec 
58°C 30 sec 
72°C 50 sec 
72°C 10 min 
10°C ∞ 
 
WT band ~325bps, KO band ~465bps 
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PCR protocol Dynamin-1 
Primer: DNW1-WT -fw (GCTCGGTGCTGGAGAATTTCGTGG) 
DNW1-New KO -as (GGCTGCTCCGTAGAGGCTCACAGG) 
DNW1-New KO -s (GTCAGTTTCATAGCCTGAAGAACG) 
PCR reaction 
5x reaction buffer  5 µl 
MgCl2 (25mM) 2 µl 
dNTP (10mM) 0.5 µl 
Primer DNW1-WT -fw (10μM) 0.8 µl 
Primer DNW1-New KO -as (10μM) 0.8 µl 
Primer DNW1-New KO -s (10μM) 0.8 µl 
DMSO 1.25 µl 
Taq Polymerase (5U/μl) 0.2 µl 
DNA (~300 ng) 3 µl 





95°C 5 min  
 
x33 
95°C 30 sec 
60°C 40 sec 
72°C 1 min 
72°C 7 min 
10°C ∞ 
 
WT band ~600bps, KO band ~250bps 
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PCR protocol Synaptojanin-1 




5x reaction buffer  5 µl 
MgCl2 (25mM) 1 µl 
dNTP (10mM) 0.5 µl 
Primer NEO M2 or Primer SJWTS1 (10μM) 1 µl 
Primer SJLA1 (10μM) 1 µl 
DMSO 1.25 µl 
Taq Polymerase (5U/μl) 0.2 µl 
DNA (~300 ng) 3 µl 





95°C 5 min  
 
x30 
95°C 30 sec 
58.5°C 30 sec 
72°C 1 min 
72°C 7 min 
10°C ∞ 
 
WT band ~580bps, KO band ~750bps 
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2.2.3 Motor behavior testing 
Behavior experiments were conducted with permission from the Niedersächsisches 
Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES) under the 
registration number 14/1701. Mice were subjected to a battery of motor behavior test, 
namely grip strength test (GS), gait analysis (GAIT) and fixed-speed/accelerated 
Rotarod (FSRR/ARR). Experiments were always performed in this order, progressing 
from low to high difficulty for the animal to minimize effects from the previous 
experience. Experiments on endophilin mutants were performed at 8 time points 
between 1-18 months (specifically at 1, 2, 3, 6, 9, 12, 15 and 18 months of age). 
Endophilin mutants crossed with Fbxo32 KO mice were tested at 5 time points 
between 1-9 months (specifically at 1, 2, 3, 6 and 9 months of age). At least 10 mice 
were tested for each tested genotype. 
On every experimental day, the health status of the animal was assessed by visual 
inspection and weight measurements. For all experiments, the average value was 
calculated for each genotype and age. Statistical analysis was performed with the 
statistics software GraphPad Prism 6. Outliers were excluded from the analysis if they 
differed more than 95% from the average values. Data were tested for normality and 
analyzed by ANOVA testing, corrected for multiple measurements by the Dunnett (for 
comparison of several groups with WT) or Tukey method (for comparison of several 
groups with each other) as specified in the results section. 
Grip strength test 
The protocol was adapted from (Mandillo, et al., 2008). A TSE grip strength meter 
equipped with a single bar grip was used to measure fore limb muscle strength in 
mice. Animals were hold by the tail and allowed to reflexively grab the metal bar. The 
mice were then pulled with constant force away from the bar and the maximum force, 
before the mice released the bar, was recorded. 15 measurements over 3 days (5 
trials / day) were recorded to accommodate for the variability by the experimenter. 
The highest value for each day was normalized to the body weight and averaged over 
3 days for analysis. 




Gait recording and analysis was performed using the DigiGait system (Mouse 
Specifics), described in (Amende, et al., 2005). For a detailed protocol, see (Rostosky 
& Milosevic, 2018). One week before the first test, the DigiGait test chamber was 
prepared with Nutella and normal chow. Test animals were then placed into the 
covered chamber for 3 minutes to habituate to the environment and form a positive 
association. On the test day the paws of the test animal were painted using red finger 
paint in order to enhance the contrast of the paws to the brown fur of the endophilin 
mutants. When the paint was dried, the animals were placed into the DigiGait test 
chamber which was covered with a dark cloth. After a few minutes of accommodation 
Table 12 - Examples of gait parameters measured by DigiGait. 
parameter definition 
Gait rhythm 
swing time time the paw is in the air 
stance time time the paw is in contact with the ground 
brake time during stance, the time that the paw area is increasing 
propel time during stance, the time that the paw area is decreasing 
norm. stance width distance between left and right fore or hind paws 
normalized to animal width 
stance / swing ratio of stance time to swing time  
paw drag area under the curve from full stance to paw lift-off; 
increases if a paw is dragged behind 
Gait posture 
limb loading maximal rate of change of paw area during brake phase, 
determined as max dA/dt; indicator of how rapidly the 
mouse decelerates 
Absolute paw angle angle between the paw and the snout-tail axis 
Paw angle variability standard deviation of the paw angle 
Shared stance percentage of hind limb stance time that both hind limbs 
are in contact with the ground at the same time 
Paw placement 
positioning 
extent of overlap between ipsilateral fore and hind paws 
during full stance 
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time, the treadmill was started and the running recorded with a high-speed camera 
under the transparent treadmill. Videos were recorded at 10 cm/s, 20 cm/s and 30 
cm/s running speed. Animals that did not run at the maximum speed or refused 
running all together, were tested on the next day and if necessary the day after that. 
If they did not run at three independent test days, animals were excluded from this 
test. Acquired videos were analyzed using the DigiGait Analysis software that extracts 
“digital paw prints” from the videos and measures gait parameters based on the time 
the paws are in contact with the treadmill and the relative positions of the paws 
towards each other. The maximum speed the animals were able to run as well as ~50 
parameters calculated from the Analysis software were considered for analysis (s. 
Table 12). 
Rotarod 
The Rotarod test was used to evaluate motor coordination and balancing in 
experimental animals. The procedure was adapted from (Wegener, et al., 2014). In 
this test, animals were placed on a 3 cm diameter rubber rod, ca. 8 cm above the 
ground, which rotated at a fixed or accelerating speed. Fall latency was measured 
with a light beam at the bottom of the Rotarod apparatus. Animals were trained for 2 
days (2 trials / day) at the low rotation speed of 5 rotations per minute (rpm) for 180 s 
/ trial. In this phase, animals were replaced on the rod if they fell down. In the testing 
phase, the rod was accelerated from 5-40 rpm over 180 s. Every animal underwent 4 
trials (2 / day) and the fall latency was measured for each trial. 
 
2.2.4 Cell culture procedures 
The cell culture experiments reported in this thesis were performed in mouse 
embryonic fibroblasts (MEFs) that carried a conditional KO for dynamin 1, 2 and 3. 
Basic Cell Culture  
Culture conditions for MEFs 
MEFs were cultured in 10 cm petri dishes or T-75 flasks in Dulbecco's Modified Eagle 
Medium (DMEM) with 10% fetal bovine serum and 1% Penicillin/Streptomycin 
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cocktail, henceforth growth medium. Cell were handled under a sterile hood and 
incubated at 37° C and 5% CO2 in an eppendorf incubator. 
Splitting cells 
Cultured cells were split every 2-3 days. Cells were washed with sterile phosphate-
buffered saline (PBS) pre-heated to 37° C and incubated with trypsin enzyme for 3 
min at 37° C. Detachment of the cells was controlled on a light microscope. The 
enzymatic reaction was stopped with growth medium and the cells collected in a 50 
ml Falcon tube. Cells were spun down at 1,000 rpm for 3 min and re-suspended in 
fresh growth medium. Cells were diluted in a 1:4 to 1:5 ratio with growth medium in a 
new petri dish. 
Cryopreservation and thawing of MEFs 
To freeze cells, cells were washed with 37° C warm PBS, detached from the petri dish 
with 3 min incubation of trypsin at 37° C and re-suspended in growth medium. They 
were then spun down at 1,000 g for 3 min and re-suspended in 375 µL DMEM. To 
this cell suspension, 375 µL freezing medium containing 10% FBS + 10% DMSO, 
were carefully added and gently mixed. The cells were divided into 3 previously 
labeled cryotubes which were stored in a plastic container filled with isopropanol in 
which cells were slowly cooled down in a -80° C freezer O/N. For long-term storage, 
cryotubes were submerged in a liquid nitrogen tank. To defrost MEFs, cells were 
thawed in a 37° C waterbath until all ice crystals were dissolved. The cells with the 
freezing medium were plated in 10 mL growth medium and incubated at 37°C, 5% 
CO2 O/N. The next day, the medium was replaced with fresh growth medium. 
Preparation of MEFs for biochemical analysis 
MEFs were collected after washing the cells with pre-heated PBS by trypsin treatment 
of the culture dish for 3 min at 37° C. The cells were re-suspended in growth medium 
to stop the enzymatic reaction and spun down at 1,000 g for 3 min. The cells were re-
suspended in 1 mL warm PBS and collected in a 2 mL tube. Cells were centrifuged 
again at 1,000 g for 3 min and the pellet lysed in 200 µL cell lysis buffer (s. Table 4) 
for 30 min on a 4° C shaker. Lysed cells were passed through a 27G syringe 20-30 
times and the samples further handled as detailed in 2.2.7. 
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Induction of triple knock-out in dynamin cTKO MEFs 
MEFs carrying a conditional TKO (cTKO) for dynamin 1, 2 and 3 as originally 
described in (Ferguson, et al., 2009; Park, et al., 2013) were kindly provided by Pietro 
De Camilli (Yale University). The cells behave like WT MEFs until the conditional KO 
is activated by 4-Hydroxytamoxifen (OHT) treatment. Before the induction of the TKO, 
cells were cultured for at least 2 passages under standard conditions. The cells were 
then split as described above except that in the final cultivation 30 mM OHT dissolved 
in pure ethanol was added to the growth medium, resulting in a final concentration of 
3 µM OHT in the petri dish. Control cells were treated with equal amounts of pure 
ethanol without OHT. After 24 h, the OHT or ethanol was renewed and after 48 h the 
medium changed to normal growth medium leaving 5-10% of the old medium, 
resulting in a concentration of 100-300 nM of OHT to prevent potentially non-induced 
cells from proliferating. Complete TKO of dynamin is established 5 days after the first 
treatment with OHT. At this stage, the cells no longer proliferate, for that reason the 
cells have to be used between day 5 and day 10 before the cells start dying. The 
efficiency of the KO was confirmed by western blot for a pan-dynamin antibody on the 
day the cells were used for experiments. Since the TKO cells no longer proliferate, 
the medium was changed every other day without splitting the cells. Ethanol treated 
control cells were split every 2 days to keep an equal cell density. 
Live imaging of transfected MEFs 
Poly-L-Lysine plate preparation 
Coverslips for live cell imaging were prepared by washing them with 1M HCl for at 
least 4 h on a shaker. The coverslips were then quickly rinsed with distilled H2O and 
washed for 20 min in distilled H2O on a shaker. After that the coverslips were quickly 
rinsed twice with 96% ethanol and then washed with absolute ethanol for 20-60 min 
and then stored in fresh absolute ethanol until further use. Before the use of the 
coverslips for cell culture they were coated with Poly-L-Lysine (PLL) to increase the 
attachment of the cells. For this, coverslips were quickly flamed with a Bunsen burner 
and inserted into a 12-well plate. 500 µL of 1 mg / mL PLL in double-distilled H2O was 
incubated for at least 30 min at 37° C on the coverslips. After this, coverslips were 
washed twice with double-distilled H2O and dried under the sterile hood for about 20 
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min. 12-well plates were stored under sterile conditions at 4° C for a maximum of 1 
month before use. 
Amaxa 4D-Nucleofector transfection 
Expression of fluorescence-tagged proteins in cells was achieved through 
transfection of MEFs with plasmid DNA carrying the desired DNA sequence. The 
Amaxa 4D-Nucleofector kit from Lonza was used following manufacturer’s 
instructions. Transfection reagent was prepared by mixing 16.4 µL Nucleofactor 
solution with 3.6 µL supplement per reaction. Cells were washed, detached from the 
petri dish with 3 min incubation with trypsin at 37° C and re-suspended in growth 
medium. After spin-down for 3 min at 1,000 g, cells were re-suspended in 4 mL PBS 
and 10 µL inserted into a Neubauer counting chamber. All cells in the 4 big squares 
were counted and the concentration in cells / mL calculated by the average number 
of cells / square x 10,000. From the cell suspension, 200,000 cells were used per 
reaction. The appropriate volume of the cell suspension was spun down for 3 min at 
1,000 g and the cell pellet re-suspended in 20 µL transfection reagent in a 1.5 mL 
tube. 0.5-1 µg Plasmid DNA were gently mixed to the cells and the suspension 
transferred to small Amaxa cuvettes while avoiding introducing air bubbles. The 
cuvettes were placed in a Nucleofactor X Unit and subjected to the program CZ-167 
for MEFs. After transfection, cells were allowed to rest for 10 min before they were 
re-suspended in growth medium. Each reaction was split on 2 wells and plated in 2 
mL growth medium / well on a 12-well plate with PLL-coated coverslips. Plasmid DNA 
was expressed for 36 h before cells were imaged on a spinning disk microscope or 
fixed for imaging on a LSM microscope. 
Live cell imaging 
Transfected MEFs were imaged on a Nikon Perkin Elmer spinning disk microscope. 
Coverslips on which the cells were grown were quickly washed in warm PBS and then 
inserted into an imaging chamber which was then filled with imaging buffer. Live cells 
were imaged in a chamber heated to 37° C with a 63x or 100x objective. Movies were 
recorded with Velocity software for 4-10 min with 15 frames / min. 
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2.2.5 Brain dissection from young and adult mice 
Tissue from living animals was collected for biochemical and histochemical analysis 
to demonstrate the in vivo relevance of the endophilin mouse model. 
Dissection of whole brain (p0) 
Newborn animals were collected a few hours after birth and kept on a warm plate for 
a maximum of 1 h before dissection. The pups were picked up and the head quickly 
decapitated with big scissors. Small scissors were inserted in the foramen magnum 
(the hole in the skull through which the spinal cord passes) and a cut made towards 
the eye and from there towards the skull midline on both sides so that the upper part 
of the skull could be removed. The whole brain was removed with a spatula and 
washed in PBS. For biochemical analysis, the brain was then stored in an 1.5 mL 
tube, quick-frozen in liquid nitrogen and stored at -80° C until further use. 
Dissection of p14 or adult mice brains 
Juvenile and adult brains were dissected into cortices, hippocampi, cerebellum and 
rest of the brain. To this end, animals were anesthetized with isoflurane and 
euthanized by cervical dislocation. The mice were then decapitated and the brain 
extracted as detailed above and placed in a small petri dish containing PBS with the 
cranial side facing down. The connections between cortices and thalamus were cut 
with a small scalpel. The brain was then turned so that the cranial side faced up again. 
Holding the brain in the midbrain between cortices and cerebellum with forceps, a cut 
was made along the midline between the 2 cortices so that they were detached from 
the brain stem. From each cortex, the hippocampus was removed by using a small 
spatula to unfold the hippocampus and a scalpel to separate it from the cortex. The 
cerebellum was detached from the brain stem with one sagittal and one transverse 
cut. All samples were stored in 1.5 mL tubes and quick-frozen in liquid nitrogen and 
stored at -80° C until further processing. 
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2.2.6 Staining procedures on brain slices and cells 
Preparation of brain slices for immunostainings 
Brain slices were obtained from juvenile and aged animals by perfusion and from p0 
animals by brain fixation. Brains were then frozen in optimum cutting temperature 
(OCT) solution and cut on a cryostat. 
Perfusion 
The perfusion protocol was modified from (Gage, Kipke, & Shain, 2012). Animals 
were weighed and anesthetized through intraperitoneal injection of 400 µg chloral 
hydrate (in PBS) / g body weight. When the animal was unresponsive to pinching 
(after ~10-15 min), the mouse was fixed on a styrofoam dish and the abdomen and 
thorax cut open to reveal the heart. A 25G5/8 perfusion needle, bend in a ~80° angle 
and attached to a peristaltic pump, was inserted into the left ventricle of the heart and 
a small cut made at the right atrium. 9 mL cold PBS / min were pumped through the 
heart for 3 min to wash out the blood from the entire body. After that, cold 4% PFA 
was pumped at 10 mL per min to pre-fix the tissue immediately. After ~7 min, the 
brain was dissected from the animal and post-fixed in cold 4% PFA over night (O/N). 
Brain fixation of p0 brains 
Brains from new-born pups were collected in the morning, a few hours after birth. 
Animals were killed by decapitation and the whole brain dissected and washed in 
PBS. Brains were then fixed in cold 4% PFA for 3 h. 
Freezing and cryostat cutting 
After fixation, brains were washed 3 times for 5 min with PBS and then dehydrated 
with increased concentration of sucrose (12%, 15%, 18% sucrose in PBS for 8-12 h 
each). Brains were then stored in a cryomold and immersed in OCT solution. The 
mold was then quick frozen in isopentane cooled down by liquid nitrogene. Samples 
were stored at -80° C until further use. Sagittal sections were cut on a cryostat set to  
-20° C. The frozen OCT blocks were attached to the cryostat cutting block and then 
cut at 10 µm thickness and collected on Super Frost Plus slides. Slides were stored 
at -20° C. 
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Immunostaining on cryosections 
Immunohistochemical stainings were performed on frozen brain sections. The 
protocol was modified from (Evilsizor, Ray-Jones, Lifshitz, & Ziebell, 2015). Sections 
were encircled with a hydrophobic marker and re-hydrated with PBS. 50 mM 
ammonium chloride was used to quench fluorescence after PFA treatment and 
washed with PBS. Samples were blocked with blocking solution for 1 h at room 
temperature (RT). The primary antibody was diluted according to producers’ 
specifications in blocking solution and incubated on the section at 4° C O/N. The next 
day, sections were washed 3 times for 10 min with PBS and incubated with a 
fluorescence-tagged secondary antibody diluted in blocking solution for 1 h at RT. 
After washing with PBS, nuclei were stained for 5 min with DAPI solution and mounted 
with Mowiol 4-88. Sections were dried for 3 h at 37° C and then stored at 4° C. 
Sections were imaged within 1 week after staining on a laser scanning microscope 
(LSM), LSM710 or LSM800, using ZEN blue or ZEN black software respectively. 
Immunostaining on cultured cells 
For immunocytochemical stainings, cells were grown on 18 mm diameter coverslips. 
As adapted from (Marchenko & Flanagan, 2007), cells were washed in PBS and fixed 
for 1 h at RT with 4% PFA. Cells were quenched with 50 mM ammonium chloride for 
20 min at RT and then blocked with blocking solution. Primary antibody was diluted 
according to manufacturer’s specifications in blocking solution without Triton-X100 
and incubated on the cells O/N at 4° C. On the following day, the cells were washed 
3 times for 10 min each in PBS and then incubated with a fluorescence-tagged 
secondary antibody diluted in secondary antibody solution. Cells were then washed 
2 times for 10 min with PBS and counter-stained with DAPI solution for 2 min. After 
final washing in PBS for 15 min, the coverslips were mounted with Mowiol 4-88, dried 
for 3 h at 37° C and then stored at 4° C. Coverslips were imaged within 1 week after 
staining on a LSM710 or LSM800 using ZEN blue or ZEN black software respectively. 
 
TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay 
Apoptotic and necrotic cell were identified using the “In Situ Cell Death Detection Kit, 
Fluorescein” from Sigma-Aldrich according to manufacturer’s instructions. In short, 12 
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brain cryosections were selected (9 test samples, 1 positive control and 2 negative 
controls), encircled with a hydrophobic marker and briefly washed with PBS. Sections 
were then post-fixed with 4% PFA for 20 min at RT, briefly washed 2 times with PBS 
and then washed for 30 min with PBS. Sections were permeabilized on ice with 0.1% 
Triton X-100 (in water) and washed 2 times for 2 min with PBS. The positive control 
was then incubated with 833 U/mL DNAse I in HBSS buffer for 10 min at RT (the other 
sections were washed in PBS in that time). TUNEL reaction mix was incubated on the 
samples and positive control for 60 min at 37° C in a wet chamber, while the negative 
controls were incubated under the same conditions with label solution only (no 
enzyme). Sections were washed for 5 min with PBS, counter-stained with DAPI and 
washed again 2 times for 5 min before mounting with Mowiol 4-88. Samples were 
stored at 4° C for a maximum of 3 days before imaging on a LSM800 using ZEN black 
software (TUNEL channel: exitation 450-500nm, detection 515-565nm). 
Golgi staining on mouse brains 
Golgi staining is a well-established method to analyze neuron morphology in brains 
that was first used already in 1873 by Camillo Golgi (Ramón-Moliner, 1970). This 
silver staining randomly stains single cells in nervous tissue and thus allows analyzing 
cell morphology in this densely packed tissue. 
Tissue Preparation  
Golgi staining was performed with the Rapid GolgiStain Kit from FD Neuroscience 
according to manufacturer’s instructions. Impregnation solution was prepared with 
equal amounts Solution A and B 24 h before the staining and kept in the dark. 
Experimental animals were anesthetized with isoflurane and euthanized by cervical 
dislocation. The whole brain was dissected as described in section 2.2.5. The brain 
was quickly rinsed with double-distilled H2O and then immersed in 4 mL impregnation 
solution in a small glass bottle. The solution was renewed the next day and the brain 
kept for a total of 14 days while staying in the dark. After this, the solution was 
replaced with Solution C and incubated for 72 h. Solution C was renewed after 24 h. 
Preparation of gelatin-coated slides 
Brain sections for Golgi staining were collected on gelatin-coated slides to increase 
attachment forces. Glass slides were placed in a slide holder and washed with hot 
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soapy water for 10 min. They were then washed for 30 min under a running water tab. 
Slides were washed with distilled water for 10 min and then dipped twice for 10 s each 
in chromalaun solution (s. Table 4). Slides were dried and stored in dust free boxes 
until further use. 
Cryostat sectioning of Golgi staining 
Brains were frozen in isopentane pre-cooled on dry ice. The samples were slowly 
immersed in isopentane and kept there for 1 min until the tissue was completely 
frozen. Brains were mounted on a cryostat sample holder with OCT and cooled on 
dry ice for 10 min. The sample holder was then transferred into the cryostat chamber 
and allowed to adjust for 5 min. Sagittal sections were cut at 100, 150 or 200 µm 
thickness and then attached to gelatin-coated slides with 1 drop of Solution C of the 
Rapid GolgiStain Kit. Slides were dried at RT O/N in the dark and stained on the next 
day. 
Golgi staining procedure  
Samples were washed in double-distilled H2O for 2 times 4 min. The silver staining 
was performed with a freshly prepared staining solution consisting of 1 part Solution 
D, 1 part Solution E of the Rapid GolgiStain Kit and 2 parts double-distilled H2O for 
10 minutes with frequent stirring. Sections were washed again for 2 times 4 min with 
new double-distilled H2O. Samples were de-hydrated with increasing ethanol 
concentration (50%, 70%, 96%, 100%, 100%, 100%, 100%) for 4 min each. The 
sections were cleared with xylene 3 times for 4 min and mounted with Entellan New. 
Golgi-stained sections were dried O/N in the dark and then stored at 4° C. Imaging 
was performed with a Leica DMI 6000 b microscope operated with LAS software and 
using a 100x dry objective. Access to the microscope was kindly granted by Prof. Dr. 
Tiago Outeiro. Analysis of spine density and shape was performed using the Imaris 
filament tracer (Figure 19). 




Figure 19 - Principle of Imaris filament tracer. Z-stacks from Golgi stained brain 
sections were projected in Imaris to trace dendrites in a semi-automated manner. 
Spines were identified and classified with the Imaris spine analyzer. 
 
 
2.2.7 Biochemical analysis 
Full brains (p0 animals) or cortex samples (p14 and older animals) were used for 
analysis of protein content in the test animals. In short, brains were homogenized, 
protein content quantified, run on an SDS-PAGE and proteins identified by western 
blot and immunological staining. The protocol is described in (Murdoch, et al., 2016). 
Brain/cortex homogenates 
Samples were removed from the -80° C freezer and immediately put in a 2 mL tube 
containing 1080 µL activated homogenization buffer (containing protease inhibitor 
and phosphatase inhibitor) and 3 metallic beads of ~4 mm diameter. Tubes were 
oscillated on a bead mill for 1 min (20 Hz for p0 brains, 30 Hz for other samples). 
Tubes were spun down with a centrifuge set to 11,000 g for 10 s and 120 µL 20% 
SDS was added to the tube. The oscillation – spin-down cycle was repeated a second 
time (without adding further SDS) and a third or fourth time if necessary (e.g. if tissue 
parts were still visible). Finally, the homogenates were mixed by passing 15-30 times 
through a 27G needle attached to a 1 mL syringe. 
Pierce BCA Protein Assay for protein quantification 
Protein content was quantified using the Pierce BCA Protein Assay kit (Bio-Rad) 
according to manufacturer’s instructions. Homogenates were diluted 1:40 in distilled 
H2O and 50 µL of the sample (in duplicate) or standard (with known concentrations of 
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albumin protein) added to 1 mL BCA working solution (consisting of 50 parts reagent 
A : 1 part reagent B). The mixture was incubated for 30 min at 37° C in the dark and 
the absorbance at 562 nm measured with a spectrophotometer. Protein content was 
calculated based on the absorbance measured in the known standards with Microsoft 
Excel 2013 software. Brain homogenates were adjusted to a protein concentration of 
50 µg in 12 µL 6x Laemmli buffer diluted 1:6 in distilled H2O. 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
SDS-PAGE was used to separate denatured proteins based on their molecular 
weight. Polyacrylamid gels were cast with the gel preparation system from Bio-Rad. 
The resolving gel, in which the proteins are separated, was made at a concentration 
of 10%, 12% or 15% polyacrylamide (see Table 13) depending on the molecular 
weight of the proteins of interest. High-concentration gels were preferably used for a 
good resolution of proteins with small molecular weight and low-concentration gels 
for proteins with high molecular weight. The gel was mixed in a 50 mL tube and then 
poured between the 2 glass plates of the gel preparation system and ~500 µL 
isopropanol added on top of the gel to level the top edge of the gel. After  ~30 min 
isopropanol was removed and the 4% stacking gel cast on top of the resolving gel. A 
10-well comb was set in the stacking gel before polymerization. The stacking gel  









dH2O 1.35 mL 3.95 mL 3.3 mL 2.3 mL 
30% Polyacrylamide 335 µL 3.35 mL 4 mL 5 mL 
1,0 M Tris (pH 6.8) 250 µL - - - 
1,5 M Tris (pH 8.8) - 2.5 mL 2.5 mL 2.5 mL 
10% SDS 20 µL 100 µL 100 µL 100 µL 
10% APS 20 µL 100 µL 100 µL 100 µL 
TEMED 2 µL 4 µL 4 µL 4 µL 
  Materials and Methods 
86 
 
accumulates the proteins from the wells so that they enter the stacking gel 
simultaneously. The brain homogenates diluted in Laemmli buffer were boiled for 5 
min at 95° C. After cool-down to RT, 50 µg sample / well were loaded together with a 
pre-stained PAGE ruler. The homogenates were run in running buffer at 70 V until the 
samples had passed the stacking gel. After that the voltage was increased to 130 V 
and the gel run until the leading band of the samples had almost passed the resolving 
gel. 
Protein transfer 
After resolving, the proteins were transferred to a nitrocellulose or polyvinylidene 
difluoride (PVDF) membrane. In case of the PVDF membranes, membranes were 
briefly activated in methanol for 15 s and washed in distilled H2O for 3 min. 
Nitrocellulose and PVDF membranes were equilibrated in cold transfer buffer before 
the transfer. The polyacrylamid gel was removed from the gel glass plates and the 
transfer was set up in the Bio-Rad wet transfer system. A “sandwich” was formed in 
this order: transfer sponge, 1 layer of Whatman paper, gel, membrane, Whatman 
paper, transfer sponge. The sandwich was clamped together, removing all air bubbles 
in the process and put in a transfer chamber filled with transfer buffer and a cooling 
pad. Transfer was run at 100 V for 90 min at 4° C. 
Imaging of fluorescence-tagged membranes with the Odyssey Infrared Imager   
After the transfer, the membrane was removed from the sandwich and blocked in 5% 
milk for 1h at RT. Several proteins of interest and a loading control were always 
stained on one membrane. For that reason, the membrane was cut, based on the 
protein ladder and the expected molecular weight of each protein. Primary antibodies 
were diluted according to manufacturer’s specifications in 5% milk and incubated O/N 
at 4° C on a shaker. The next day, the membrane was briefly rinsed 3 times with tris-
buffered salibe containing 1% tween 20 (TBS-T) and then washed 3 times 10 min 
each with TBS-T. A fluorescence-tagged secondary antibody was used at a dilution 
of 1:7500 and incubated on the membrane for 1 h at RT in the dark while shaking. 
The membrane was then quickly rinsed 3 times with TBS-T and washed for 3 times 
10 min with TBS-T. The membrane was briefly washed 3 times with TBS and then 
imaged on an Odyssey setup. The detected signal was exported as JPEG images 
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and band density quantified using Fiji software. Membranes were dried between 2 
Whatman papers and stored under dry conditions. 
Chemiluminescence development of membranes 
After transfer, the membranes were processed as for imaging on the Odyssee setup 
until the washing step after the primary antibody (s. above). An horseradish 
peroxidase (HRP)-conjugated secondary antibody was used at a dilution of 1:2000-
1:5000 and incubated on the membrane for 50 min at RT while shaking. The 
membrane was then quickly rinsed 3 times with TBS-T and washed for 3 times 10 
min with TBS-T. The membrane was briefly washed 3 times with TBS and then 
incubated with Luminata Western HRP substrate classic or forte for 3 min. The signal 
was detected on X-ray films with an AGFA Curix 60 processor. The developed films 
were dried and scanned on an Epson Perfection V850 Pro Scanner. The band density 
was quantified with Fiji software.  
  88 
3. Results 
3.1. Characterization of motor behavior tests for aging mice 
 
This study was largely conducted in an endophilin-A (henceforth endophilin) deficient 
mouse model. There are three genes that encode for endophilin in mammals, 
therefore different genetic combinations of endophilin KOs were used to elucidate the 
influence of specific endophilin proteins on motor behavior and CNS morphology 
(Figure 20). The genotypes used for this thesis were endophilin 1KO-2WT-3WT mice, 
which have a normal lifespan and fertility and show no motor impairments, as well as 
endophilin 1KO-2HT-3WT, endophilin 1KO-2WT-3KO and endophilin 1KO-2HT-3KO 
mice, which have reduced lifespan and fertility and display seizures with aging (Figure 
20).  
To address how motor behavior changes with aging, the gait of BL6 WT animals was 
analyzed on a motorized treadmill.  The setup was equipped with a high-speed video 
 
Figure 20 - The endophilin mouse model. Comparison of different endophilin-A 
mutants and the synaptojanin-1 and dynamin-1,3 mouse models. Complete KO of any 
of these endocytic proteins leads to death within a few hours after birth, while animals 
with partial deletion of the proteins have either a strong, mild or normal phenotype, 
depending on how many alleles are deleted in the model. Modified from (Murdoch, et 
al., 2016).  
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camera under the transparent treadmill to record the underside of the animal while 
running (Figure 21 A). From the recorded videos several gait parameters can be 
calculated. The principle of this calculation is to measure the paw area over time for 
every single paw (Figure 21 B) and determine parameters that define gait rhythm and 
posture at an adjustable speed. Examples for these parameters are listed in Table 12. 
 
Figure 21 - Principle of gait recording. (A) Schematic drawing and photo of a 
DigiGait treadmill. (B) Principle of gait analysis on the DigiGait setup. The underside 
of the animal is filmed with a high-speed camera and the paw area over time 
determined. In addition paw positioning in relation to snout-tail axis and midline is 
determined. Modified from (Rostosky & Milosevic, 2018). 
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Analysis of young and aged WT animals showed that stance width did not change 
with age (Figure 22 A) but stance/swing timing and limb loading did increased (Figure 
22 B and D) and paw drag decreased with age (Figure 22 C). This shows that some 
aspects of gait are not affected by age while other parameters can be used to study 
normal and accelerated aging. As a result, gait analysis was added to a battery of 
motor behavior tests to describe aging and neurodegeneration in endophilin mutants. 
 
Figure 22 - Gait parameters change in aging WT mice. (A) Normalized stance 
width (distance between hind limbs / body width), (B) stance-swing timing (stance 
time / swing time), (C) paw drag (paw area between full stance and paw lift-off) and 
(D) limb loading (max dA/dt; maximal deceleration) of the hind limbs of BL6 WT 
animals from the age of 1-18 months. Running speed 20 cm/s. Normalized stance 
width was stable over aging but stance/swing timing and limb loading increased over 
time while paw drag decreases with age. Significance by Dunnett-corrected one-way 
ANOVA (compared to 1 month) is displayed in the tables. ****=p<0.0001; 
***=p<0.001; **=p<0.01; *=p<0.05.  
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3.2. Motor behavior in endophilin-A mutants 
 
3.2.1 Endophilin mutants display reduced muscle strength 
Motor behavior tests (gait analysis, Rotarod) were performed on endophilin mutants 
between the age of 1-18 months to minimize suffering of endophilin 1KO-2HT-3KO 
animals that display epileptic seizures and die between the ages of 18-20 months. 
Firstly, test animals were measured for body weight and muscle strength to assess 
general motor capacity to perform in motor behavior tests.  
The body weight was found to increase throughout life in WT animals but was reduced 
in endophilin 1KO-2HT-3KO animals starting at an age of 9 months (Figure 23 A). 
Other endophilin mutants had normal body weight compared to WT. The maximal grip 
strength was unchanged in endophilin mutants at a young age but reduced with aging 
starting already at an age of 3 months in endophilin 1KO-2HT-3KO mice (Figure 23 
B). The grip strength normalized to body weight declined in WT animals over aging 
but declined faster in various endophilin mutants (Figure 23 C). 
 
 
Figure 23 - Grip strength is reduced in endophilin mutants. (A) Body weight, (B) 
maximal grip strength and (C) normalized grip strength (max grip strength / body 
weight) of WT (black), endophilin 1KO-2WT-3WT (dark green), 1KO-2HT-3WT (light 
green), 1KO-2WT-3KO (dark blue) and 1KO-2HT-3KO (light blue) mice over the age 
of 1-18 months. Graphs show mean±SEM. Significance by Dunnett-corrected one-
way ANOVA (compared to WT) is displayed in the tables above the charts. 
****=p<0.0001; ***=p<0.001; **=p<0.01; *=p<0.05. kgf= kilogram force 
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3.2.2 Motor coordination is severely impaired in endophilin mutants 
To assess motor coordination and balancing, endophilin mutants were then subjected 
to Rotarod testing (Figure 24). In this test, animals were trained for two days for two 
trials of 180 seconds each during which the animals were running on a rod that rotated 
on a constant speed of 5 rotations per minute (rpm). During this fixed-speed Rotarod 
(FSRR) test, most endophilin mutants initially performed as well as WT animals but 
displayed decreased fall latency depending on the amount of missing endophilin 
alleles and their age. For example, endophilin 1KO-2WT-3WT mice performed as 
good as WT animals until the age of 18 months while 1KO-2HT-3KO animals 
performed significantly worse than WT animals already at an age of 1 months (Figure 
24 A). 
After the training phase, animals were tested on the accelerated Rotarod (ARR). 
Similar to the results of the FSRR, endophilin mutants showed decreased 
 
Figure 24 - Rotarod performance is impaired in endophilin mutants. Fall latency 
from the fixed-speed (A) and accelerated Rotarod (B). WT (black), endophilin 1KO-
2WT-3WT (dark green), 1KO-2HT-3WT (light green), 1KO-2WT-3KO (dark blue) and 
1KO-2HT-3KO (light blue) mice were tested over the age of 1-18 months. Fall latency 
was significantly reduced in endophilin mutants depending on the number of missing 
endophilin alleles and age. Graphs show mean±SEM. The 6-month time point for 
endophilin 1KO-2WT-3KO mice was excluded from the analysis of FSRR due to 
technical problems at the test day. Significance by Dunnett-corrected one-way 
ANOVA (compared to WT) is displayed in the tables above the charts. ****=p<0.0001; 
***=p<0.001; **=p<0.01; *=p<0.05. 
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fall latency of the ARR (Figure 24 B). Again, it can be observed that the more 
endophilin alleles are missing, the earlier the motor deficiencies are recorded in 
endophilin mutants. 
Given endophilin’s links to neurodegeneration and especially to PD (see chapter 
1.7.1), endophilin mutants were tested by video based gait recording to detect gait 
abnormalities. On the DigiGait setup animals were recording running on a transparent  
Figure 25 - Running speed is reduced in endophilin mutants. (A) Average running 
speed of WT (black), endophilin 1KO-2WT-3WT (dark green), 1KO-2HT-3WT (light 
green), 1KO-2WT-3KO (dark blue) and 1KO-2HT-3KO (light blue) animals on a 
DigiGait treadmill over the age of 1-18 months. Endophilin 1KO-2HT-3KO mice have 
a significantly reduced running speed from the age of 3 months. Graph shows 
mean±SEM. Significance by Dunnett-corrected one-way ANOVA (compared to WT) 
is displayed in the table above the chart. ****=p<0.0001; ***=p<0.001; **=p<0.01; 
*=p<0.05. (B) Percentage of animals able to run 30 cm/s (dark green), 20 cm/s (light 
green), 10 cm/s (orange) or refuse to run on the DigiGait (red) for the indicated 
genotypes and ages. The percentage of animals refusing to run on the DigiGait 
increased continuously in endophilin 1KO-2HT-3KO mice starting from the age of 6 
months. 
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treadmill at 10, 20 and 30 cm/s. However, some endophilin mutants were not able to 
run at the maximum recording speed or refused running on the setup altogether 
(Figure 25). 
Specifically, endophilin 1KO-2HT-3KO were capable of running at the highest tested 
speed at a young age, but 81.5% of these animals refused running at the age of 18 
months (Figure 25 B). Because of this, the running speed of 20 cm/s was selected to 
perform a detailed gait analysis. This speed records the mice while running (unlike at 
10 cm/s which comes closer to walking than running) but includes more animals for 
analysis than videos recorded at 30 cm/s as more animals are able to run at 20 cm/s. 
From these videos recorded on the DigiGait setup, several parameters were 
calculated to describe gait in WT mice and the different endophilin mutants (as 
detailed in Rostosky & Milosevic, 2018). A list of analyzed parameters is found in 
Table 12. 
 
3.2.3 Gait rhythm and posture are altered in endophilin mutants 
At a medium running speed of 20 cm/s, swing time (time the paw is in the air) and 
stance time (time the paw is in contact with the belt) were not changed in either fore 
limbs (Figure 26 A-B) or hind limbs (Supplemental Figure 1 A-B). However, during 
stance in fore limbs the propel time (time between max. paw area to paw lift-off) was 
reduced in all tested endophilin mutants in favor of brake time (time from paw first 
contact to the belt to max. paw area; Figure 26 C-D) while these parameters were not 
changed in hind limbs (Supplemental Figure 1 C-D). These data indicate that the gait 
rhythm is overall very similar in WT and endophilin deficient mice, though fine 
differences can be spotted in fore limb brake/propel timing. 
Besides measuring basic gait rhythm, video based gait recording was used to 
describe the posture of the animal during running. One example for such a parameter 
is the paw angle (the angle of the paw to the snout-tail axis). The paw angle was 
decreased in all endophilin mutants while at the same time the paw angle variability 
(the standard deviation of the paw angle) was increased (Figure 27 A-B). Moreover, 
endophilin 1KO-2HT-3KO mice relied more often on shared stance (Figure 27 C) and 
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had a decreased overlap of fore and hind paws on each side (Figure 27 D). This 
indicates that the posture of endophilin mutants is slightly changed during running. 
 
Figure 26 - Fore limb coordination is impaired in endophilin mutants. Gait timing 
parameters of WT (black), endophilin 1KO-2WT-3WT (dark green), 1KO-2HT-3WT 
(light green), 1KO-2WT-3KO (dark blue) and 1KO-2HT-3KO (light blue) animals 
recorded from the fore limbs on a DigiGait treadmill over the age of 1-18 months. (A) 
Stance time = time the paw is in contact with the ground. (B) Swing time = time the 
paw is in the air. (C) Brake time = during stance, the time that the paw area is 
increasing. (D) Propel time = during stance, the time that the paw area is decreasing. 
While stance and swing time were not affected in endophilin mutants, brake time was 
increased in aged endophilin deficient animals and at the same time propel time was 
decreased. Running speed = 20 cm/s. Graphs show mean±SEM. Significance by 
Dunnett-corrected one-way ANOVA (compared to WT) is displayed in the tables 
above the charts. ****=p<0.0001; ***=p<0.001; **=p<0.01; *=p<0.05. 
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In summary, endophilin deficient mutants displayed progressive motor impairments 
depending on the number of deleted endophilin alleles and the age. The impairments 
could be observed by a mild reduction of body weight and muscle strength and a very  
 
Figure 27 - Posture parameters are changed in running endophilin mutants. 
Hind limb posture parameters at 20 cm/s for WT (black), endophilin 1KO-2WT-3WT 
(dark green), 1KO-2HT-3WT (light green), 1KO-2WT-3KO (dark blue) and 1KO-2HT-
3KO (light blue) animals recorded from the hind limbs on a DigiGait treadmill over the 
age of 1-18 months. (A) Paw angle = angle between the paw and the snout-tail axis. 
(B) Paw angle variability = standard deviation of the paw angle. (C) Shared stance = 
time both hind limbs are in contact with the ground at the same time. (D) Paw 
placement positioning = extent of overlap between ipsilateral fore and hind paws 
during full stance. Running speed = 20 cm/s. Graphs show mean±SEM. Significance 
by Dunnett-corrected one-way ANOVA (compared to WT) is displayed in the tables 
above the charts. ****=p<0.0001; ***=p<0.001; **=p<0.01; *=p<0.05. 
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strong reduction in general motor coordination (Rotarod) and running ability (running 
speed on the DigiGait). These changes were most obvious in endophilin 1KO-2HT-
3KO mice which have only 1 out of 6 endophilin alleles left. In addition to the strong 
phenotype on the Rotarod, gait rhythm was mildly affected in the fore limbs of these 
animals and overall posture during running also deviated from WT controls. In 
summary, the motor deficits in endophilin mutants go beyond the normal motor 




3.3. Motor behavior in other endocytic mutants 
 
To investigate if the observed motor behavior phenotype is shared by other mouse 
models for defective endocytosis, aged synaptojanin-1HT and dynamin 1HT-3KO 
mice were also tested by motor behavior tests. Similar to endophilin 1KO-2WT-3WT 
these animals have no apparent phenotype by home cage observation and have a 
normal life span. 
 
3.3.1 Synaptojanin-1 HT mice have no obvious motor impairments 
As synaptojanin-1 KO mice die within a few hours after birth, motor behavior tests 
were conducted on aged synaptojanin-1 HT animals and controls. Gait analysis 
showed that synaptojanin-1 HT and WT animals were able to reach the same 
maximum speed at 18 months of age (Figure 28 A). Detailed analysis of gait 
parameters revealed no differences in key parameters such as the shared stance 
(Figure 28 B). Further analysis revealed that neither muscle strength nor Rotarod 
performance were altered in synaptojanin-1 HT animals (Figure 28 C-D). Overall, no 
motor impairments could be detected with the employed methods in aged 
synaptojanin-1 HT mice. 




Figure 28 - Motor behavior is unaffected in synaptojanin-1 deficient mice. (A) 
Percentage of animals able to run 30 cm/s (dark green) and 20 cm/s (light green) for 
the indicated genotypes and ages. (B-C) Motor parameters for WT (black) and 
synaptojanin-1 HT (blue) animals at 12, 15 and 18 months of age. (B) Shared stance 
= time both hind limbs are in contact with the ground at the same time at 20 cm/s. (C) 
Grip strength normalized to body weight. (D) Fall latency from the ARR. Graphs 
represent mean±SEM. No significant differences were detected between 
synaptojanin-1 WT and HT animals by two-tailed Student’s t-tests. 
 
 
3.3.2 Dynamin mutants display mild motor impairments 
The other tested model used was dynamin-1,3 deficient animals. Like endophilin TKO 
and synaptojanin-1 KO animals, dynamin-1,3 DKO mice die shortly after birth and can 
hence not be used for motor behavior testing (Figure 20 A). Motor behavior testing 
was thus performed on aged dynamin 1HT-3KO animals. These animals were able to 
run on the maximal running speed on the DigiGait treadmill both at young and older 
ages (Figure 29 A). They displayed an increase in the percentage of shared stance 
as compared to WT animals at a young age but the difference was no longer observed 
at 18 months of age (Figure 29 B) as the usage of shared stance also increased with 
aging in WT animals (compare also Figure 27 C). 
On the other hand, grip strength was unaffected in the tested dynamin mutants at 3 
months of age but was significantly lower in aged dynamin-1,3 mutants (Figure 29 C). 
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Rotarod performance was significantly reduced at 3 months of age but remained on 
that level until the age of 15 months, while the performance of WT animals gradually 
decreased with aging (Figure 29 D, compare also Figure 24). At 18 months however, 
the ARR performance of dynamin-1,3 mutants was again significantly decreased as 
compared to WT (Figure 29 D). 
These data show that aged synaptojanin-1 HT animals have no motor impairments 
that could be detected with the employed methods. Dynamin 1HT-3KO mice display 
mild motor impairments that become evident at a young age. However, while motor 
performance deteriorates with aging in WT animals, the motor abilities deteriorate 
much less of dynamin 1HT-3KO mice. 
 
Figure 29 - Motor behavior is slightly impaired in dynamin-1,3 deficient mice. 
(A) Percentage of animals able to run 30 cm/s (dark green) and 20 cm/s (light green) 
for the indicated genotypes and ages. (B-C) Motor parameters for WT (black), and 
dynamin 1HT-3KO (turquois) animals at 3, 15 and 18 months of age. (B) Shared 
stance = time both hind limbs are in contact with the ground at the same time at 20 
cm/s. (C) Grip strength normalized to body weight. (D) Fall latency from the ARR. 
Locomotion was not affected in aged dynamin mutants while grip strength and 
Rotarod performance was slightly decreased in dynamin mutant. Graphs represent 
mean±SEM. Significance stars represent ***=p<0.001; **=p<0.01; *=p<0.05 by two-
tailed Student’s t-tests.  
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3.4. Cell death in endophilin mutants 
 
As defective endocytosis is strongly linked to various forms of neurodegeneration 
(see chapter 1.7.1) the different endophilin mutants were tested for cell death as a 
sign of neurodegeneration in the CNS. In the first step, endophilin 1,2 DKO 
(henceforth DKO), 18 month-old 1KO-2HT-3KO and appropriate control animals were 
perfused with PFA to pre-fixate the brain and avoid degradation. Cryosections of 
these brains were used for the stainings described in this section. Likewise, brains 
from p0 endophilin TKOs were dissected, frozen and used for stainings. Endophilin 
DKO and TKO animals have a significantly reduces lifespan (a few hours for TKOs 
and ~21 days for DKOs, see Figure 20) and are smaller than their littermates. DKO 
animals also display ataxia and neurodegeneration (Milosevic, et al., 2011). 
 
3.4.1 TUNEL staining reveals cell death in endophilin DKOs and aged 1KO-
2HT-3KO mice but not TKOs 
TdT-mediated dUTP-biotin nick end labeling (TUNEL) test was first performed on 
endophilin DKO brains to visualize all apoptotic and necrotic cells. Examination of 
different brain regions, including the cortex, hippocampus and cerebellum, revealed 
that while the number of TUNEL positive cells in WT and endophilin 1KO-2WT-3WT 
brains was extremely low, more TUNEL-positive cells were found in all brain regions 
of endophilin DKO mice (Figure 30). 
TUNEL staining on endophilin TKO and control brains collected ~3-4 hours after birth 
revealed a large number of apoptotic/necrotic cells both in control and endophilin TKO 
brains (Figure 31 A). In fact, the number of TUNEL positive cells was slightly higher, 
yet not significantly so, in WT brains than in endophilin TKO brains. On the other 
hand, 18-month-old endophilin 1KO-2HT-3KO brains showed a low number of 
TUNEL-positive cells while no such cells were detected in WT cortex or hippocampi 
(Figure 31 B). Together, these data show a slight increase in apoptotic and/or necrotic 
cells which cannot be observed in p0 endophilin TKO brains, possibly due to high 
prevalence of apoptotic cells shortly after birth (Figure 31 A, WT signal). 




Figure 30 - Increase of apoptotic / necrotic cells in endophilin DKO brains. (A-
D) 10 µm thick cryosections of p18 WT (B), endophilin 1KO-2WT-3WT (C) and 
endophilin DKO (D) brains stained by TUNEL. (A) WT brains treated by DNAse were 
used as positive control. Cortex (left), hippocampus (middle) and cerebellum (right) 
were imaged for TUNEL signal. Scale bars represent 50 µm. (E) Quantification of 
TUNEL signal in (B-D). Graphs represent mean±SEM. 






Figure 31 - Increase of apoptotic/necrotic cells in aged endophilin mutants. (A) 
10 µm thick cryosections of p0 WT and endophilin TKO brains stained by TUNEL. WT 
brains treated by DNAse were used as positive control (left). Motor cortex (top) and 
hippocampus (bottom) were imaged for TUNEL signal. (B) 10 µm thick cryosections 
of 18-month-old WT and endophilin 1KO-2HT-3KO brains stained by TUNEL. WT 
brains treated by DNAse were used as positive control (left). Motor cortex (top) and 
hippocampus (bottom) were imaged for TUNEL signal. Scale bars represent 50 µm. 
(Right) Quantification of TUNEL signal. Graphs represent mean±SEM. 
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As TUNEL staining revealed that there is an increase in necrotic/apoptotic cells in 
endophilin DKO and aged 1KO-2HT-3KO brains, cryosections from these animals 
were tested for glia cell activity. Glia cells aid in the removal of cell debris after cell 
death (reviewed in Khakh & Sofroniew, 2015; Nayak, Roth, & McGavern, 2014, see 
also chapter 1.1). Immunostaining for the astroglia cell marker glial fibrillary acidic 
protein (GFAP) showed a prominent increase of gliosis in p18 endophilin DKO brains 
(Figure 32 A) that was not detected in 18-month-old endophilin 1KO-2HT-3KO brains 
(Figure 32 B). 
 
 
Figure 32 - Gliosis in the cortex of endophilin mutants. (A) 10 µm thick 
cryosections of p18 WT, endophilin 1KO-2WT-3WT and endophilin DKO brains 
immunostained for the glial fibrillary acidic protein (GFAP). (B) 10 µm thick 
cryosections of 18-month-old WT and endophilin 1KO-2HT-3KO brains 
immunostained for GFAP. Scale bars represent 50 µm. (right) Quantification of GFAP 
intensity. GFAP intensity was increased in endophilin DKO but not in endophilin 1KO-
2HT-3KO brain sections. Graphs represent mean±SEM. *=p<0.05 by two-sided 
Student’s t-test. 
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3.4.2 The apoptosis marker caspase 3 is enriched in endophilin but not in 
synaptojanin-1 brain sections 
Given the high level of TUNEL signal in WT brain sections, an increase in cell death 
in endophilin TKO brains might be undetectable by the TUNEL assey because 
apoptosis occurs as part of normal development at p0 also in WT brains and may 
obscure any abnormal increase in apoptosis. To address this possibility, brains were 
immunostained for caspase 3 activity. Cleavage of caspase-3 is an early step in 
apoptosis (Porter & Jänicke, 1999). Immunostainings on cryosections showed that 
the number of cleaved caspase 3 postive cells was significantly increased in 
endophilin TKO brains (Figure 33). This finding suggests that there is an increase in 
apoptotic activity in endophilin TKO brains. 
 To understand whether the increase in caspase 3 activity is a commen feature of 
endocytic deficient animals, brain sections from synaptojanin-1 KO mice were also 
subjected to caspase 3 immunostainings. These stainings show that while cleaved 
caspase 3 signal does trend up in synaptojanin-1 KO brains, the difference was not 
significant (Figure 34). 
 
Figure 33 - Increased apoptotic activity in the endophilin TKO cortex. 10 µm thick 
cryosections of p0 WT, endophilin 1KO-2WT-3KO and endophilin TKO brains 
immunostained for cleaved caspase 3. DAPI co-staining. Scale bar represents 50 µm. 
Insert shows one cleaved caspase 3 positive nucleus. (Right) Quantification of 
TUNEL signal. Graphs represent mean±SEM. Significantly more cleaved caspase 3 
positive cells were found in endophilin TKO brains compared to WT. *=p<0.05 by one-
sided Student’s t-test. 




Figure 34 - No increase of apoptotic activity in synaptojanin-1 deficient cortex. 
10 µm thick cryosections of p0 WT and synaptojanin-1 KO brains immunostained for 
cleaved caspase 3. DAPI co-staining. Scale bar represents 50 µm. (Right) 
Quantification of TUNEL signal. Graphs represent mean±SEM. The number of 
cleaved caspase 3 positive cells in synaptojanin-1 KO sections trended compared to 
WT. No significant differences were found by one-sided Student’s t-test. 
 
 
3.4.3 A-synuclein levels and distribution are altered in endophilin DKOs 
Given the links of defective endocytosis to PD (see chapter 1.7.1) and the observed 
motor deficits in endophilin deficient mice (see chapter 3.2), a prominent factor for 
PD, α-synuclein, was investigated in endophilin DKO brains. A-synuclein is found in 
protein aggregates throughout the brain of most PD patients. To test whether α-
synuclein forms aggregates or is enriched in the endophilin mouse model, brain 
sections were stained for α-synuclein. Overview stainings of the hippocampus 
showed a decrease in overall α-synuclein intensity compared to littermate controls 
(Figure 35 A). Interestingly, further investigation of α-synuclein puncta showed no 




Figure 35 - A-synuclein decreases in endophilin DKO brains and forms bigger 
puncta. Immunostainings for α-synuclein of 10 µm thick cryosection from p18 
endophilin 1KO-2WT-3WT and endophilin DKO brains. Overview (A, C) and detailed 
recording (B,D) of the hippocampus (A-B) and motor cortex (C-D) (A and C) Scale 
bar 400 µm. A-synuclein intensity is quantified in the graphs. (B and D) Scale bar 40 
µm. Number of α-synuclein puncta and puncta size is quantified in the graphs. Graphs 
represent mean±SEM. *=p<0.05 by two-sided Student’s t-test.   




increase in the number of α-synuclein puncta (Figure 35 B). However, the average 
size of these puncta was significantly higher in endophilin DKO than in control 
hippocampi. The decrease in α-synuclein intensity was also found in the cortex of 
endophilin DKOs, but there was no change in α-synuclein puncta in this brain region 
(Figure 35 C-D). 
To look into more subtle changes of brain morphology, the Golgi silver staining 
method, which randomly stains single cells in the nervous system, was used on 
endophilin DKO mice. Brain sections were imaged and processed with the Imaris 
filament tracer (Figure 36 A). The spine density as well as the spine classification was 
analyzed. However, no significant changes in the spine density or the number of 
mature mushroom-type spines were found in the hippocampus and substantia nigra 
of endophilin DKO brains (Figure 36 B). 
 
Figure 36 - Spine density and size are not changed in endophilin DKO mutants. 
(A) Reconstruction of dendritic spines in the substantia nigra by Imaris filament tracer 
of p18 endophilin 1KO-2WT-3KO and DKO brain sections. (B) Spine analysis of 
endophilin DKO and littermate controls. Spine density = number of spines / µm 
dendrite. Elongated spines = spines that have a mean head width ≥ mean neck width 
and length > 2 µm. Mushroom type spines = spines that have a max head width > 
mean neck width x 1.5. Graphs represent mean±SEM. No significant changes were 
found in endophilin DKO brain sections by two-sided Student’s t-test. 




In summary, endophilin mutants show an increase in cell death by TUNEL staining in 
endophilin DKO and 18-month-old endophilin 1KO-2HT-3KO brains that in case of 
the endophilin DKOs is accompanied by gliosis. In p0 endophilin TKO brains, an 
increase of caspase 3 activity could be detected, that was not observed in 
synaptojanin-1 KO brains. In addition, immunostainings for the PD associated protein 
α-synuclein showed differences in the levels and distribution in endophilin DKO brain 
sections. However, dendritic spine analysis revealed no difference in these animals. 
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3.5. Autophagy impairments in endophilin mutants 
 
NGS analysis of endophilin TKO and DKO brains has revealed that the most strongly 
up-regulated gene in endophilin deficient brains is the E3 ubiquitin ligase Fbxo32 
(Murdoch, et al., 2016; see also chapter 1.4.1). Fbxo32 up-regulation was further 
confirmed by quantitative PCR and western blot analysis of endophilin TKO and DKO 
brains (Murdoch, et al., 2016).  
 
3.5.1 Fbxo32 is misregulated in aged endophilin 1KO-2HT-3KO mice 
Brain homogenates from aged endophilin 1KO-2HT-3KO mice were thus analyzed by 
western blot and it was found that Fbxo32 is not changed at the age of 3 or 9 months, 
but in fact become up-regulated by the age of 18 months (Figure 37). 
 
Figure 37 - Fbxo32 protein levels are increased in aged endophilin 1KO-2HT-
3KO brains. Fbxo32 levels relative to HPRT loading control was assessed by western 
blot at 3, 9 and 18 months. Change toward WT is shown in the graph. Fbxo32 is up-
regulated in 18-month-old endophilin 1KO-2HT-3KO mice. Graphs represent mean 
fold change vs WT±SEM. *=p<0.05 by two-sided Student’s t-test. 
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The expression of Fbxo32 is regulated by the transcription factors Foxo1 and Foxo3A 
(Sandri, et al., 2004). Foxo3A was also found to be up-regulated in endophilin TKO 
and DKO brains by NGS analysis, while Foxo1 levels are unchanged (Murdoch, et 
al., 2016). Of interest, the phosphorylation of Foxo3A at Ser253, which inhibits its 
transcriptional activity, was found to be decreased (Murdoch, et al., 2016). 
Immunostaining for this inhibitory phosphorylated form of Foxo3A in endophilin TKO 
cryosections also showed an altered distribution of Foxo3A in the hippocampus where 
it was accumulated in small, high-intensity puncta (Figure 38). These findings suggest 
that the transcriptional regulation of Fbxo32 is functioning abnormally and thereby 
favor high expression levels of Fbxo32 in endophilin mutants. 
 
Figure 38 - Foxo3A-P mislocalizes in endophilin TKO brains. Immunostaining for 
Foxo3A(Ser253)-P (green), co-stained for DAPI (blue) in the hippocampus of p0 WT 
(top) and endophilin TKO (bottom) cryosections. Phosphorylated Foxo3A formed 
puncta that give a high intensity signal in endophilin TKO brain sections. Scale bar 
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3.5.2 Poly-ubiquitinated proteins accumulate in endophilin mutants but not in 
synaptojanin-1 or dynamin deficient brains 
 
As Fbxo32 is an E3 ubiquitin ligase that targets proteins for degradation through the 
UPS (see chapter 1.6.2), brains from endophilin DKO and TKO mice were analyzed 
for levels of poly-ubiquitinated proteins. To this end, brain homogenates were 
analyzed by western blots using three distinct markers of poly-ubiquitination: total 
poly-ubiquitin, K48-linkage specific poly-ubiquitin and K63-linkage specific poly- 
ubiquitin. K48- and K63- specific antibodies reflect different systems of the lysine 
 
Figure 39 - Increase of poly-ubiquitinated proteins in endophilin DKO and TKO 
brains. (A) Relative protein levels (normalized to GAPDH or actin) of total poly-
ubiquitin (left), K48 linkage specific poly-ubiquitin (middle) and K63 linkage specific 
poly-ubiquitin (right) in p18 endophilin 1HT-2HT-3WT and endophilin DKO brain 
homogenates was assessed by western blot analysis. (B) Relative protein levels 
(normalized to actin) of K48 linkage specific poly-ubiquitin (left) and K63 linkage 
specific poly-ubiquitin (right) in p0 WT and endophilin TKO brain homogenates was 
assessed by western blot analysis. Total poly-ubiquitination as well as K48 specific 
poly-ubiquitination was increased in the endocytic mutants, while K63 specific poly-
ubiquitination was unchanged. Graphs represent mean±SEM. **=p<0.01; *=p<0.05 
by two-sided Student’s t-test. 
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based elongation of the ubiquitin tail. While K48-linkage of ubiquitin marks proteins 
for degradation through the UPS, K63-linkage plays a role in signaling (Sadowski, 
Suryadinata, Tan, Roesley, & Sarcevic, 2012; Pickart & Fushman, 2004; Ben-
Saadon, Zaaroor, Ziv, & Ciechanover, 2006; Silva, Finley, & Vogel, 2015; see also 
chapter 1.5.5). 
In endophilin DKO brains, total poly-ubiquitin levels were significantly increased 
compared to littermate controls (Figure 39 A). This raise was likely due to an increase 
in K48 specific ubiquitination, as, measured by specific antibodies, there was a 
significant increase in K48 specific poly-ubiquitin levels while the levels of K63-linked 
poly-ubiquitin were unchanged (Figure 39 A). It has previously been shown that total 
polyubiquitin levels are up-regulated in endophilin TKO brains (Cao, Milosevic, 
Giovedi, & De Camilli, 2014). In addition, in endophilin TKO brain homogenates K48-
specific poly-ubiquitin was increased significantly, while at the same time, K63 poly- 
ubiquitin levels were normal (Figure 39 B). This shows that endophilin mutants have 
an increase of proteins being marked for proteasomal degradation. 
 
Figure 40 - Poly-ubiquitination is unaffected in synaptojanin and dynamin 
mutants. (A) Relative protein levels (normalized to GAPDH) of total poly-ubiquitin in 
p0 WT and synaptojanin-1 KO (left) and WT, dynamin 1WT-3KO and dynamin 1,3 
DKO (right) brain homogenates were assessed by western blot analysis. (B) 
Quantification of protein levels in (A) Graphs represent mean±SEM. No significant 
differences were detected by two-sided Student’s t-test. 
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Synaptojanin-1 KO and dynamin 1,3 DKO brains were collected at p0 to test whether 
this finding is also observed in other endocytic mutants. Interestingly, in both mouse 
models, there was no detectable increase of poly-ubiquitination (Figure 40). This 
indicates that these endocytic mutants do not have an increase in E3 dependent 
protein-ubiquitination or that their UPS is capable of compensating for such an 
increase. 
 
3.5.3 Autophagy markers are dysregulated in endophilin mutants 
Given the proposed role of Fbxo32 as a regulator between protein degradation 
through the UPS and the autophagy system (Zaglia, et al., 2014; see also chapter 
1.6.3), several autophagy markers have been investigated in endophilin DKO and 
TKO brains (Murdoch, et al., 2016). This includes the early autophagy marker Atg5, 
which plays a role in the formation of the autophagophore (see chapter 1.5.2) and 
 
Figure 41 – Atg5 protein levels are reduced in aged endophilin 1KO-2HT-3KO 
brains. Atg5 levels relative to HPRT loading control were assessed by western blot 
at 3, 9 and 18 months. Atg5 was down-regulated in 9 and 18-month-old endophilin 
1KO-2HT-3KO mice. Graphs represent mean fold change vs WT±SEM. *=p<0.05 by 
two-sided Student’s t-test. 
 
  Results 
114 
 
was found to be significantly down-regulated in both endophilin TKO and DKO 
animals (Murdoch, et al., 2016).  
To understand if autophagy is also affected in the model of aged endophilin 1KO-
2HT-3KO mice used for the motor behavior tests (see chapter 3.2) brain 
homogenates from these animals were analyzed by western blot. Biochemical 
analysis showed that while Atg5 levels were normal at 3 months of age, they were 
significantly reduced at the ages of 9 and 18 months in endophilin 1KO-2HT-3KO 
brains (Figure 41). 
Two other autophagy factors, Atg9a and Atg16l, have been reported to be trafficked 
through CME (Ravikumar, Moreau, Jahreiss, Puri, & Rubinsztein, 2010; Puri, Renna, 
Bento, Moreau, & Rubinsztein, 2014). As they are part of the machinery that forms 
the autophagosome, their availability during the process might be a crucial factor for 
effective autophagy. As endophilin plays a key role in CME, it is possible that defective 
endocytosis of these two factors could result in impaired autophagy. 
However, testing for protein levels of both autophagy factors showed that they were 
not changed in endophilin TKO (Figure 42 A) or endophilin DKO brain homogenates 
(Figure 42 B). This indicates that both factors are available at normal levels in 
endophilin mutants and are therefore unlikely to be the cause of autophagy 
impairments in endophilin deficient brains.  
Interestingly, the other family member of the endophilin family, endophilin B, has 
previously been reported to play a role in autophagy (reviewed in Kjaerulff, Brodin, & 
Jung, 2011; see also chapter 1.3.1). Given the structural similarity of endophilins A 
and B, it is possible that endophilin A might play a similar role in autophagy as its 
family member endophilin B. However, endophilin B1 protein levels were not changed 
in endophilin A TKO brain homogenates (Figure 42 C). This indicates that in case 
endophilin A does play a role in autophagy, endophilin B is not able to compensate 
for its loss in endophilin TKO brains. 
To confirm that defective endocytosis is not the cause of the low levels of autophagy 
markers, other endocytic mutants were also tested for Atg5 protein levels. When 




Figure 42 - Levels of Atg9a and Atg16l are unchanged in endophilin mutants. 
(A) Relative protein levels (normalized to HPRT) of Atg9a and Atg16l of p0 WT, 
endophilin 1KO-2WT-3KO and endophilin TKO brain homogenates. (B) Relative 
protein levels (normalized to HPRT) of Atg9a and Atg16l of p18 endophilin 1HT-2HT-
3WT and endophilin DKO brain homogenates. Part of the western blots for this figure 
were done by Dr. Amandeep Arora (ENI, Göttingen). (C) Relative protein levels 
(normalized to HPRT) of endophilin B1 of p0 WT, endophilin 1KO-2WT-3KO and 
endophilin TKO brain homogenates. Graphs represent mean±SEM. No significant 
changes were detected by two-sided Student’s t-test. 
 
testing synaptojanin-1 KO and dynamin 1,3 DKO mouse brain homogenates by 
western blot, they revealed no change in Atg5 levels in these animals (Figure 43). 
This provides further evidence that the loss of endophilin does not indirectly result in 
the autophagy impairment by abolishing endocytosis of important autophagy factors 
but suggests a more direct role of endophilin in this process. 
In summary, biochemical analysis of endocytic mutants showed that the up-regulation 
of the E3-ubiquitin ligase Fbxo32 is a common feature of all endophilin mutants  




Figure 43 - Atg5 protein levels are unchanged in synaptojanin and dynamin 
mutants. (A) Relative protein levels (normalized to HPRT) of Atg5 in p0 WT and 
synaptojanin-1 KO (left) and WT, dynamin 1WT-3KO and dynamin 1,3 DKO (right) 
brain homogenates were assessed by western blot analysis. (B) Quantification of 
protein levels in (A) Graphs represent mean±SEM. No significant differences were 
detected by two-sided Student’s t-test. 
 
 
tested. In the same mutants, protein homeostasis seems to be impaired as there is 
an increase of poly-ubiquitinated proteins that are marked for UPS degradation 
accompanied by a decrease in the early autophagy marker Atg5. The impaired 
proteostasis however, is likely not caused by defective endocytosis as two autophagy 
factors, that have been reported to undergo CME, are present at normal levels in 
endophilin mutants and because other endocytic mutants do not display the same 
phenotype. This points to a direct role of endophilin in the process of autophagy. 
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3.6. Rescue of motor impairments in endophilin mutants by genetic 
reduction of Fbxo32 
 
3.6.1 Fbxo32 co-localizes with endophilin on SV necks 
To further understand the connection between Fbxo32 and endophilin, Fbxo32 
localization was assessed in a cell model of arrested endocytosis. Specifically,  
 
Figure 44 - Fbxo32 localizes to SV necks during endocytosis. Spinning disk live 
cell imaging of dynamin TKO MEFs transfected with Fbxo32-mCherry and either 
endophilin2-GFP (A) or clathrin-light-chain (CLC)-EGFP (B-C). (C) Time lapse of the 
dashed insert in (B). On arrested endocytic pits, Fbxo32 co-localizes with endophilin 
2 and juxtaposed to CLC. Scale bar 7 µm. 
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dynamin TKO MEFs were cultured (Ferguson, et al., 2009; Rock, et al., 1994) and 
transfected with Fbxo32 with either endophilin 2 or clathrin light chain (CLC). In this 
model, dynamin dependent scission of the SV from the plasma membrane is 
completely abolished. As a result, stable clathrin-coated pits (CCPs) are enriched that 
have elongated necks. In these cells, Fbxo32 co-localized prominently with endophilin 
2 (Figure 44 A) and was located juxtaposed to CLC (Figure 44 B). Interestingly, in co-
transfections of Fbxo32 with CLC, Fbxo32 was observed to be enriched on long 
tubular structures “crowned” with CLC signal (Figure 44 C). 
As these data imply that Fbxo32 might play a role in endocytosis, endophilin levels 
were assessed in a mouse model that carries a genetic deletion of Fbxo32, kindly 
provided by Prof. Marco Sandri. These mice have a normal phenotype when they are 
young but develop muscle atrophy at the age of ~16 months (Bodine, et al., 2001; 
Zaglia, et al., 2014). Levels of all three endophilins were unchanged in p0 brains 
collected from Fbxo32 HT and KO mice (Figure 45). Though that does not rule out a  
 
Figure 45 - Endophilin levels are normal in Fbxo32 KO brains. Relative protein 
levels (normalized to HPRT) of endophilin 1 (A), endophilin 2 (B) and endophilin 3 (C) 
in p0 WT, Fbxo32 HT and Fbxo32 KO brain homogenates was assessed by western 
blot analysis. (bottom) Quantification of protein levels. Graphs represent mean±SEM. 
No significant differences were detected by two-sided Student’s t-test. 
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role of Fbxo32 in endocytosis, it shows that at p0 endophilin influences the levels of 
Fbxo32 (Figure 33 and Murdoch, et al., 2016) but not vice versa. 
 
3.6.2 Genetic reduction of Fbxo32 does not affect grip strength in endophilin 
mutants 
In order to elucidate if the observed motor impairments and the mild cell death in the 
brains of various endophilin mutants could be a result of high Fbxo32 levels, 
endophilin deficient mice were crossed with the Fbxo32 KO mouse line. As NGS and 
qPCR analysis showed a ~2-fold increase of Fbxo32 (Murdoch, et al., 2016), the 
mutants were crossed in such a way, that the offspring had 50% gene expression of 
Fbxo32 left. Genetic reduction of Fbxo32 was confirmed by genotyping (Figure 46). 
The systemic consequences of this reduction were then assessed by motor behavior 
tests. 
 
Figure 46 - Genotyping for Fbxo32 deficient endophilin mutants. Offspring of 
Fbxo32 KO mice crossed with endophilin 1KO-2HT-3KO mice was tested by PCRs 
for Fbxo32, endophilin 1, endophilin 2 (WT and KO reaction separated) and 
endophilin 3. Genetic full deletion (KO) or heterozygous (HT) deletion of Fbxo32 was 
confirmed by this method. 
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Chapter 3.2 of this thesis illustrated motor deficits that occur in several endophilin 
mutants depending on how many endophilin alleles were deleted and the age of the 
test animals. These deficits could be a result of defective endocytosis. However, other 
tested endocytic mutants showed no or only mild motor impairments (chapter 3.3). 
Given that endophilin mutants overexpress Fbxo32 and seem to have a dysregulation 
of autophagy (chapter 3.5), it is also possible that problems in protein degradation 
contribute to the phenotype.  
In that case, genetic reduction of Fbxo32 levels could potentially ameliorate the 
observed motor behavior deficits. For this reason, animals that only have one Fbxo32 
allele (Fbxo32 HT) and were either endophilin 1KO-2WT-3WT, 1KO-2HT-3WT or 
1KO-2HT-3KO were tested for their motoric abilities with the same tests used in 
chapter 3.2. The results from endophilin 1KO-2HT-3KO with WT and HT Fbxo32 
levels are shown in this section. 
 
Figure 47 - Weight and grip strength are decreased in Fbxo32 deficient 
endophilin 1KO-2HT-3KO mice. (A) Body weight and (B) normalized grip strength 
of BL6 WT (black), Fbxo32 KO (grey), Fbxo32 WT-endophilin 1KO-2HT-3KO (blue) 
and Fbxo32 HT-endophilin 1KO-2HT-3KO (light blue) animals. Graphs show 
mean±SEM. Significance by Dunnett- (v.s WT) or Tukey-corrected (vs. endophilin 
1KO-2HT-3KO) one-way ANOVA is shown in the tables above the chart. ***=p<0.001; 
**=p<0.01; *=p<0.05. kgf= kilogram force 
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The reduction of Fbxo32 affected the body weight, though the body weight was 
reduced in Fbxo32 HT-endophilin 1KO-2HT-3KO mutants only at a young age and no 
longer at 6 and 9 months of age (Figure 47 A and Supplemental Figure 2). In addition, 
the grip strength was lower in these animals, especially in young Fbxo32 HT-
endophilin 1KO-2HT-3KO mice (Figure 47 B-C and Supplemental Figure 2). This 
reduction in grip strength might be an early indicator for the development of muscle 
atrophy at the age of 16 months which has been reported for Fbxo32 KO mice 
(Bodine, et al., 2001; Zaglia, et al., 2014). 
 
3.6.3 Rescue of motor coordination deficits in endophilin mutants by genetic 
reduction of Fbxo32 
When motor coordination in these animals was assessed by Rotarod testing, genetic 
reduction of Fbxo32 seemed to be beneficial. As described before, endophilin 1KO- 
 
Figure 48 - Rotarod performance is ameliorated upon genetic reduction of 
Fbxo32 in endophilin 1KO-2HT-3KO mice. (A) Fall latency from the fixed speed 
Rotarod and (B) accelerated Rotarod of BL6 WT (black), Fbxo32 KO (grey), Fbxo32 
WT-endophilin 1KO-2HT-3KO (blue) and Fbxo32 HT-endophilin 1KO-2HT-3KO (light 
blue) animals. Graphs show mean±SEM. Significance by Dunnett- (v.s WT) or Tukey-
corrected (vs. endophilin 1KO-2HT-3KO) one-way ANOVA is shown in the tables 
above the chart. ****=p<0.0001; **=p<0.01; *=p<0.05. 
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2HT-3KO mice fell significantly earlier from the Rotarod in both the training and the 
testing phase (Figure 24). This motor deficit was apparent already at an age of 1 
month and deteriorated with aging. Interestingly, Fbxo32 HT-endophilin 1KO-2HT-
3KO mice performed significantly better in this task, though they did not perform as 
well as WT animals (Figure 48). In endophilin 1KO-2WT-3WT and 1KO-2HT-3WT 
mice, partial deletion of Fbxo32 also trended to increase Rotarod performance, 
though the difference was not significant (Supplemental Figure 3). 
Fbxo32 deficient endophilin mutants were also tested on the DigiGait treadmill. The 
average running speed was mostly unaffected by Fbxo32 reduction (Figure 49 and 
Supplemental Figure 4), but it did decrease the running speed of endophilin 1KO-
2HT-3WT animals at 6 and 9 months (Supplemental Figure 4). On the other hand 
side, the genetic reduction of Fbxo32 trended to improve the average running speed 
of 9-month-old endophilin 1KO-2HT-3KO mice though the difference was not 
significant (Figure 49). 
 
Figure 49 - Maximal running speed of Fbxo32 deficient endophilin 1KO-2HT-
3KO mice. Average running speed of BL6 WT (black), Fbxo32 KO (grey), Fbxo32 
WT-endophilin 1KO-2HT-3KO (blue) and Fbxo32 HT-endophilin 1KO-2HT-3KO (light 
blue) animals. Graphs show mean±SEM. Significance by Dunnett- (v.s WT) or Tukey-
corrected (vs. endophilin 1KO-2HT-3KO) one-way ANOVA is shown in the tables 
above the chart. ****=p<0.0001; **=p<0.01. 
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3.6.4 Genetic reduction of Fbxo32 has no additional effect on gait rhythm in 
endophilin mutants 
As before, gait rhythm was assessed by measuring timing of the paws in air and on 
the ground. Fore limb stance and swing time were not affected by genetic deletion of 
Fbxo32 in any of the tested endophilin mutants (Figure 50 A), though it trended to 
increase swing time in all one-month-old endophilin mutants (Figure 50 B and 
Supplemental Figure 5). This trend was no longer observed at 3 months. The same 
parameters were found to be unchanged in the hind limbs of endophilin mutants 
(Supplemental Figure 7). However, genetic reduction of Fbxo32 trended to increase 
the swing time of endophilin 1KO-2WT-3WT and 1KO-2HT-3WT mice (Supplemental 
Figure 7 B). The trend was only significant in 6-month-old Fbxo32 HT-endophilin 1KO-
2WT-3WT animals. Overall, the gait rhythm of both fore and hind limbs of endophilin 
1KO-2HT-3KO mice was not changed upon genetic reduction of Fbxo32. 
During stance, the timing of brake and propel phase was not changed in the fore limbs 
of enophilin 1KO-2HT-3KO animals that are heterozygous for Fbxo32 (Figure 50 C). 
Only in young Fbxo32 HT-endophilin 1KO-2WT-3WT and Fbxo32 HT-endophilin 
1KO-2HT-3WT, the propel time decreased (Supplemental Figure 6 A) while at the 
same time the brake time trended up (Supplemental Figure 6 B). This was no longer 
the case from the age of 3 months onwards. Taken together, fore limb gait rhythm is 
only impacted in a minor way after additional deletion of Fbxo32 in endophilin 
mutants. The observed changes, if at all, only occur at a young age and are no longer 
observed after the age of 2 months. 
Again, in the hind limbs of the same animals, Fbxo32 reduction had little impact on 
the brake / propel timing. Only 2-month-old Fbxo32 HT-endophilin 1KO-2HT-3WT had 
a significantly longer brake time when compared to Fbxo32 WT-endophilin 1KO-2HT-
3WT mice (Supplemental Figure 8A). This change was no longer present in older 
animals and was not observed in any of the other tested endophilin mutants. 
Congruously, propel time was not further affected in any of the analyzed Fbxo32 
deficient endophilin mutants (Supplemental Figure 8B). 




Figure 50 - Fore limb gait rhythm is not affected in Fbxo32 deficient endophilin 
1KO-2HT-3KO mice. Gait timing parameters of BL6 WT (black), Fbxo32 KO (grey), 
Fbxo32 WT-endophilin 1KO-2HT-3KO (blue) and Fbxo32 HT-endophilin 1KO-2HT-
3KO (light blue) animals. (A) Stance time = time the paw is in contact with the ground. 
(B) Swing time = time the paw is in the air. (C) Brake time = during stance, the time 
that the paw area is increasing. (D) Propel time = during stance, the time that the paw 
area is decreasing. Running speed = 20 cm/s. Graphs show mean±SEM. Significance 
by Dunnett- (v.s WT) or Tukey-corrected (vs. endophilin 1KO-2HT-3KO) one-way 
ANOVA is shown in the tables above the chart. ****=p<0.0001; ***=p<0.001; 
**=p<0.01; *=p<0.05. 
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3.6.5 Posture is ameliorated in endophilin mutants after genetic reduction of 
Fbxo32 
When looking into the posture of the different endophilin mutants, DigiGait analysis 
showed that the paw angle was reduced in all tested endophilin deficient groups, even 
though the change was not significant at all ages (compare Figure 27 A). Genetic 
reduction of Fbxo32 in the same mutants seemed to inverse the observed effect. The 
trend was present in all tested groups in the age of 1-6 months and was significant in 
2 months old Fbxo32 HT-endophilin 1KO-2HT-3WT mice (Supplemental Figure 9 A) 
and 3- and 6-month-old Fbxo32 HT-endophilin 1KO-2HT-3KO animals (Figure 51 A). 
However, the paw angle variability was not changed upon reduction of Fbxo32 levels 
(Figure 51 B and Supplemental Figure 9 B). 
The positioning of the paws during running on the DigiGait treadmill was also 
unaffected by genetic reduction of Fbxo32 expression. While it did significantly 
decrease the overlap of ipsilateral fore and hind limbs of 3-month-old endophilin 1KO-
2HT-3WT mice (Supplemental Figure 10 A), this parameter was unchanged in other 
Fbxo HT-endophilin mutants (Figure 51 D and Supplemental Figure 10 A). However, 
the percentage of shared stance, which was on average increased in endophilin 
mutants (compare Figure 27 C), trended to decrease in young endophilin 1KO-2WT-
3WT and 1KO-2HT-3WT mutants that are HT for Fbxo32 (Supplemental Figure 10 
B). This decrease was significant in 1- and 2-month-old Fbxo32 HT-endophilin 1KO-
2WT-3WT mice. At a higher age however, Fbxo32 reduction had no influence on the 
percentage of shared stance during running and it also had no impact on endophilin 
1KO-2HT-3KO mice. 
Of note, full KO of Fbxo32 had very little effect on motor behavior. Fbxo32 KO mice 
trended to have increased fall latency from the Rotarod, yet the difference was never 
significant. In fact, the only significant changes by ANOVA analysis were a decreased 
grip strength at 1 month and an increase of fore limb propel time at the age of 3 
months. Both changes, however, were no longer observed at higher ages. Posture 
parameters measured by DigiGait analysis were also found to be unchanged in 
Fbxo32 KO mice. 




Figure 51 – Fbxo32 deficiency in endophilin 1KO-2HT-3KO mice ameliorates 
posture during running. Hind limb posture parameters at 20 cm/s of BL6 WT (black), 
Fbxo32 KO (grey), Fbxo32 WT-endophilin 1KO-2HT-3KO (blue) and Fbxo32 HT-
endophilin 1KO-2HT-3KO (light blue) animals. (A) Paw angle = angle between the 
paw and the snout-tail axis. (B) Paw angle variability = standard deviation of the paw 
angle. (C) Paw placement positioning = extent of overlap between ipsilateral fore and 
hind paws during full stance. (D) Shared stance = time both hind limbs are in contact 
with the ground at the same time. Graphs show mean±SEM. Significance by Dunnett- 
(v.s WT) or Tukey-corrected (vs. endophilin 1KO-2HT-3KO) one-way ANOVA is 
shown in the tables above the chart. ****=p<0.0001; ***=p<0.001; **=p<0.01; 
*=p<0.05. 
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3.6.6 Comparison of motor impairments in endophilin mutants with and 
without genetic reduction of Fbxo32 
The changes in motor behavior of endophilin mutants with normal and reduced levels 
of Fbxo32 are summarized in Table 14. As reported in chapter 3.2, endophilin mutants 
displayed motor impairments depending on the age and the severity of the endophilin 
deletion. These changes of endophilin 1KO-2HT-3KO mice are summarized in 
column 3 of Table 14, while the additional effects of the 50% Fbxo32 expression until 
the age of 9 months are summarized in column 4. 
 
Table 14 - Summary of motor behavior parameters in endophilin mutants with WT and 
HT levels of Fbxo32 





Weight / muscle strength 
Body weight − ↓ ↘ 
Max grip 
strength 
Maximal grip strength 









FSRR Fall latency from the fixed 
speed RotaRod 
↓ ↑ 
ARR Fall latency from the 
accelerated RotaRod 
↓ ↑ 
Running speed Maximal running speed at 
which a video was recorded 





time the paw is in contact 
with the ground, influences 
the gait rhythm 
− − 





time the paw is in the air, 
influences the gait rhythm 
− − 
Fore limb brake 
time 
during stance, the time that 
the paw area is increasing, 




during stance, the time that 
the paw area is decreasing, 




time the paw is in contact 
with the ground, influences 




time the paw is in the air, 
influences the gait rhythm 
− − 
Hind limb brake 
time 
during stance, the time that 
the paw area is increasing, 




during stance, the time that 
the paw area is decreasing, 





angle between the paw and 





standard deviation of the 
paw angle, gait posture 
parameter 
↗ − 
Shared stance percentage of hind limb 
stance time that both hind 
limbs are in contact with the 
ground at the same time, 




extent of overlap between 
ipsilateral fore and hind 




In the endophilin mutants, slight changes were observed in body weight and muscle 
strength. These changes were further enhances by Fbxo32 reduction. The strongest 
motor impairment in endophilin mutants was the fall latency from the Rotarod. This 
impairment was partially rescued in endophilin mutants that are HT for Fbxo32. 
However, the reduction of Fbxo32 had little to no effect on the gait rhythm of both fore 
  Results 
129 
 
and hind limbs, but tended to ameliorate the paw angle and positioning in endophilin 
1KO-2HT-3KO mice. 
In summary, though endophilin mutants with partial genetic deletion of Fbxo32 still 
display some motor impairments, especially in the grip strength, motor coordination 
is significantly improved in these mutants. These findings are in accordance with the 
hypothesis that genetic reduction of Fbxo32 has a positive effect on the motor 
disabilities observed in endophilin mutants. While there are still many open questions 
in this area, the data presented here show that the modulation of a protein involved 
with proteostasis (through the UPS and autophagy) directly affects the motor behavior 
of a living mouse model for defective endocytosis and autophagy.   
  130 
4. Discussion 
 
Defects in endocytosis have previously been linked to neurodegeneration (Ralser, et 
al., 2005; Ren, et al., 2008; Shi, et al., 2009; Trempe, et al., 2009; Milosevic, et al., 
2011; Matta, et al., 2012; Edvardson, et al., 2012; Köroğlu, Baysal, Cetinkaya, 
Karasoy, & Tolun, 2013; Ambroso, Hegde, & Langen, 2014; Arranz, et al., 2015). 
While the evidence of a connection between the two processes is compelling, a 
concrete mechanism, which also factors in the aspect of aging, is still missing. This 
study aims to shed further light into the question if defects in endocytosis per se cause 
neurodegeneration or if the observed phenotypes from previous studies stem from 
secondary or completely unrelated processes. 
The endophilin-A mouse model offers a great potential to study the onset and 
progression of neurodegeneration in a model that has various degrees of protein KO 
due to its presence in three closely related genes. While endophilin TKO have a very 
strong phenotype and die within a few hours after birth, endophilin 1 single KOs show 
no apparent phenotype, with other mutants displaying mild to strong phenotypes 
depending on the number of missing endophilin alleles and the age. 
Several publications about the endophilin mouse model were conducted on 
endophilin TKO and DKO animals (Milosevic, et al., 2011; Cao, Milosevic, Giovedi, & 
De Camilli, 2014), yet little work has been done on aging endophilin 1KO-2HT-3KO 
mice. This study gives a detailed description of the motor abilities of endophilin 1KO-
2HT-3KO animals and compares biochemical and immunohistochemistry data from 
these animals to endophilin TKO and DKO brains. 
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4.1. Motor impairments in endocytic mutants 
 
Of the many links between endocytic proteins and neurodegeneration, the 
overarching majority points to a connection to PD (Shi, et al., 2009; Trempe, et al., 
2009; Matta, et al., 2012; Ambroso, Hegde, & Langen, 2014; Arranz, et al., 2015; 
Soukup, et al., 2016; Cao, et al., 2017; Quadri, et al., 2013; Krebs, et al., 2013; Olgiati, 
et al., 2014). In PD, dopaminergic neurons are degenerating, causing problems with 
motor planning and coordination. As a result, many symptoms of PD patients can be 
recognized by people without medical training as the motor impairments, especially 
in the gait, are often very prominent. In this thesis, the progression of motor 
impairments was therefore used as an indicator for neurodegeneration in endocytic 
mutants. 
The most striking observation when testing the motor abilities of various endophilin 
mutants is the progressive decrease of fall latency from the Rotarod (Figure 24). The 
test is designed to measure motor coordination and concentration. This decrease in 
fall latency in the endophilin mouse model depends on the age (as it happens in all 
groups including the WT control group) and on the number of missing endophilin 
alleles. While the difference to the WT group is already significant in endophilin 1KO-
2HT-3KO mice at the age of 1 month, for endophilin 1KO-2HT-3WT mice it becomes 
only significant at 3 months of age and never for endophilin 1KO-2WT-3WT mice. 
The finding also suggests a more important role of endophilin 2 than of endophilin 3 
in motor coordination: Compared to the endophilin 1 single KO (endophilin 1KO-2WT-
3WT), endophilin 1KO-2HT-3WT mice carry only an additional 50% deletion of 
endophilin 2 expression, yet the motor coordination is severely decreased in the latter 
group but not in the former. However, endophilin 1KO-2WT-3KO mice, which 
compared to endophilin 1KO-2WT-3WT mutants carry an additional full deletion of 
endophilin 3, perform better during the task than endophilin 1KO-2HT-3WT mice. The 
difference between endophilin 2 and 3 is made even more evident by comparing the 
life expectancy of endophilin 1,2 DKOs and 1,3 DKOs (endophilin 1KO-2WT-3KO): 
endophilin 1,2 DKOs die within  3 weeks after birth, while endophilin 1,3 DKOs live 
for around 18 months. 
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The reason for this might be the fact that endophilin 3 accounts for only 3-5% of all 
endophilin protein in the brain, while endophilin 2 accounts for 10-15% and endophilin 
1 for 80-85 % (Milosevic, et al., 2011 and unpublished data from Dr. Ira Milosevic). 
Therefore, the loss of endophilin 3 might be more easily compensated for by the 
remaining other endophilins. Another explanation might be the different distribution of 
the three endophilins. While endophilin 1 and 3 are mostly brain specific (plus little 
expression of endophilin 3 in the testis), endophilin 2 is expressed ubiquitously 
(Giachino, et al., 1997; Ringstad, Nemoto, & De Camilli, 1997; So, et al., 2000). 
Therefore, the loss of endophilin 2 could potentially have negative effects in organs 
other than the brain that could not be compensated for by endophilin 1 or 3. However, 
another BAR protein, amphiphysin, is similar to endophilin in structure and binding 
properties and is expressed ubiquitously. It may be able to compensate to some 
degree for the loss of endophilin 2 (Wu, Matsui, & Tomizawa, 2009; Dong, Gou, Li, 
Liu, & Bai, 2015; Tsutsui, Maeda, Tsutsui, Seki, & Tokunaga, 1997; Ren, Vajjhala, 
Lee, Winsor, & Munn, 2006). 
Before tests were conducted, general health and fitness were always assessed for 
the endophilin mutants. The body weight and grip strength of endophilin 1KO-2HT-
3KO mice compared to WT mice progressively decreases with aging (Figure 23). This 
could potentially contribute to the poor performance of these animals on the Rotarod. 
However, endophilin 1KO-2WT-3WT mice have even lower relative grip strength but 
still perform as well as WT animals in the Rotarod task. 
The poor motor performance is also observed in the maximal running speed on the 
DigiGait (Figure 25). The ability to run at the highest speed on the treadmill 
progressively decreases with age in endophilin 1KO-2HT-3KO animals, meaning that 
it is difficult for these animals to keep up with the treadmill even when it is set to the 
moderate running speed of 20 cm/s that was used for analysis of gait parameters. In 
light of this, the data obtained from endophilin 1KO-2HT-3KO mice capable of running 
at this speed has to be interpreted with care as the relative low number of animals 
that were recorded forms a subset of the group that can be expected to perform better 
than the non-runners that cannot be analyzed. In addition, the low number of 
effectively recorded animals also complicated the statistical analysis of this group. 
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In PD patients, problems with motor planning and coordination lead to symptoms that 
manifest in the alteration of gait rhythm and posture (Bovonsunthonchai, Vachalathiti, 
Pisarnpong, Khobhun, & Hiengkaew, 2014; Ellis, et al., 2015; Grajić, Stanković, 
Radovanović, & Kostić, 2015). Video based gait analysis offers the possibility to 
evaluate about 50 gait parameters that describe all aspects of walking (Rostosky & 
Milosevic, 2018). This approach revealed that the timing of the gait phases swing and 
stance time is overall unchanged in endophilin mutants compared to WT in neither 
fore nor hind limbs (Figure 26 and Supplemental Figure 1). Still, when dissecting the 
stance time into brake and propel time, endophilin mutants showed a strong tendency 
to increase brake time and thereby decrease propel time in their fore limbs. Like the 
other motor impairments, this change in gait timing becomes more prominent with 
aging. The exact meaning of this change can only be speculated, but could indicate 
a delay in the fore limbs before the initiation of the next step. 
Interestingly, this phenotype was not observed in the hind limbs of the same animals. 
Generally speaking, differences between hind and fore limbs are likely because of 
slightly different functions of the limbs: hind limbs have a much higher muscle mass 
than fore limbs and can therefore contribute more acceleration. As the fore limbs are 
in the front of the animals they likely function to determine which direction the animal 
is going to. It has previously been published that gait dynamics may differ between 
fore and hind limbs (Amende, et al., 2005). In the hind limbs of endophilin mutants 
there are no meaningful alterations of gait or stance timing. It is unclear why brake 
and propel time are changed in fore but not in hind limbs. One possible explanation 
is that the finer coordination in the fore limbs is impaired, but the more general 
swing/stance timing is compensated by the strong acceleration of the hind limbs. 
Because of this, the lack of coordination only becomes visible in the timing of the 
brake and propel during stance.  
The second group of parameters measured by video-based gait analysis concerns 
the posture of the animals during running (Figure 27). Endophilin mutants have an 
overall decrease in their paw angle. High paw angles are thought to be a sign for 
posture instability and have been reported in a model of demyelinating disease 
(Powell, Anch, Dyche, Bloom, & Richter, 1999). However, in an acute model for PD, 
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mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), the paw 
angle of hind limbs also trended to be smaller than in WTs (Amende, et al., 2005), 
showing that both smaller and higher paw angles are observed in different mouse 
models for neurological diseases. 
One parameter that is often measured in patients with gait anomalies is the 
percentage of shared stance, also known as double support. It is the percentage of 
the stance time that both feet are on the ground at the same time and is known to be 
increased in PD patients (Hausdorff, Cudkowicz, Firtion, Wei, & Goldberger, 1998; 
Bryant, et al., 2011). This parameter can roughly be translated to the hind limb double 
support in mice. This was found to be increased in endophilin mutants, particularly 
with aging. An increase is often interpreted as a sign of instability as the shared stance 
allows re-balancing in between the steps. 
Taken together, the data reported in the first part of this thesis show that endophilin 
mutants display mild to strong motor impairments depending on the test age and the 
severity of the endophilin deletion. Given endophilin’s well-established role in 
endocytosis, this data points in the direction suggested by the above-mentioned 
literature, namely that defective endocytosis may be related to neurodegeneration, 
or, more specifically, a PD like phenotype. However, it is unclear if the observed 
phenotype is a direct consequence of defective endocytosis or if it might be caused 
by potential additional roles of endophilin. 
One approach to answer that question is to study motor behavior in other endocytic 
mutants: if they give similar results as the endophilin model, this would suggest a 
common cause for a common phenotype. The results obtained in this thesis from 
aged dynamin 1HT-3KO and synaptojanin 1HT mice were to some degree 
contradictory. Synaptojanin-1 deficient mice had no motor impairments in any of the 
tests used while dynamin mutants have reduced fall latency from the Rotarod though 
not as low as that of endophilin 1KO-2HT-3KO mice (Figure 28 and Figure 29).  
As the motor impairments in the endophilin mutants are only visible when a critical 
amount of endophilin is deleted (endophilin 1KO-2WT-3WT mice have no phenotype), 
it is possible that the 50% genetic reduction of synaptojanin-1 is not sufficient to cause 
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motor deficits. Interestingly, another model of synaptojanin-1 deficiency was 
published during the course of this thesis. This model carries a R258Q synaptojanin-
1 mutation that was previously identified in patients of Early-Onset Parkinsonism 
(Cao, et al., 2017; Krebs, et al., 2013; Quadri, et al., 2013; Olgiati, et al., 2014). Mice 
carrying a knock-in (KI) for this mutated synaptojanin-1 instead of WT synaptojanin-1 
have defects in endocytosis similar to those described in synaptojanin-1 KO mice, yet 
unlike the full KO animals, the synaptojanin-1 R258Q KI mice survived until adulthood 
and could thus be used for motor behavior tests.  
In fact, the authors show that synaptojanin-1 R258Q KI mice have obvious motor 
impairments as assessed by grip strength, Rotarod and other tests though their gait 
is normal (Cao, et al., 2017). In light of this, it is likely that aged synaptojanin-1 HT 
mice simply have enough synaptojanin-1 left to fulfill normal function while mice with 
synaptojanin-1 mutation show similar motor deficits as endophilin and dynamin 
mutants. In summary, deficiency of any of the three endocytic proteins endophilin, 
synaptojanin-1 and dynamin can cause motor deficits, but they may only become 
obvious when the deficiency is strong. 
 
4.2. Neurodegeneration in the endophilin mouse model 
 
Neurodegeneration is defined as the death of neurons in the CNS. In the various 
known neurodegenerative diseases, this cell death occurs in different brain regions 
and therefore affects different brain functions. In order to understand if the motor 
deficits in endophilin mutants are accompanied by cell death in the CNS, cryosections 
from the brains of these mutants were analyzed for different markers of cell death and 
neurodegeneration. This work was primarily done on endophilin DKO mice as these 
mice have a very strong phenotype that includes cerebellar ataxia and because 
neurodegeneration in the form of retraction of the climbing fibers in the cerebellum of 
these animals has already been published (Milosevic, et al., 2011). Endophilin TKO 
mice have an even stronger phenotype, but as they die shortly after birth, it is more 
difficult to discriminate between developmental and degenerative deficits. 
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TUNEL staining for apoptotic and necrotic cells showed that there is an increase of 
cell death in several brain regions of the endophilin DKO brains (Figure 30). The 
extent of this cell death is relatively low and the overall morphology of the brain is not 
changed (i.e. no shrinking of specific brain parts). A slight increase in cell death was 
also detected in 18-month-old endophilin 1KO-2HT-3KO mice (Figure 31). However, 
the same assay in endophilin TKO brain sections showed a strong background 
TUNEL signal in the WT brains that was about as strong as the signal in endophilin 
TKO brains. This could be due to normal post-natal developmental apoptosis 
(Galluzzi, et al., 2009). It is possible that because endophilin TKO brains were 
collected shortly after birth and TUNEL staining detects only the final stages of 
apoptosis, additional cell death through the effect of endophilin TKO was not detected 
with this test.  
To test this hypothesis, apoptosis in endophilin TKO brains was further measured by 
immunohistochemistry for the early apoptosis marker cleaved caspase 3 (Figure 33). 
Indeed, using this test, an increase in the number of early apoptotic cells was found 
in endophilin TKO brain sections. 
As synaptojanin-1 KO mice have a similar phenotype as endophilin TKOs with regard 
to defective endocytosis (Milosevic, et al., 2011; Cremona, et al., 1999), cell death in 
these mutants was also assessed by cleaved caspase 3 staining. While there was a 
tendency to an increased cell death, the difference was not significant (Figure 34). 
This suggests that the timing of cell death is different in the distinct endocytic mutants, 
or that the slight cell death in endophilin TKO brains is caused by a CME-independent 
mechanism. 
While the cell death detected in endophilin DKO was mild, it was accompanied by a 
relatively strong astrogliosis, visualized by GFAP immunostaining (Figure 32). 
Astroglia support neurons and their up-regulation could be an attempt to aid the dying 
cells to avoid apoptosis (Khakh & Sofroniew, 2015). The strong activation of astroglia 
might be an indication that they are successfully providing the cells with nutrients and 
neurotransmitters that they lack, as they can no longer obtain these by endocytosis, 
and thereby minimize the observed cell death. It is noteworthy, that the strong 
difference in GFAP signal between endophilin DKO and WT brain slices might be 
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further enhanced by the fact that GFAP is expressed in very low levels in healthy 
conditions that are sometimes below the detection rate (Khakh & Sofroniew, 2015). 
This means that the number of astroglia in WT brains could be similar to that of 
endophilin DKOs; they might simply not express enough GFAP to be detected. 
As both the literature and the observation of motor disabilities in endocytic mutants 
point to a connection between defective endocytosis and PD, α-synuclein, a marker 
for this particular disease, was examined more closely. In fact, α-synuclein levels 
were reduced in endophilin mutants and larger puncta were detected in endophilin 
DKO brain section than in control sections (Figure 35). However, when comparing the 
spine density or the frequency of mature spines, no differences between WT and 
endophilin DKO brain sections were found (Figure 36). 
Taken together, signs of cell death were found in endophilin mutants, but the extend 
of that cell death is relatively mild. While in the endphilin DKOs, the cell death is 
accompanied by a gliosis, no direct connections to a specific cell type or region were 
found with the methods employed here. More detailed experiments using several cell-
type specific markers are necessary to investigate if a specific cell type is more prone 
to cell death in the endophilin mutants or if the slight increase in cell death might be 
caused by defective endocytosis resulting in the death of neurons distributed 
throughout the brain. It may also be worth it to perform more experiments that focus 
on neurodegeneration in the cerebellum. As this brain region is involved in motor 
coordination and has been reported to show signs of neurodegeneration in endophilin 
DKO mice (Milosevic, et al., 2011), further investigation could possibly shed light onto 
the motor deficits found in aged endophilin mutants. 
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4.3. Altered autophagy in endocytic mutants 
 
In addition to endophilin’s well established role in endocytosis (Cestra, et al., 1999; 
Verstreken, et al., 2003; Sundborger & Hinshaw, 2014), data presented in this thesis 
and elsewhere (Murdoch, et al., 2016; Soukup, et al., 2016) indicate that endophilin 
may also be implicated in autophagy. In the endophilin mouse model, the strongest 
indication for this additional role is the robust up-regulation of the E3 ubiquitin ligase 
Fbxo32 in different endophilin mutants that was confirmed for aged endophilin 1KO-
2HT-3KO mice in this thesis (Figure 37). 
Fbxo32 was originally described as an E3 ubiquitin ligase that is part of an SCF 
complex (Bodine, et al., 2001; Gomes, Lecker, Jagoe, Navon, & Goldberg, 2001) but 
was afterwards found to also play a role in autophagy and was, in fact, suggested to 
act as a mediator between the UPS system and autophagy (Zaglia, et al., 2014). This 
is validated by several studies that report both loss and overexpression of Fbxo32 
can have potentially negative effects on cells, especially muscles (Bodine, et al., 
2001; Zaglia, et al., 2014; Bühler, et al., 2016; Sakai, et al., 2017; Lee, Kim, Kim, 
Choi, & Nam, 2017). 
In agreement with this hypothesis, there is an increase in the number of proteins that 
are marked for degradation (Figure 39) and a decrease in the autophagy marker Atg5 
(Figure 41) in aged endophilin mutants. These and other markers have been reported 
to be changed in a similar way in endophilin DKO and TKO brains (Murdoch, et al., 
2016). Moreover, it has been shown that Fbxo32 and endophilin co-localize in WT 
MEFs on autophagic structures and that reduction of endophilin leads to a decrease 
of Atg5 and LC3 positive structures (Murdoch, et al., 2016; Soukup, et al., 2016). 
Impairments in autophagy in the endophilin mouse model could also contribute to the 
observed motor deficits and mild neurodegeneration. It has previously been 
suggested that defects in autophagy can cause neurodegeneration (Douglas & Dillin, 
2010; Nixon, 2013; Liang & Sigrist, 2018). A recent study further points to a 
connection of defective autophagy to motor dysfunction in aged mice (Sato, et al., 
2018). It seems likely that the observed motor deficits in the endophilin mouse model 
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are caused by a combination of defective endocytosis and a dysregulation of 
autophagy. 
As endocytosis is a transport processes that regulates the internalization of different 
proteins important for several cellular processes, it is possible that the failure of 
autophagy is an indirect effect of defective endocytosis in endocytic mutants. Two 
autophagy factors, Atg9a and Atg16l do in fact are trafficked through CME as part of 
their normal trafficking and aid in the formation of the autophagophore (Ravikumar, 
Moreau, Jahreiss, Puri, & Rubinsztein, 2010; Puri, Renna, Bento, Moreau, & 
Rubinsztein, 2014). Both proteins are present at normal levels in endophilin TKO and 
DKO brains (Figure 42). While this finding does not exclude the possibility that other 
autophagy factors might be present in reduced levels because of defective 
endocytosis and thereby cause the autophagy failure, it seems unlikely that these two 
proteins, which are known to undergo CME, are not affected by defective endocytosis 
while others are. 
To further assess the connection between endocytosis and proteostasis, brains from 
dynamin 1,3 DKO and synaptojanin-1 KO mice were tested for poly-ubiquitin and Atg5 
levels (Figure 40, Figure 43). These proteins were found to be unchanged, pointing 
to a more direct role of endophilin in autophagy. However, recent studies in zebrafish 
and drosophila have shown that synaptojanin-1 likely does play a role in autophagy 
(George, Hayden, Stanton, & Brockerhoff, 2016; Vanhauwaert, et al., 2017). 
Interestingly, the first study was performed in highly active zebrafish cone 
photoreceptors and found that the synaptojanin-1 5-phosphatase domain is required 
for functional autophagy and endocytosis (George, Hayden, Stanton, & Brockerhoff, 
2016). The second study focused on the drosophila neuromuscular junction and 
human derived induced neuronal cell lines and reports that the second phosphatase 
domain in synaptojanin-1, the SAC-1 domain, is in fact responsible for autophagy but 
has no role in endocytosis (Vanhauwaert, et al., 2017). 
Of note, the mouse study that used the same human synaptojanin-1 mutation as 
Vanhauwaert et al. and that was previously reported to be found in patients of Early-
Onset Parkinsonism (Krebs, et al., 2013; Quadri, et al., 2013; Olgiati, et al., 2014), 
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reported defects in endocytosis in mice carrying this mutation. This study did not 
investigate autophagy (Cao, et al., 2017). 
While these three studies contradict each other to some degree and further work in 
this field will be needed to understand the mechanisms, it seems likely that the 5-
phosphatase domain functions in endocytosis, as has been suggested by several 
studies (McPherson, et al., 1996; Cremona, et al., 1999; Mani, et al., 2007; Chang-
Ileto, et al., 2012). The SAC1 domain, on the other hand, probably has a distinct or 
additional function, and likely is involved in autophagy (Soukup, Vanhauwaert, & 
Verstreken, 2018). Again, the existence of two distinct phosphatase domains with 
possibly distinct functions, together with the contradiction in the literature as to if the 
SAC1 domain plays a role in endocytosis, makes it difficult to distinguish if the 
connection between synaptojanin-1 deficiency and impaired autophagy is because of 
defective endocytosis or because of distinct functions of this protein independent of 
endocytosis. 
This also has some influence on the interpretation of the motor deficits in these 
animals. The mutation in synaptojanin-1 R258Q KI mice, which reportedly have motor 
impairments (Cao, et al., 2017), is located in the SAC1 domain. While in the same 
study the authors described endocytic defects in these mutants, it is unknown whether 
they also have autophagy impairments as might be expected given the same mutation 
leads to problems with autophagosome maturation in drosophila (Vanhauwaert, et al., 
2017). As long as it remains unclear if synaptojanin-1 R258Q KI mice have autophagy 
impairments, it is difficult to judge if the motor deficits in synaptojanin-1 R258Q KI 
mice are caused by defective endocytosis, impaired autophagy or a combination of 
both.  
In summary, both endophilin and synaptojanin-1 deficiency can lead to motor deficits, 
neurodegeneration and autophagy impairments. It remains to be clarified how the 
observed phenotypes influence each other and what is the ultimate cause for the 
motor deficits in both models. 
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4.4. Partial rescue of endophilin phenotype by Fbxo32 reduction 
 
Another way to dissect the influence of endocytosis and autophagy impairments on 
motor behavior is to improve autophagy in the endophilin mutants. Given Fbxo32 ’s 
proposed role as a mediator between the UPS and autophagy and thereby 
proteostasis, we hypothesized that the elevated levels of Fbxo32 in the endophilin 
model could cause the imbalance in autophagy. As a result, endophilin mutant mice 
were crossed with Fbxo32 KO mice and the genetic reduction of Fbxo32 was 
confirmed by PCR (Figure 46). 
Fbxo32 KO mice have a mild reduction in grip strength at a young age but their motor 
behavior until the age of 9 months is largely normal. Previous reports on Fbxo32 mice 
suggest that they have a normal phenotype until the age of 9 months but then develop 
autophagy impairments and cardiomyopathy until the age of 16 months (Zaglia, et al., 
2014). As a result, this thesis did not aim to completely delete Fbxo32 from endophilin 
mutants, but rather to have a genetic reduction of Fbxo32 to 50 % expression levels 
to counteract the ~2-fold up-regulation of Fbxo32 detected by NGS and qPCR 
(Murdoch, et al., 2016). 
Therefore, the most interesting genotype to understand the consequences of Fbxo32 
reduction on motor behavior were Fbxo32 HT-endophilin 1KO-2HT-2KO mice as 
endophilin 1KO-2HT-3KO mice had the most obvious motor deficits that are visible 
already at a young age. Interestingly, the reduction of Fbxo32 levels did indeed 
ameliorate motor performance. This was most obvious on Rotarod performance, 
which trends to increase in all endophilin mutants with reduced Fbxo32 expression 
and is statistically significant for Fbxo32 HT-endophilin 1KO-2HT-3KO animals 
(Figure 48). 
Genetic reduction of Fbxo32 expression decreased the grip strength in young 
endophilin mutants. This phenotype might be an early indicator for the muscle atrophy 
that occurs in Fbxo32 KO mice at the age of 16 months (Bodine, et al., 2001; Zaglia, 
et al., 2014). However, the reduction in grip strength does not deteriorate with age 
and is in fact not present in 9-month-old Fbxo32 HT-endophilin 1KO-2HT-3KO mice 
(Figure 47). 
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The amelioration of motor behavior in endophilin mutants through the genetic 
reduction of Fbxo32 indicates that the high expression levels of Fbxo32 in the 
endophilin mouse model could partially cause the observed motor deficits. The motor 
coordination is only partially rescued which can be explained by two theories:  
- The motor impairments in endophilin mutants are only caused by autophagy 
misregulation. While genetic reduction of Fbxo32 is beneficial, it does not bring 
the relative Fbxo32 / endophilin levels into perfect balance, as a consequence 
the motor behavior is not fully rescued. 
- The motor impairments in endophilin mutants are caused by deficiencies in 
endocytosis AND autophagy. Genetic reduction of Fbxo32 helps to improve 
the autophagy failure and the remaining difference to the WT motor 
performance is caused by the still defective endocytosis. 
 
The literature published to this date indicates that a tight regulation of Fbxo32 is 
important to coordinate proteostasis (Zaglia, et al., 2014; Murdoch, et al., 2016). 
Specifically, fibroblasts that overexpress Fbxo32 die earlier and have increased 
caspase activity, but this phenotype can be rescued by a co-overexpression of any of 
the three endophilins (Murdoch, et al., 2016). Therefore, it is realistic that even a small 
misbalance in this protein can eventually lead to an impaired protein turnover which 
over time can have tremendous effects on synapses. These structures are especially 
vulnerable to proteostasis failure, as they are located far away from the protein 
translation machinery around the nucleus and have to keep up the tightly regulated 
processes important for synaptic transmission (Douglas & Dillin, 2010; Nixon, 2013; 
Liang & Sigrist, 2018; Soukup, Vanhauwaert, & Verstreken, 2018). 
On the other hand side, it is striking that synaptojanin-1 R258Q KI and dynamin 1HT-
2KO mice display motor deficits similar to those of endophilin mutants, though they 
are less pronounced (see above and Cao, et al., 2017). This can indicate that defects 
in endocytosis can cause motor deficits by themselves, or that synaptojanin and 
dynamin are also related to autophagy. Recently, some publications were able to 
show a role for synaptojanin in autophagy (George, Hayden, Stanton, & Brockerhoff, 
2016; Vanhauwaert, et al., 2017). 
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There is currently no study about autophagy in a dynamin animal model, but some 
basic studies already showed that dynamin could potentially be involved in autophagy 
as well (Totta, Busonero, Leone, Marino, & Acconcia, 2016; Fang, et al., 2016). In 
light of this, the two processes of endocytosis and autophagy might be more closely 
related than previously expected. After all, both processes require the organization of 
membrane to transport cellular components to their destination. Because of this, it is 
not unrealistic, that some of the involved players, namely endophilin, synaptojanin 
and possibly dynamin, are the same for both processes. 
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4.6. Endophilin’s role in synaptic proteostasis – A model 
 
Taking into consideration the data reported here and in the literature about endocytic 
proteins and autophagy, it seems likely that endophilin plays an additional role in 
autophagy (reviewed in Soukup, Vanhauwaert, & Verstreken, 2018). Endophilin can 
sense and induce membrane curvature through its N-BAR domain (Bai, Hu, Dittman, 
Pym, & Kaplan, 2010; Farsad, et al., 2001; Gallop, et al., 2006; Masuda, et al., 2006). 
Interestingly, the binding affinity is regulated through the PD protein LRRK2 
(Ambroso, Hegde, & Langen, 2014; Soukup, et al., 2016).  
The role of endophilin in autophagy could therefore be to recruit membrane, possibly 
from the membrane or from endosomes, for the initiation of the phagophore which is 
the first step in the autophagy process. This would explain why endophilin is observed 
on early autophagosomes, but only to a lesser extent on late autophagosomes 
(Murdoch, et al., 2016). In this model, the regulation of the PIs during the transport  
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and on the forming autophagosome might be regulated by synaptojanin-1 which is 
recruited through endophilin (Milosevic, et al., 2011; Cestra, et al., 1999; Verstreken, 
et al., 2003).  
Fbxo32 has been reported to co-localize with endophilin on autophagic (Murdoch, et 
al., 2016) and endocytic structures (Figure 44). It was also found to be able to tabulate 
membranes (Murdoch, et al., 2016). It remains unclear if Fbxo32 has a direct role in 
autophagy or acts mostly as a regulator through its action as an E3 ubiquitin ligase. 
More work will be needed to understand the specific mechanisms of how endocytic 
proteins and Fbxo32 work on autophagy, but it seems evident at this point that 
proteins involved in endocytosis and autophagy are critical for proteostasis at the 
synapse and therefore, in the long run, for neuronal survival. 
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5. Summary and Conclusion 
Ever since the discovery of neurodegenerative diseases, scientists have wondered 
about the cause of these detrimental diseases. The large number of studies published 
on this topic has taught us that there is no straightforward answer to this question; 
rather that genetic and environmental influences as well as aging contribute to the 
disruption of different proteins and cellular processes that ultimately cause cell death 
in the affected brain regions. Recently, an interesting hypothesis has emerged 
suggesting that protein dysregulation in various neurodegenerative diseases 
eventually disrupts synaptic proteostasis as a common denominator and thereby 
causes - or at least contributes to - neurodegeneration. 
Synaptic proteostasis comprises protein synthesis, trafficking, endocytosis and 
protein degradation by the UPS and/or autophagy. Endophilin-A has been well 
studied for its role in endocytosis but data presented here and elsewhere imply that 
endophilin-A has an additional, previously unknown role in autophagy. This double 
function makes endophilin an interesting protein for investigating synaptic 
proteostasis. As endophilin-A is encoded by three genes in mammals, the complex 
mouse model brings the advantage of studying the impact of endophilin-A deficiency 
dependent on the number of deleted endophilin alleles. In fact, using different 
endophilin-A mutants, data presented in this thesis could show that endophilin 
deficient mice display motor impairments that deteriorate with aging and that the 
model displays a mild form of neurodegeneration throughout the brain. 
In an effort to discriminate between the impact of disrupted endocytosis and 
autophagy on the systemic level, the motor abilities of two additional models for 
defective endocytosis, synaptojanin-1 and dynamin-1,3 deficient mice, were also 
assessed. No motor deficits were detected in aged synaptojanin-1 HT mice, while 
some motor impairments were found in dynamin mutants. However, another 
synaptojanin-1 mouse model was recently published that reportedly displays motor 
deficits. Instead of a deletion of synaptojanin-1, this model carries a mutation of 
synaptojanin-1 that was previously identified in patients of Early-Onset Parkinsonism. 
Interestingly, another study investigated the same mutation in a drosophila model and 
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found that autophagy is also disrupted by this mutation. As a result, it remains difficult 
to judge if defects in endocytosis alone can cause the observed motor deficits. 
A second approach to solve this question was the genetic reduction of Fbxo32 in the 
endophilin-A mouse model. The E3 ubiquitin ligase Fbxo32 is highly up-regulated in 
endophilin-A mutant brains and was proposed to act as a mediator between the UPS 
system and autophagy. Hypothetically, reducing Fbxo32 to WT levels could rescue 
the disruption of autophagy in the endophilin-A deficient mice and consequently the 
impact of defective autophagy on the systemic level. Indeed, genetic reduction of 
Fbxo32 ameliorated the motor deficits of endophilin-A mutants. The fact that the motor 
behavior is ameliorated but not completely rescued could indicate that both defective 
endocytosis and autophagy impairments contribute to the observed motor deficits in 
endophilin mutants. 
In context with other literature published on the subject, it seems evident that 
disruption of synaptic proteostasis is potentially harmful to cells, especially to the 
vulnerable synaptic structures that need to perform critical processes far away from 
the nucleus. The research of medical strategies that aim to facilitate proteostasis in 
the brain therefore seems like a promising line of research. Manipulation of autophagy 
mediators such as Fbxo32 may eventually proof to become an interesting therapeutic 
target for patients of several neurodegenerative diseases. 
  





This thesis gives some information about the role of endocytosis and autophagy in 
neurodegeneration, yet there are still open questions. Endophilin seems to play a role 
in autophagy, however, the exact function is yet unknown. It can be speculated that 
endophilin acts through the N-BAR domain to recruit membrane to form the 
phagophore, but if that membrane is derived from the plasma membrane following 
endocytosis or if endophilin retrieves it from other organelles is completely unknown 
at this point. Further studies will be necessary to elucidate the timing, regulation and 
binding partners of endophilin in this process. 
In addition, it is very striking that synaptojanin-1, another endocytic protein and 
binding partner of endophilin, has recently been suggested to also function in synaptic 
autophagy. It will be very interesting to learn if the mouse model that carries a 
synaptojanin-1 mutation discovered in PD patients and was reported to show motor 
impairments also has autophagy impairments. This has been shown in a drosophila 
model but so far not in the mouse model. 
Besides that, it would also be worthwhile to investigate in more detail if other mouse 
models for endocytic proteins such as the auxilin mouse model or the dynamin model 
used here have similar autophagy impairments. 
From the data known today, it seems that endocytosis and autophagy are two related 
processes that are connected by the use of some identical proteins and their function 
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Supplemental Figure 1 - Hind limb gait rhythm in endophilin mutants. Gait timing 
parameters of WT (black), endophilin 1KO-2WT-3WT (dark green), 1KO-2HT-3WT 
(light green), 1KO-2WT-3KO (dark blue) and 1KO-2HT-3KO (light blue) animals 
recorded from the hind limbs on a DigiGait treadmill over the age of 1-18 months. (A) 
Stance time = time the paw is in contact with the ground. (B) Swing time = time the 
paw is in the air. (C) Brake time = during stance, the time that the paw area is 
increasing. (D) Propel time = during stance, the time that the paw area is decreasing. 
In hind limbs, basic gait rhythm parameters are not changed in endophilin mutants. 
Running speed = 20 cm/s. Graphs show mean±SEM. Significance by Dunnett-
corrected one-way ANOVA (compared to WT) is displayed in the tables above the 
charts. ****=p<0.0001; ***=p<0.001; **=p<0.01; *=p<0.05. 





Supplemental Figure 2 - Weight and grip strength tend to decrease in Fbxo32 
deficient endophilin mutants. (A) Body weight, (B) maximal grip strength and (C) 
normalized grip strength of Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-2WT-
3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light green) and Fbxo32 
HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in animals with WT 
Fbxo32 levels and the corresponding endophilin genotype (as reported in Figure 23) 
are shown as grey dashed bars for comparison. Graphs show mean±SEM. 
Significance by Tukey-corrected one-way ANOVA compared to the corresponding 
endophilin mutant. ***=p<0.001; **=p<0.01; *=p<0.05. kgf= kilogram force 
 
 





Supplemental Figure 3 - Rotarod performance is ameliorated upon genetic 
reduction of Fbxo32 in endophilin mutants. (A) Fall latency from the fixed speed 
RotaRod and (B) accelerated Rotarod of Fbxo32 KO (black), Fbxo32 HT-endophilin 
1KO-2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light green) and 
Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in animals 
with WT Fbxo32 levels and the corresponding endophilin genotype (as reported in 
Figure 24) are shown as grey dashed bars for comparison. Graphs show mean±SEM. 
Significance by Tukey-corrected one-way ANOVA compared to the corresponding 










Supplemental Figure 4 - Maximal running speed of Fbxo32 deficient endophilin 
mutants. Average running speed of Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-
2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light green) and 
Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in animals 
with WT Fbxo32 levels and the corresponding endophilin genotype (as reported in 
Figure 25) are shown as grey dashed bars for comparison. Graphs show mean±SEM. 
Significance by Tukey-corrected one-way ANOVA compared to the corresponding 
endophilin mutant. ***=p<0.001; *=p<0.05. 
 
 




Supplemental Figure 5 - Fore limb gait rhythm is not affected in Fbxo32 deficient 
endophilin mutants. Gait timing parameters of Fbxo32 KO (black), Fbxo32 HT-
endophilin 1KO-2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light 
green) and Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in 
animals with WT Fbxo32 levels and the corresponding endophilin genotype (as 
reported in Figure 26) are shown as grey dashed bars for comparison. (A) Stance 
time = time the paw is in contact with the ground. (B) Swing time = time the paw is in 
the air. Running speed = 20 cm/s. Graphs show mean±SEM. No significance to the 
corresponding endophilin mutant was detected by Tukey-corrected one-way ANOVA 
compared.  
 




Supplemental Figure 6 - Fore limb stance rhythm tends to ameliorate in Fbxo32 
deficient endophilin mutants. Gait timing parameters of Fbxo32 KO (black), Fbxo32 
HT-endophilin 1KO-2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT 
(light green) and Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values 
measured in animals with WT Fbxo32 levels and the corresponding endophilin 
genotype (as reported in Figure 26) are shown as grey dashed bars for comparison. 
(A) Brake time = during stance, the time that the paw area is increasing. (B) Propel 
time = during stance, the time that the paw area is decreasing. Running speed = 20 
cm/s. Graphs show mean±SEM. Significance by Tukey-corrected one-way ANOVA 
compared to the corresponding endophilin mutant. **=p<0.01; *=p<0.05. 
 
 




Supplemental Figure 7 - Hind limb gait rhythm in Fbxo32 deficient endophilin 
mutants. Gait timing parameters of Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-
2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light green) and 
Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in animals 
with WT Fbxo32 levels and the corresponding endophilin genotype (as reported in 
Supplemental Figure 1) are shown as grey dashed bars for comparison. (A) Stance 
time = time the paw is in contact with the ground. (B) Swing time = time the paw is in 
the air. Running speed = 20 cm/s. Graphs show mean±SEM. Significance by Tukey-
corrected one-way ANOVA compared to the corresponding endophilin mutant. 
*=p<0.05. 
 




Supplemental Figure 8 - Hind limb stance rhythm in Fbxo32 deficient endophilin 
mutants. Gait timing parameters of Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-
2WT-3WT (dark green), Fbxo32 HT-endophilin 1KO-2HT-3WT (light green) and 
Fbxo32 HT-endophilin 1KO-2HT-3KO (blue) animals. Values measured in animals 
with WT Fbxo32 levels and the corresponding endophilin genotype (as reported in 
Supplemental Figure 1) are shown as grey dashed bars for comparison. (A) Brake 
time = during stance, the time that the paw area is increasing. (B) Propel time = during 
stance, the time that the paw area is decreasing. Running speed = 20 cm/s. Graphs 
show mean±SEM. Significance by Tukey-corrected one-way ANOVA compared to the 
corresponding endophilin mutant. *=p<0.05. 
 




Supplemental Figure 9 – Fbxo32 deficiency in endophilin mutants ameliorates 
the paw angle during running. Hind limb paw placement parameters at 20 cm/s for 
Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-2WT-3WT (dark green), Fbxo32 HT-
endophilin 1KO-2HT-3WT (light green) and Fbxo32 HT-endophilin 1KO-2HT-3KO 
(blue) animals. Values measured in animals with WT Fbxo32 levels and the 
corresponding endophilin genotype (as reported in Figure 27) are shown as grey 
dashed bars for comparison. (A) Paw angle = angle between the paw and the snout-
tail axis. (B) Paw angle variability = standard deviation of the paw angle. Graphs show 
mean±SEM. Significance by Tukey-corrected one-way ANOVA compared to the 
corresponding endophilin mutant. ***=p<0.001; *=p<0.05. 
 




Supplemental Figure 10 - Fbxo32 deficiency in endophilin mutants tends to 
ameliorate posture during running. Hind limb posture parameters at 20 cm/s for 
Fbxo32 KO (black), Fbxo32 HT-endophilin 1KO-2WT-3WT (dark green), Fbxo32 HT-
endophilin 1KO-2HT-3WT (light green) and Fbxo32 HT-endophilin 1KO-2HT-3KO 
(blue) animals. Values measured in animals with WT Fbxo32 levels and the 
corresponding endophilin genotype (as reported in Figure 27) are shown as grey 
dashed bars for comparison. (A) Paw placement positioning = extent of overlap 
between ipsilateral fore and hind paws during full stance. (B) Shared stance = time 
both hind limbs are in contact with the ground at the same time. Graphs show 
mean±SEM. Significance by Tukey-corrected one-way ANOVA compared to the 
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